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The gastrointestinal parasite of dogs and their related species, Toxocara canis, is a 
prime example of a zoonotic parasite. It is the principal agent of visceral larva migrans 
and also a cause of ocular larval migrans. As a result of the close association that dogs 
have with man, the parasite enjoys a world-wide distribution. Infections can be 
contracted from contaminated soil and handling of infected dogs, and is particularly 
prevalent amongst professions that have a close association with dogs, such as hydatid 
control officers in New Zealand. Once inside the non-canid host, the parasite enters a 
state of arrested development, in which it neither grows nor differentiates. In this state 
the parasite releases up to 1% of its body weight in excretory/secretory antigens per 
day. Assuming that this high protein production was in some way linked to immune 
evasion, a modest EST project was undertaken using a cDNA library generated from 
infective larvae. The hypothesis behind this approach was that the high protein output 
demonstrated by these parasites would be mirrored at the mRNA level. 
In total 266 clones were sequenced, the majority of which were from the both the 5' 
and 3' ends of the transcripts. Homologues for these genes were sought by similarity 
searching against the GenBank protein and the dbEST nucleotide databases. Cluster 
analysis of the clones identified 129 distinct gene products, all but three of which 
represented new genes. The majority of the genes (96) were represented by single 
clones, although 8 transcripts were present at high frequencies, each composing >2% 
of all the clones sequenced. These high abundance transcripts include a mucin and a 
novel C-type lectin, which together comprise the two major excretory/secretory 
antigens released by the parasite. 
Four highly expressed novel transcripts were found, termed ant genes (abundant novel 
transcripts). Together these genes represented 18% of all the cDNA clones isolated, 
but no similar sequences occur in the C. elegans genome. While the coding regions of 
these genes are dissimilar, they exhibit a remarkable level of similarity in their 3' UTR 
at the nucleotide level. The discovery of these abundant, parasite specific genes, of 
newly-identified lectins and mucins, as well as a range of conserved and novel 
proteins, provide defined candidates for future analysis of the molecular basis of 
immune evasion by Toxocara. 
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It has been over forty years since the syndrome of visceral larva migrans (VLM) was 
first described by Paul Beaver and colleagues in 1952 (Soulsby, 1993). This was to 
be the starting point which paved the way to the vast body of literature that has since 
appeared on many aspects of the parasite, including the periodicity and range of 
pathology caused by Toxocara species. 
1.0.1 Lifecycle of T. canis in the dog 
The ascarid gastrointestinal parasitic nematode of canids, Toxocara canis, was first 
described by Werner in 1782 (Morgan and Hawkins, 1953). Later, in 1905, Stiles 
began the taxonomic classification of the parasite (Yorke and Maplestone, 1926), but it 
was not until 1958 that the complete lifecycle was finally defined by Sprent (Gillespie, 
1987) (see fig 1 below). 
The life cycle of T. canis is typically complex of ascarid infections, involving both 
intermediate and paratenic hosts (Gillespie, 1987). Mature dogs become infected by 
predation of infected hosts, from contact with other infected dogs or from contact with a 
contaminated environment (fig 1). Once within the host the parasite undergoes a period 
of somatic migration following a defined route which includes passage through such 
organs as the lungs, liver and heart. A high infecting dose can result in increasing 
levels of mobidity and mortality to the host. This period of somatic migration 
culminates with the larvae reaching full patency in the gut of the canid. Once the 
parasite reaches adulthood the adult female is capable of producing up to 20,000 eggs 
per day, up to a period of 6 months. Although surrounded by a tough resilient coating 
the eggs are susceptible to desiccation, sunlight and temperatures below -15°C. The 
eggs are very long lived but require suitable conditions in terms of temperature and 
humidity before reaching complete development after a duration of 2-6 weeks. 
(Gillespie, 1988). 
Although not all the migrating larvae will go on to reach full patency, some will deviate 
from their migration and enter a state of arrested development within muscle and organs 
of the host. This state of arrested development not only provides a means for the 
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Figure 1.1. Diagramatic representation of the Toxocara canis lifecycle (Smyth, 1994). 
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parasites continued existence via predation of an infected host, but also a source of 
infection of subsequent generations through the bitch. Arrested larvae within the 
pregnant bitch can become activated upon receiving hormonal cues released during 
pregnancy. Once activated, the larvae undergo a period of somatic migration whereby 
the developing embryos become infected in utero, via the placenta. Puppies can also 
become infected via the transmammary route, resulting from the ingestion of larvae in 
the milk of the infected bitch. This two pronged attack in infection of the puppies is 
highly effective resulting in a 100% infection rate of the puppies. The bitch and 
puppies then enter a cycle of re-infection during weaning, via the faeces and vomitus. 
Infections can be eliminated with the use of anthelmintics (Gillespie, 1988). 
1.0.2 Lifecycle in humans 
The first incidence of T. canis in humans was diagnosed in a human eye in 1952 by 
Paul Beaver. Since that time, Toxocara infections have been found not only in the eye 
but in the brain, liver, lungs and to lesser extents in other regions of the body . It has 
always been very difficult to diagnose T. canis infections and as a result Toxocara 
related illness have often been misdiagnosed. The unnecessary enucleation of the eye 
due to the incorrect diagnosis of retinoblastoma, a type of cancer of the eye, led to 
increased awareness of this parasitic zoonosis. 
Human infections are mainly contracted by children resulting from the ingestion of 
contaminated soil (pica) (e.g. sandpits, gardens) (Dent et al., 1956), or from handling 
of infected dogs (Fig. 1). In this way other helminth eggs can be ingested, and 
infections contracted. Hence in some cases T. canis infection have often been 
associated with Trichuris and Ascaris infections. Although the main cause of VUVI is 
due to T. canis other ascarids are also known to cause this syndrome, such as 
Baylisascaris procyonis and to a lesser degree, Lagochilascaris minor and T. cati 
(Gillespie, 1988). 
The pathology associated with these zoonoses tends to arise from the aberrant migratory 
behaviour of the parasite brought on by the parasite being in the atypical host and 
therefore receiving inappropriate environmental cues. 
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1.0.3 Epidemiology of Toxocara infections 
Toxocara canis is regarded as one of the most widely distributed nematode parasites of 
mammals, sharing a high prevalence in taxa as dissimilar as the primates and cetaceans 
(Maizels and Robertson, 1991; Page et al., 1991). The domestic dog represents a large 
reservoir of T. canis throughout the world. In 1993 it was reported that there were 
approximately 55 million dogs residing in 40% of households in the US, and 7.4 
million in 26% of households in the UK (Glickman, 1993). Comparable rates of dog 
ownership were also reported for other developed countries, including France, 
Germany and Japan. Published data indicates that of 42,000 dogs 15% are infected 
with the parasite. These figures would be higher in underdeveloped countries. Uga et 
at (Uga et al., 1996) showed that the incidence of environmental contamination with 
Toxocara eggs was in the region of 13 - 69% dependant on the district. The reason 
attributable for the differences was thought due to the fact that there were fewer places 
for animals to defecate, particularly with reference to the defecation habits of cats (Uga 
et al., 1996). 
1.0.4 Toxocariasis 
Most of the existing data on toxocariasis is focused on T. canis, primarily because of 
the close association shared between humans and dogs; this makes the probability of 
transmission to humans a very real risk. Although cats also share a close bonds with 
humans, the incidences of T. cati infections are far less frequent. 
Human infections with Toxocara can lead to a variety of syndromes which collectively 
are referred to as Toxocariasis. The pathological syndromes are dependant on the level 
and frequency of the infecting dose. Most of the pathologies associated with Toxocara 
infections result from the particular tropism the parasites appear to have for 
neurological and ocular tissue. 
There are a number of syndrome associated with Toxocara the best characterised of 
which are, ocular larva migrans (OLM) or ocular toxocariasis (OT) and visceral larval 
migrans (VLM), There is also a third form of the disease known as covert toxocariasis. 
All of these result from the prolonged migration of the parasite within the host. It is 
generally accepted that the syndromes of VLM and OLM are caused by a large 
infecting dose or a small infecting dose respectively. The pathology resulting from the 
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two syndromes is very different, and results primarily from the infecting dose as 
opposed to the response of the host immune system. However, it is possible for OLM 
to occur in conjunction with VLM where the infecting dose is high. 
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Figure 1.2. Schematic highlighting the epidemiological features associated with toxocariasis. The 
schematic also highlight potential routes by which preventative measures could be implemented in 
order to reduce the impact on humans. 
The syndrome of VLM is associated with the migration of larvae within the host. 
Generally these infections are associated with children, particularly those between the 
ages of 2 - 7 years where there is a history of contact with dogs and pica (Glickman, 
1993). Although adults, particularly those with a close association with dogs 
professionally (veterinarians and dog breeders) have shown signs of infection. One 
study showed that 15.7% of dog breeders in a kennel were seropositive for Toxocara. 
A similar study based around hydatid disease control officers in New Zealand showed 
that 25.6% were seropositive compared to 3.3% of the control population (Gillespie, 
1988). The resultant clinical signs of VLM are directly linked with the level of the 
infecting dose and also the level of exposure. Symptoms associated with VLM are 
abdominal pain, fever, coughing wheezing and asthma (Glickman, 1993). Treatment of 
VLM involves antihistamines, corticosteroids and bronchodilators. Although effective 
in the treatment of dogs the use of anthelmintics in humans is somewhat controversial 
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OLM results from as little as one migrating larva into the region of the eye. The 
resulting eosinophilc inflammation can lead to damage to the retina or optic nerve. In 
severe cases this aggressive eosinophilc recruitment leads to partial or full loss of 
sight. It is often the case that partial sight loss often goes undetected until discovered 
through a routine medical examination. If the sight of the inflammation is not in an 
essential area and the level of inflammation is mild then visual defects may go 
undetected (Gillespie, 1988; Glickman, 1993). Although an infection of both children 
and adults it was found that OLM tended to occur more in adults than in children and is 
also more common in males (2:1)(van Knapen and Buijs, 1993). Treatment of OLM is 
similar to that of VLM (Glickman, 1993). 
The third classification of toxocariaisis has less obvious clinical symptoms which 
include coughing, headaches and behavioural disturbances. This syndrome is termed 
covert toxocariasis (CT) due to the fact that the symptoms presented tend to be 
common, non-specific complaints (Taylor, 1993). Although it has been suggested that 
this syndrome is in fact the more common of the characterised syndromes associated 
with toxocariasis (Taylor, 1993). Serological studies revealed a statistically valid link 
between high serum antibody titres to T. canis and one or more of the associated 
symptoms (Glickman, 1993). 
A number of other syndromes have been linked with Toxocara infections of which 
include epilepsy, asthma and neurological deficits. Although there has been conflicting 
evidence for the link between asthma and epilepsy (Glickman, 1993). 
1.0.5 Ultrastructure of the nematode cuticle 
T. canis belongs to the phylum Nematoda, one of the most abundant groups of animals 
on the earth, second only to the insects. Both these groups owe much of their success 
to the possession of a resilient extracellular layer, termed the cuticle (Page, 1991a). 
Much of the understanding of the nematode cuticle has come about from research on the 
well characterised free-living nematode Caenorhabditis elegans (Blaxter and Robertson, 
1998). The lack of a suitable parasitic nematode model species has meant that to date 
the knowledge obtained about nematode cuticles, in fact nematodes as a whole, is 
primarily from C. elegans with a small proportion of the information obtained from 
studies on adenophorean nematodes and plant parasites (Blaxter and Robertson, 1998). 
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The cuticle of T. canis is completely surrounded by a 10-20 nm electron dense layer that 
lies 10 nm distal to the epicuticular surface. This structure, termed the surface coat or 
glycocalyx is a negatively charged structure that binds the compounds ruthenium red, 
cationised ferritin (Himmelhoch et al., 1977; Himmeihoch and Zuckerman, 1983; 
Jansson et al., 1986; Page et al., 1992a; Zuckerman et al., 1979) and wheat germ 
agglutinin (WGA) (Page et al., 1992d). The surface coat has been implicated in the 
evasion of the host immune mechanisms (Badley et al., 1987; Page et al., 1992c). 
Figure 1.3 shows an oblique freeze fracture section through a T. canis larva. The 
figure shows the internal surface of the surface coat with the invaginations of this 
structure into the troughs of the cuticle. This demonstrates the complete coverage of the 
parasite effected by this structure. 
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Figure 1.3 Electron micrograph showing an oblique freeze fracture section through the surface of an 
infective T. canis larva. From the figure the internal layer of the surface coat can be seen as well as the 
invaginations into the grooves of the epicuticle. 
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1.0.6 Toxcara canis excretory/secretory (TES) antigens 
TES 70 
Preliminary protein 1 
sequence shows similarity 
to TES 32 
TFSSS 
Preliminary protein sequence 
shows similarity to TES 32 
TES 32 
C-type lectin 
(Loukas eta! submitted) 
- TES 400 
Proteoglycan; little 
TES 120 
Components of surface coat 
heavily O-glycosylated 




binding protein (Gems et ad., 
1995) 
Figure 1.4 Antigen profile of T. canis TES. Information relating to the previously characterised bands 
is indicated. 
The importance of TES products in Toxocara was first documented by de Savigny in 
1975 (de Savigny, 1975). In his report he stated that T. canis infective larvae cultured 
in serum -free medium remained metabolically active for a period of many months. 
During this time the parasite was shown to produce copious quantities of proteins 
which proved to be immunologically reactive in serodiagnostic assays. 	This 
observation proved to be a milestone in terms of the immunological studies of 
Toxocara and other nematodes. 
The vast majority of helniinth species secrete varying quantities of what basically 
amounts to a cocktail of proteins. The components of these parasite cocktails have 
been investigated as potential targets of the immune response and also for their ability 
to interfere with host immunity (Maizels et al., 1993). 
There are seven major bands in T. canis excretory/secretory (TES) antigen that have 
been characterised to varying degrees. Both TES 26 and TES 120 (Figure 1.4) were 
first obtained as part of a nematode spliced leader PCR using cDNA prepared from the 
infective larvae (Gems et al., 1995). TES 26 was shown to be a member of a family of 
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genes some of which bound the lipid phosphatidylethanolamine with a high degree of 
specificity. TES 120 was shown to be hyperabundant at the mRNA level (Gems et al., 
1995) and from previous experiments to be an abundant component of the parasite 
surface coat by a combination of techniques which included surface iodination and 
electron microscopy (Gems and Maizels, 1996). Gel profiles of TES 120 showed it to 
migrate as multiple bands (Figure 1.4). Further characterisation of this molecule 
showed it to be a heavily O-glycosylated mucin-like protein. Recently, a number of 
clones were isolated from a T. canis expressed sequence tag (EST) project, 
characterisation of which has shown that they form part of a putative family of mucins 
(Tetteh et al, manuscript submitted) (Loukas et al, manuscript in preparation). At 
present five mucin genes have been identified and designated MUC-1 to -5 (see 
Chapters 3 and 5). 
TES 32 is an N-linked glycoprotein found in the excretory/secretory antigen as well as 
being a component of the parasite surface associated with the cuticle beneath the 
surface coat. This antigen also represent the major TES product secreted by cultured 
infective larvae (Gems and Maizels, 1996; Page and Maizels, 1992). Sequence 
relating to TES 32 was isolated from the T. canis EST project (Tetteh et al manuscript 
submitted) and latter shown to belong to a novel family of calcium dependent lectins 
described as the C-type lectins or CTLs (Loukas et al manuscript submitted). The key 
feature of C-type lectins is the presence of a carbohydrate recognition domain (CRD). 
This group can be classified into two groups depending on the sugars they bind. 
Those that bind galactose and its derivatives (Gal-type) and those that bind mannose, 
glucose and their derivatives (Man-type). To date the TES 32 C-type lectin, Tc-al-1, 
is unique in its ability to bind both GalNac and D-mannose (Loukas et al manuscript 
submitted). 
Of the remaining five antigens no information presently exists for TES 45 and the only 
information ascertained so far for TES 400 is that it is a heavily glycosylated molecule 
with a small peptide backbone. This leads to the conclusion that TES 400 may be a 
proteoglycan (Meghji and Maizels, 1986). Both TES 55 and TES 70 have shown at 
the sequence level to bear similarity to TES 32, the novel C-type lectin (Loukas et al 
manuscript submitted). 
The significance of investigating the excretory/secretory material of nematode species 
is supported by the success obtained by a number of groups. The acetyicholinesterase 
from a number of nematode systems have been investigated by many groups as a 
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1991); two putatively protective excretory-secretory (ES) antigens were isolated from 
the nematode parasite of ruminants, Haemonchus contortus (Schallig et al., 1997). 
Initial studies with these low molecular weight products afforded a significant degree 
of protection against H. contortus in sheep (Schallig and van Leeuwen, 1997). 
1.0.7 Proteases 
Cysteine peptidases can be classified into 35 families (Barrett and Rawlings, 1996). 
Barrett and Rawlings (Barrett and Rawlings, 1996) arranged these 35 families into five 
clans each of which was thought to have originated from separate evolutionary 
origins. The clans were designated CA, CB, CC, CD and CE of which clan CA was 
the largest and also contained the papain (Cl) family of peptidases (Barrett and 
Rawlings, 1996) (see Table 1). 
Proteolytic enzymes have long attracted the interest of investigators in terms of their 
possible applications as tools in protein sequence analysis (Abe et al., 1993) and their 
ability to regulate a variety of biological processes, and subsequently their potential as 
therapeutic targets (Barrett and Rawlings, 1996). Proteases, in particular cysteine 
peptidases, are present in virtually all living organisms from DNA and RNA viruses to 
mammalian systems (Barrett and Rawlings, 1996). The cysteine peptidase group of 
enzymes represents a large group classified into 35 families, of which the papain sub-
group is the largest. Papain was also the first cysteine protease to be identified (Light 
et al 1964), and represents the achetypical cysteine protease. Of the cysteine 
peptidases identified to date, the majority are classed as endopeptidases with some 
acting additionally or exclusively as exopeptidases (Barrett and Rawlings, 1996). 
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Table 1.1 
CLAN 	FAMILY NAME EC - 
CA Cl Papain 3.4.22.2 
Chymopapain 3.4.22.6 
Caricain 3.4.22.30 
Glycyl endopeptidase 3.4.22.25 








Decapod digestive endopeptidase - 
Cathepsin L 3.4.22.27 
Fasciola cysteine peptidase - 
Cathepsin S 3.4.22.27 
Cathepsin 0 - 
Cathepsin K 3.4.22.38 
Cathepsin H 3.4.22.16 
Aleurian - 
Histolysain 3.4.22.35 
Nematode cysteine endopeptidase - 
Cathepsin B 3.4.22.1 
Schistosotna cathepsin B - 
Dipetidylpeptidase I 3.4.14.1 
House dust mite cysteine endopeptidase - 
Cruzain - 
Leishinainia cysteine endopeptidase - 
Plasmodium cysteine endopeptidase - 
Theileria cysteine endopeptidase - 
Dictyostelium cysteine endopeptidase - 
Baculovirus cysteine endopeptidase - 
Yeast bleomycin hydrolase - 
Lactococcus PepC - 
Streptococcus aminopeptidase - 
Porphyromonas tpr proteinsase - 
C2 it-Calpain 3.4.22.17 
m-Calpain 3.4.22.17 
Drosophila sol protein - 
CIO Streptococcus streptopain 3.4.22.10 
Porphyromonas streptopain - 
CB 	C3 Polio picornavirus piconain 3C 	 3.4.22.28 
Polio piconavirus picornain 2A 3.4.22.29 
Cowpea mosaic comovirus 24 kDa endopeptidase 	 - 
Grapevine fanleaf nepovirus endopeptidase 	 - 
Hepatitis A virus picornain 3C 	 - 
C4 Tobacco etch potyvirus Lla proteinase 	 - 
C24 Feline calicivirus 2C endopeptidase - 
C30 Murine hepatitis coronavirus p80 endopeptidase 	 - 
C37 Southhampton virus endopeptidase 	 - 
C38 Parsnip yellow fleck virus endopptidase 	 - 
W. 
Table I. I. (continued) 
CLAN FAMILY NAME 	 EC 
cc 	C6 Tobacco etch potyvirus helper component proteinase 	 - 
C7 Chestnut blight fungus virus p29 endopeptidase 	 - 
C9 Sindbis togavirus nsP2 proteinase 	 - 
C16 Mouse hepatitis coronavirus papain-like endopeptidase 1 	- 
C21 Tymovirus endopeptidase 	 - 
C23 Blueberry scorch carlavirus endopeptidase 	 - 
C27 Rubella rubivirus putative endopeptidase - 
C28 Foot-and-mouth disease virus leader proteinase 	 - 
C29 Murine hepatitis coronavirus papain-like endopeptidase 2 	- 
C31 Porcine respiratory and reproductive syndrome 	arterivirus 	- 
PCP a endopeptidase 
Equine arterivirus PCP a endopeptidase 	 - 
C32 Equine arterivirus PCP 13 endopeptidase - 
C33 Equine arterivirus Nsp2 endopeptidase 	 - 
C34 Apple chiorotic leaf spot closterovirus putative papain-like 	- 
endopeptidase 
C35 Apple 	stem 	grooving 	capillovirus 	putative 	papain-like 	- 
endopeptidase 
C36 Beet 	necrotic 	yellow 	vein 	furovirus 	putative 	papain-like 	- 
endopeptidase 
CD 	C 14 	Interleukin- 113-converting enzyme 	 3.4.22.36 
CED3 protein 	 - 
Apopain 	 - 
CE 	C5 Adenovirus endopeptidase 	 - 
- Cli Clostropain 	 3.4.22.8 
- 	C12 Ubiquitin C-terminal hydrolase PGP 9.5 	 - 
Ubiquitin conjugate hydrolase YUH1 - 
Ubiquitin conjugate hydrolase L3 	 - 
- 	C13 Schistosoma haemoglobinase - 
a-legumain 	 - 
13-legumain 3.4.22.34 
- 	C15 Pyroglutamylpeptidase I 	 3.4.19.3 
- Cl 9 Isopeptidase T 	 - 
Ubpl ubiquitin peptidase 	 - 
Ubp2 ubiquitin peptidase - 
Ubp3 ubiquitin peptidase 	 - 
lJbp4 ubiquitin peptidase - 
Doa4 ubiquitin peptidase 	 - 
UbpS ubiquitin peptidase - 
- 	C22 Trichomonas cysteine proteinase 	 - 
- C25 Gingipain R 	 3.4.22.37 
Tablel 1.1 Shows the characterisation of the cysteine peptidases into clans and families as 
demonstrated by Barret and Rawlings (Barrett and Rawlings, 1996). The table was originally 
composed based on the comparison of available amino acids and is arranged in terms of common 
ancestory. 
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The biomedical importance of these enzymes is undisputed. Cysteine peptidases are 
thought to be involved in the pathophysiology of mammals, including man; in both 
bacterial and parasitic pathogens, in the physiology and pathology of plants and are 
also involved in the replication of viruses (Barrett and Rawlings, 1996). 
Cysteine peptidases are so defined when the thiol group acts as the nucleophile in 
enzymatic reactions (Barrett and Rawlings, 1996). To date the activity of cysteine 
peptidases is thought to rest on that of a catalyitc triad of amino acids at the reactive 
site, with the second member, histidine, serving as a general base. The arrangement 
of the cysteine and histidine within the triad (Cys/His, His and Cys) in the linear 
sequence is taken as evidence that the cysteine peptidases may have been derived from 
many evolutionary origins (Barrett and Rawlings, 1996). 
Proteases are utilised by parasitic worms for a range of functions. These include, 
among other things, hydrolysis of haemoglobin and manipulation of the host immune 
response (such as cleavage of immunoglobulin and complement components) (Dowd 
et al., 1994). Figure 1.5 shows a diagrammatic representation of the interaction 
between a cathepsin L peptidase and it's substrate (Dalton et al., 1995a). 
Peptidases have been reported from many helminths including Haemonchus contortus 
(Gamble et al., 1996; Karanu et al., 1993; Rhoads and Fetterer, 1995), Schistosoma 
mansoni (Ghendler et al., 1996), Brugia pahangi (Hong et al., 1993), Toxocara canis 
(Robertson et al., 1989) and Ancylostoma caninum (Dowd et al., 1994; Hotez and 
Cerami, 1983). 
Identification and localisation of proteases could enable immunological and 
chemotherapeutical strategies to be employed against the parasite (Gamble et al., 1996; 
Wasilewski et al., 1996). The identification of such functionally important proteases 
in T. canis would further expand the usefulness of this parasite as a model system by 
which to study parasite survival in the host. 
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S, subsite 	 S1 subsite 
Schistosomecathepsin L 
Figure 1.5 Schematic representation highlighting the key interactions between a cathepsin L 
peptidase - in this example the S. mansoni cathepsin L - and it's substrate. The amino acids of the S1 
subsite of the cathepsin L peptidase (indicated in figure) interact with the P1 residue situated on the N-
terminal side of the scissle peptide bond and are involved in the catalytic cleavage of the bond 
(indicated by arrow). The interactions between the amino acids of the enzyme S2 subsite and the 
residue at the P., position (in this example, Phenylalanine) of the substrate determine the specificity of 
the cysteine peptidases. In this diagrammatic example the cathepsin L-like proteinases have a 
preference for hydrophobic residues, such as the phenylalanine at position P2. 
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1.0.8 Mucins 
Mucus glycoproteins or mucins are a family of heavily glycosylated, high molecular 
weight proteins (400 to> 1000 kDa) found on the surface of a variety of epithelial cells 
(Devine and McKenzie, 1992; Kim et al., 1996). Many of these include mammary 
glands, digestive tract, kidney and testes (Devine and McKenzie, 1992). Mucins can 
be broadly divided into two groups, those that are membrane associated and those that 
are secreted. The secreted forms can be further subdivided into those likely to form 
gels and the nature of the gel formed (Kim et al., 1996). 
The structure of mucins consists of a non-globular protein backbone, with 
carbohydrate side chains of varying lengths, sequence, composition and anomeric 
linkages attached via many O-glycosidic linkages. A major feature of mucins is the 
presence of repeat peptide sequences, of different amino acid composition and length, 
flanked on either side by non-repetitive domains; these repeat domains have high 
levels of serine and/or threonine present, potential 0-glycosylation sites (Kim et al., 
1996). The core proteins of mucins are composed of high levels of serine, threonine, 
alanine, proline and glycine with low amounts of aromatic and sulphur containing 
amino acids (Devine and McKenzie, 1992; Kim et al., 1996). The glycosylation of 
mucins accounts for 50 - 85% of the total molecular weight of mucins giving them a 
much higher buoyant density than non-glycosylated proteins. This high level of 
glycoslation differs between species, for example, whereas human mucins are highly 
glycosylated, mucins from sheep possess one carbohydrate molecules per mucin 
(Devine and McKenzie, 1992). 
hg et at (1996) purified a secreted filamentous mucin-like proteophosphoglycan from 
the protozoan parasite Leishmania major. 	The secretion of novel, complex 
glycoconjugates is thought to be important in the survival and development of the 
parasite within the sandfly vector and its mammalian host (hg et al., 1996; McConville 
and Bacic, 1990) 
1.0.9 Diagnosis of Toxocara canis 
The initial attempts at diagnosis of Toxocara infections was based predominately on 
assays that detected Toxocara antibodies. Before that, diagnosis was based on 
morphological identification carried out on specimens obtained by biopsy or from 
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necropsy (Nichols, 1956). Apart from the technical difficulty involved, classification 
of the isolated organisms also proved to be a problem. Such as the accurate 
determination of the parasites genus. The problem with the majority of the techniques 
employed was that they lacked specificity; failing to distinguish toxocaral infections 
from those of ascariasis, filariasis and trichinellosis. Among the tools employed in the 
diagnosis of VLM infections were the skin sensitivity test, where reactions to Toxocara 
antigens were observed e.g. larval precipitation, complement fixation and 
immunofluorescent testing (van Knapen and Buijs, 1993). To compound the 
problems already plaguing these techniques false positive results were arising from 
crossreactivity between the antigens beings used and the heterophile antibodies or 
isohaemaglutinins (Cypess et al., 1977). Often the antigens used in these earlier 
assays were derived from adult material, a stage of the parasite not present in humans 
as the parasite does not develop beyond the infective larvae. 
de Savigny (1975) described the successful culturing of the infective larva of Toxocara 
canis. While in culture the parasites remained in a developmentally arrested yet 
metabolically active state releasing approximately 1% of the body weight in excretory-
secretory antigen (TES) per day (Meghji and Maizels, 1986). These antigens are 
composed of material found in the cuticle and also a fuzzy outermost layer of the 
parasite termed the surface coat (Page et al., 1992a; Page et al., 1992b). These 
antigens used in conjunction with an enzyme linked immunosorbent assay (ELISA) 
(van Knapen and Buijs, 1993) and also immunofluoresence (Gillespie et al., 1993) 
provided investigators with suitable diagnostic tools in the diagnosis of toxocaral 
infections. The first assay system which later became commercially available was 
based on the detection of human anti-Toxocara antibodies (Jacquier et al., 1991). 
Gillespie et al later described an antigen capture method which detected repeat elements 
found the TES antigens of T. canis (Gillespie et al., 1993). 
Despite the fact that an ELISA kit has been established since 1991 (Jacquier et al., 
1991), the system is still not ideal in that it cannot distinguish between active infections 
and dormant infections (Gillespie et al., 1993). The problems of species cross-
reactivity still appear to be evident (Gillespie et al., 1993; Lynch et al., 1988). So it 
would appear that the search is still on for a Toxocara specific diagnostic antigen. In a 
report by Loukas et al., (1998) the identification of a cathepsin L-like cysteine protease 
was described. In a preliminary experiment using a bank of human serum, patients 
previously exposed to T. canis recognised the cathepsin whereas the control sera did 
not. Further experiments are presently underway to investigate the likelihood of rTc- 
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cpl-1 being an effective diagnostic antigen for the diagnosis of human toxocariasis 
(Loukas et al., 1998). 
1.0.10 Arrested larval Development 
The phenomenon of arrested development, also refered to as hypobiosis, is an 
evolutionary adaptation designed to protect the organism from harsh, less favourable 
times. In such situations the larvae arrest their developmental cycle for a period of 
several months to years. In some species hyperbiotic rates of up to 100% were 
observed. In such cases it is thought unlikely that environmental cues alone could be 
responsible. Jacquiet et al (1996) hypothesise that factors in the parasite were 
genetically predetermined to promote the onset of hypobiosis (Jacquiet et al., 1996). 
Although T. canis is a ubiquitous parasite, its level of incidence in humans both in 
developing and developed countries is minor (Page, 1991). The ability to collect the 
excretory/secretory antigens provides the investigator with the opportunity to investigate 
a biochemically conserved set of nematode antigens derived from an important parasite 
compartment. The state of arrested development of the larvae in vivo is mirrored in 
vitro, where larvae cultured in serum-free culture media are capable of surviving for in 
excess of 18 months (de Savigny, 1975). This may prove to be of value in the 
diagnosis or prophylaxis of a complicated zoonosis (Meghji and Maizels, 1986), 
providing information that could prove to be of value in the study of other less hardy 
parasite systems. T. canis larvae provide a unique opportunity to examine the release of 
antigenic molecules by a pathogenic organism (Maizels et al., 1987), primarily because 
they remain in this arrested state for many years, lying dormant in the musculature or 
the nervous system. In this state the parasite is developmentally and reproductivley 
arrested but is metabolically active releasing a steady 1% of its body weight in ES 
antigens per day (Gems and Maizels, 1996; Meghji and Maizels, 1986). 
The unique ability of T. canis to survive for extended periods in artificial culture media 
provides an excellent system by which to study many facets of the parasites biology. 
This includes the nature of the surface coat and the nature and function of the parasites 
antigens. 
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1.0.11 Immunomodulation of the host immune responses 
Helminthic parasites employ a variety of immune evasive strategies to be able to avoid 
the defensive measures generated by the host immune system (see section 1.0.5 and 
1.0.6) (Finkelman et al., 1991). 	The characteristics features associated with 
multicellular parasite infections are classically the induction of the Th2 immune 
response featuring production of IgE, eosinophilia and mastocytosis. Due to the 
persistant nature of T. canis infections the infective larvae elicit strong, persistant 
immune responses demonstrated in particular by 1gM, IgG and IgE antibodies to 
Toxocara excretory/secretory antigens (TES)(see section 1.0.6). Although it has 
recently been reported that it is now possible to distinguish, serologically, between the 
different syndromes presented during toxocaral infections (Obwaller et al., 1998) it 
still remains unanswered as to how exactly these responses are being induced and by 
what. In order to ba able to devise an approapriate chemotherapeutic strategy or 
vaccine approach a number of fundamental questions must be tackled. 
Diagnosis: Although constantly improving, existing methods remain 
unsatisfactory, particularly in terms of sensitivity and treatment surveilance 
(Zhong-Jin et al., 1999). 
Immunopathology: A large proportion of the pathology associated with T. 
canis is associated with immune-mediated inflammatory responses. Although 
there is some evidence that some damage arises from migrating larvae (Smith, 
1991). It has also been suggested (Obwaller et al., 1998) that the pathology 
seen in T. canis infections is the result of an inappropriate immune response by 
the host, in terms of parasite clearance or hypersensitivity (see section 1.0.4). 
This point is of particular interest as it could be a deliberate strategy by the 
invading parasites to misdirect the host immune response 
Parasite survivallpersistance within the host. 
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1.2.1 Aims of project 
Toxocara serves well as a model system by which to study some of the many facets of 
parasitic nematode biology. The longevity exhibited by the parasites in culture together 
with the vast amount of excreted antigen released by the parasite enables investigators 
to study an important parasite compartment. It also allows investigators to characterise 
a biochemically conserved set of nematode antigens derived from an important parasite 
of some medical concern. 
At the outset of the project it was proposed that the purpose of this proposal was to 
provide information that would serve to expand existing knowledge about the parasite 
as a whole. The purpose of this was to obtain data that could be applied to the 
treatment and/or control of Toxocariasis and also applied to the treatment and control of 
other more important zoonoses of medical concern. 
To tackle the task ahead it was determined that in order to achieve the somewhat 
ambitious goals of the project the most significant approach would be the initiation of 
an expressed sequence tag (EST) project (Chapter 3). The significance of this 
approach was that since the parasite stage being investigated was developmentally 
arrested, reproductively immature yet metabolically active, the focus of its energies 
would be directed solely at being able to survive the malign environment of the host 
immune system. 
By these criteria the goals of the project have been met. 
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2.0 Materials and Methods 
2.0.1. Collection and culture of T. canis adults. 
Adult parasites were collected from The Royal Veterinary College, Potters Bars, North 
London from postmortemed dogs suspected of having a Toxocara canis infection. The 
gut of the dog was removed and washed over a sieve using warm physiological saline. 
After being washed free of mucous and other debris the worms were subjected to an 
extensive washing protocol comprised of 5 washes in physiological saline followed by 
5 washes in supplemented RPMI (see appendix) to remove as much of the 
contaminating material as possible. The parasites were left in supplemented RPMI for 
approximately 5 hours at room temperature (r.t.) before being washed a further 5 times 
in supplemented RPMI. Adult worms were cultured in 150 cm2 vented culture flasks 
(Coming Costar) at 37°C and under 5% CO2. The worms were maintained in this state 
for approximately 7 days; significant deterioration was observed after this period. The 
mediui* was changed on a daily basis to collect the adult excretory/secretory (ES) 
material and to harvest the eggs. After the 7 days the worms were washed free of 
RPMI and the males stored at -70°C. The females were stored in a 5% formalin 
solution at room temperature to encourage further embryonation of eggs before 
subsequent bifurcation of the adults. 
2.0.2. In vitro culture of T. canis larvae 
Infective larvae were hatched from embryonated ova obtained from adult female 
worms as described above, and more recently from the Center for Parasitology, The 
University of Texas. Hatching was performed following a modification of techniques 
described in de Savigny (1975), Oaks and Kayes (1979), Smith (1989) and Maizels 
(1984). Culturing was performed following a modification of the Oaks and Kayes 
(1979) protocol. Briefly, embryonated ova were aliquoted into siliconised 50 ml 
centrifuge tubes and washed free of formalin with sterile water by centrifuging at 
1000g for 5 mins. The pellet was then resuspended to a 10% v/v suspension in sodium 
hypochlorite and incubated for 10 minutes at 37°C, or until the tough pitted outer shell 
had been dissolved. During the incubation period the tube was agitated at regular 
intervals to disperse the ova and prevent the build up of froth formed from the 
dissolved egg shell proteins. A Swinnex 47 filter unit (Millipore) was assembled with 
a 10 jim nylon filter and supported in a clamp stand above a large beaker. The banel of 
a 50 ml syringe was attached to the top of the filter unit to function as a funnel. On 
completion of the incubation period the egg suspension was immediately passed 
through the Swinnex unit, followed by approximately 500 mls of sterile water. On 
completion the unit was reversed and the syringe barrel re-attached to the upturned 
unit. Supplemented RPMI was the forced through the filter unit using the attached 
syringe to flush the eggs of the filter membrane. Eggs were collected in a 50 ml 
siliconised centrifuge tube; a steady stream of CO2 was bubbled through the 
suspension for 4-5 mins to initiate the hatching of the larvae. The suspension was then 
aliquoted into a modified Baermann apparatus (see below) and incubated overnight at 
37°C, 5% CO2. The hatched larvae were collected over a period of several days as 
they emerged, and were cultured in 25 cm  vent cap culture flasks at a density of 
25,000 - 35, 000 larvae per 10 mls of supplemented RPMI at 37°C, 5% CO2. The 
culture supernatent from the larvae was replaced once a week with fresh media; the 
culture supernatant was centrifuged at 1500 g for 10 min and stored at -80°C. 
2.0.3 Construction of Baermann apparatus 
The construction of the Baermann apparatus was performed following a modification 
of the method outlined in Oaks (1979). Essentially, the elongated tip of a Pasteur 
pipette was snapped off and flame polished to remove any sharp edges. The pipettes 
were then siliconised in dimethlydichlorosilane (DMCS) solution, followed by 
extensive washes, once with 70% alcohol, followed by two with water then completed 
with a final wash of 70% alcohol . The dried pipettes were loosely plugged with 
cotton wool (approximately 1 inch) and autoclaved before use. 
2.0.4 Preparation of larval T. canis excretory/secretory (TES) products 
Approximately 2 litres of culture supernatent was thawed from -70°C storage and 
concentrated under a nitrogen induced pressure of 30 lbs/in2 over a 10,000 molecular 
weight cut-off membrane using an Amicon ultraconcentration unit. The concentrated 
TES material was washed with two volumes of sterile phosphate buffered saline 
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(PBS), and concentrated to a final volume of 3 mls; storage was in 0.5 ml aliquots at - 
70°C. 
2.0.5 1251  labelling of soluble proteins 
TES products (10 jig) were labelled as described in (Maizels et al., 1991). The 
labelled protein were loaded onto a G-25 column (Pharmacia) and washed with 5 mIs 
of PBS, and a succession of 250 Al aliquots collected. 1 Al of each tube was tested for 
total activity and percentage tricholoacetic acid (TCA) precipitability. The fractions with 
>80% TCA precipitated radioactivity (usually the first peak) were retained. The 
labelled aliquots were stored at -20°C. 
2.0.6 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS PAGE) 
Preparation of the separating portion of the gel was performed following the details 
outlined below: 
Separating gel: (- 20mls) 
7.5% 	10% 	12% 	15% 
Acrylamide/BIS 
39: 0.5 (40% stock) 






3.75 ml 5.0 ml 6 ml 7.5 ml 
5.0 ml 5.0 ml 5.0 ml 5.0 ml 
200 Al 200 Al 200 Al 200 Al 
11.0 ml 9.7 ml 8.7m1 7.2m1 
100 Al 100 Al 100 Al lOOjil 
8 A 8 A 8 A 8 A 
The water, Tris, acrylamide and sodium dodecyl sulphate (SDS) were properly mixed 
together, before addition of the ammonium persuiphate (APS) and the TEMED. 
The Stacking portion of the gel was followed as outlined overleaf: 
Stacking fiel (5%: (— 10 ml 
Acrylamide/BIS 39: 0.5 (40% stock) 1.25 ml 
1.0 M Tris Base pH 6.8 1.25 ml 
Distilled Water 7.45 ml 
10%SDS 100ul 
10% APS 50 ,al 
TEMED 10,ul 
2.0.7 5 = 25% SDS-PAGE Gradient gels 
The SDS PAGE gradient gels were set up using the Hoeffer SE 600 gel system. The 
gel components were prepared as outlined in (Maizels lab manual). Essentially the gels 
were prepared as detailed below: 




4.2 ml Acrylamide 
	
21 ml Acrylamide 
4.2 ml Solution M* 4.2 ml Solution M* 
25.2 ml Distilled water 
	
8.4 ml Distilled water 
10 jil TEMED 
	
10 [d TEMED 
150 Al APS 100p1 APS 
* solution M - see appendix 
The stacking portion of the gel was prepared as outlined below: 
Stack: 20 ml 
2.5 ml Acrylamide 
2.5 ml Solution S* 
15 ml Distilled water 
10 til TEMED 
200 IL' APS 
* solution S - see appendix 
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2.0.8 RNA preparation 
RNA was extracted from 40,000 T. canis infective larva using the TRISOLVTM  RNA 
isolation reagent (Gibco BRL). The procedure was outlined in the protocol (as 
supplied with reagent) but essentially the 40,000 infective larva were homogenised in 
100 /Ll of the TRISOLVTM  reagent using a microhomogeniser (Biomedix). The volume 
of the homogenate was increased to 1 ml with the TRISOLV reagent and incubated at 
room temperature for 5 minutes before proceeding with the extraction. On completion 
of the extraction, the RNA was resuspended in 100 l water to which was added 100 
mM EDTA, pH 8.0. Due to the instability of the RNA, 10l of 3M sodium acetate 
(pH 7) and 250 itl of 100% ethanol was added and the tube stored at -70°C. 
2.0.9 Construction of T. canis infective larva cDNA library 
The infective larva cDNA library was a kind gift from Cindy Tripp and Robert Grieve 
(Heska, Fort Collins). The library had been constructed from 200,000 T. canis 
infective larvae following a single step guanadine-phenol-chloroform extraction 
protocol. cDNA synthesised from the mRNA obtained was unidirectionally cloned 
into the Uni-Zap XR phage vector (Stratagene), using packaging extracts from 
Stratagene. 	The amplified 	library contained 1.9x109 phage/ml with 91% 
recombinants. The possibility of host contamination was essentially eliminated 
because eggs were first incubated in vitro in formalin, and subsequently larvae 
collected through Baermann filters were cultured in serum-free RPMI 1640 medium 
for extended periods. 
2.0. 10 Picking of individual clones 
Single clones were identified as serendipitously picked phage from the plated library. 
The methodology used was that outlined in the Stratagene protocol. Essentially, 1 l 
of serially diluted cDNA library was incubated with 200 ItI of XL 1-Blue E. coli for 15 
inins at 37°C. The cells were then mixed with 3 mIs Lauria-Burtani (LB -see appendix) 
top agar (48°C), poured onto previously prepared 82 mm agar plates supplemented 
with tetracycline (12.5 jig/ml) and allowed to set. The plates were then incubated at 
37°C overnight. Single plaques were cored out from semi-confluent plates using 
sterile Pasteur pipettes and the agar plug ejected into 1.5 ml centrifuge tubes containing 
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500 Al of SM buffer, with 20 l chloroform as a preservative. The cored plaques were 
briefly vortexed and left at 4°C overnight (o/n) to allow the phage to elute from the agar 
plug. 
2.0.11 Excision of phage insert 
The methodology for this procedure was as described in the Stratagene cDNA 
synthesis kit (Stratagene) manual. SOLR and XL1-Blue bacteria were streaked out 
onto kanamycin and tetracyline plates, respectively, from frozen stocks and incubated 
at 37°C o/n. The following day single colonies were picked from each plate and used 
to inoculate 10 mls of LB broth containing the appropriate antibiotic and this was 
allowed to grow 0/n at 37°C in a shaking incubator. A 0.5 ml aliquot was taken from 
each culture and used to inoculate 50 mls of LB-kan (SOLR) and LB-tet (XL 1-Blue) 
broth in conical flasks. The flask were then incubated at 37°C in a shaking incubator 
until mid log phase (OD600  of 0.2 - 0.5; approximately 3 hours. XL1-Blue bacteria 
were centrifuged and resuspended in 10 mM Mg504 to an OD of 1.0; the SOLR 
bacteria were allowed to continue growth at room temperature (rt) or stored at 4°C o/n. 
Aliquots of 200 Al of the XL 1-Blue bacteria were combined in a 15 ml centrifuge tube 
with 250 pd of the eluted phage stock plus 1 1il of the ExAssist helper phage 
(Stratagene). The reaction was incubated for 15 mins at 37°C. 3 mls of LB broth was 
added and the tube incubated in a shaking incubator for 2-2 /2 at 37°C. Once completed 
the tube was incubated at 70°C for 15 mins and centrifuged for 15 mins. The 
supernatants, containing the excised phagemid, were aliquoted into two 1.5 ml tubes 
and stored at -80°C. 
2.0.12 Preparation ofphagemid DNA 
Preparation of phagemid DNA from excised phagemid stocks was performed as 
outlined, in the Strategene cDNA synthesis kit manual (Strategene). Briefly, 10 and 
100 itl of each phagemid was aliquoted into two 1.5 ml centrifuge tubes respectively, 
each with 200 itl of SOLR cells (OD = 1.0). The tubes were incubated at 37'C for 
15 mins; 100 Al of each was spread onto LB-ampicillin (50 g/ml) plates and 
incubated o/n at 37°C. A single colony from each phagemid was used to inoculate 10 
mls of LB-amp and incubated o/n at 37°C in a shaking incubator. 
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Phagemid DNA was prepared from the 10 ml o/n culture using the Qiagen Spin 
Miniprep plasmid kit (Qiagen, Germany). The procedure used was according to the 
Qiagen manual. The purified phagemid was eluted into 50 il of water and stored at 
-20°C. 
2.0.13 Dye Terminator cycle Sequencing Reaction 
The phagemid templates previously prepared were sequenced using the dye terminator 
(dt) cycle sequencing chemistry with AmplitaqTM DNA polymerase (FS enzyme - 
Perkin Elmer). Two microlitres of each plasmid template was used in a dt reaction as 
standard (see table below): 
Template 	 2.0 /Ll 
Dye terminator mix 	4.0 Itl 
Primer (20 ng/d) 0.5 Itl 
Water 	 3.5 Al 
The reaction was carried out as outlined in the Perkin Elmer manual. Using the 
Bluescript primers M13 Forward & M13 Reverse, T3 and T7. 
Samples were completed for sequencing on the ABI, following a precipitation step 
designed to remove unincorporated primer and reaction mix. This protocol was 
outlined in the Perkin Elmer manual. 
The dt reactions were analysed using an ABI 377 automated sequencer (Applied 
Biosystems, Foster City, CA). All clones were sequenced from the 5' end, and most 
were subjected to 3' sequencing except where 5' sequences gave high quality sequence 
through the poly-A+ tail, or where the 5' sequence showed unequivocal identity with a 
previously characterised T. canis clone. Most of the clones were sequenced multiple 
times to reduce eliminate the incidence of error in the sequence data. 
2.0.14 Analysis of sequence data 
Sequence data was edited in the first instance using the program SeqEd v 1 .0.3 
(Applied Biosystems) which allowed comparison between the electropheretic trace and 
the nucleotide sequence. This was used to identify and remove vector sequence and 
riI 
flanking sequences. Sequences were aligned using AsemblyLign and the MacVector 
6.0 (Oxford Molecular). It was possible to perform nonredundant database searches 
using BLAST (Basic Local Alignment Search Tool) (Altschul et al 1990) on the 
National Center for Biotechnology Information (NCBI) server. 
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Genome sequencing is increasing at an exponential rate. Since the pioneering studies 
on Ascaris more than a century ago, the genomes of parasitic nematodes have been 
under intense investigation. At present a vast body of data derived from genome 
sequencing projects is rapidly accumulating in public databases and it is predicted that 
investigators would soon have the necessary foundation with which to determine 
biological function from sequence data (Miklos and Rubin, 1996). A prediction already 
close to being realised. 
One of the main functions of genome sequencing projects such as whole genome or 
expressed sequence tag (EST) sequencing is to provide a database of sequence 
information, preferably from a model species (Miklos and Rubin, 1996). With this 
information it would be possible to answer fundamental questions relating to the 
elucidation of biochemical pathways (Blattner et al., 1997; Bult et al., 1996), 
identifying homologues which determine the function in different species including 
humans (McCombie et al., 1992; Sonnhammer and Durbin, 1997) and ascertain 
virulence factors. 
As a gene discovery approach, whole genome sequencing is not a new idea. In 
comparison to other animal genomes those of nematodes are unusually small - the 
genome size of ascarids is in the order of 0.51 - 2.4 x 108  bp with repeated sequences 
accounting for 13 - 32% (Hammond and Bianco, 1992). Nonetheless, it is an 
uneconomical and time-consuming option when compared to the EST approach. ESTs 
are generally generated from single reads from one or both ends of a clone. This is an 
efficient means of identifying new genes and characterising the expressed gene content 
of cells and tissues (Adams et al., 1992; Adams et al., 1991; Hoog, 1991). EST 
sequencing is a versatile approach that can be scaled large or small depending on the life 
stage under investigation can be biased towards genes of importance to the parasite 
against which chemotherapeutic targets can be designed; those expressed at medium or 
high abundance during the lifecycle stage. 
In contrast to this, however, El-Sayed and Donelson (1997) showed in their survey of 
the Trypanosoma brucei rhodesiense genome that this was not always the case. Using a 
single pass sequencing approach on both ESTs and genome survey sequences (GSSs) 
they showed very little difference in the novel gene discovery potential. 
The arrested stage of T. canis is remarkable for surviving without development for as 
long as 9 years in vivo (Beaver, 1966), without reproduction or differentiation, and 
without succumbing to attack by the host immune system. In the absence of cell 
division, tissue growth or gametogenesis, we hypothesised that a significant proportion 
of T. canis larval protein production is likely to be directed at immune evasion, and that 
this may be reflected in the spectrum of mRNAs being synthesised by the arrested 
larvae. We therefore adopted the Expressed Sequence Tag (EST) approach and now 
report on the discovery of 126 new genes representing approximately 1% of the 
organisms predicted gene complement. 
Table 3. 1. 
dbEST rank Organism Description 	 EST entries 
1 Homo sapiens (human) 847,851 
3 Caenorhabditis elegans (nematode) 72,521 
4 Arabidopsis thaliana (thale cress) 33,932 
6 Drosophila melanogaster (fruit fly) 16,859 
7 Brugia malayi (parasitic nematode) 10,806 
8 Toxoplasma gondii (protozoan) 10,671 
10 Schistosoma mansoni (blood fluke) 3,441 
12 Saccharomyces cerevisiae (baker's yeast) 3,042 
13 Plasmodiumfalciparum (malaria parasite) 2,872 
14 Trypanosoma brucei rhodesiense (protozoan) 2,732 
16 Zea mays (maize) 1,757 
17 Onchocerca volvulus (nematode) 1,765 
19 Sus scrofa (pig) 1,323 
21 Dictyostelium discoideum 795 
25 Trypanosoma cruzi (protozoan) 575 
28 Schistosomajaponicum (blood fluke) 538 
29 Leishmania major (protozoan) 535 
36 Gallu gallus (chicken) 216 
40 Trypanosoma brucei brucei (protozoan) 143 
44 Canisfamiliaris (dog) 107 
51 Toxocara canis (parasitic nematode) 86 
58 Strongyloides stercoralis (nematode) 57 
70 Meloidogynejavanica (root-knot nematode) 22 
80 Urechis caupo (carp) 10 
82 Trichostrongylus vitrinus (parasitic nematode) 9 
91 Diclyocaulus viviparus (bovine lung worm) 2 
94 Hydra vulgaris 1 
96 	 Total (organisms) 
Total (EST entries) 	 1,303,930 
Table 3.1 Summary of the EST sequences entered into the dbEST database showing 
the number of EST's deposited into the public database. 
Note: The above information was compiled from the dbEST Summary of Organisms 
(http://biology.bjmu.edu.cnlbiology/ncbihtml3458cd57.HTM) which was last updated 
on 31.10.97. 
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3.2 Materials and Methods: 
3.2.1 T. canis infective larvae cDNA Library 
A description of the construction of the cDNA library by Dr. Tripp (Heska, Fort 
Collins) is given in Chapter 2: Materials and Methods. 
3.2.2 Selection of individual clones 
XL1-Blue E. coli bacteria were streaked out from frozen stocks onto Lauria-Bertani 
(LB) agar plates containing 12.5 jg/ml tetracycline (tet) and grown overnight at 37°C. 
A 10 ml culture of XL 1-blue E. coli cells was prepared from a single colony and 
allowed to grow for approximately 16 hours or overnight in a 37°C shaking incubator. 
A 0.5 ml aliquot of this culture was used to inoculate 50 mls of LB tet in a conical flask 
This was grown until an OD6,, of 0.5 was reached, approximately 3 hours. The T. 
canis infective stage cDNA library was titrated in SM buffer (Chapter 2: Materials and 
Methods) to yield 101 - 10 plaque forming units (pfu) per ml. One microlitre of each 
phage dilution was added to 200 Itl of XL1-Blue E. coli bacteria and placed at 37°C for 
15 minutes to allow attachment of the phage to the cells. After this period the cells were 
mixed with 3 ml of top agar (Chapter 2: Materials and Methods), which had been 
previously melted and cooled to 50°C, and plated out onto agar plates and allowed to 
set. Once set the plates were incubated at 37°C overnight. The following day plaques 
were cored out from agar plates, using a pasteur pipette, where the density allowed 
single plaques to be picked with no possibility of contamination. This corresponded to 
the dilutions 10, 10 and 10. The cored single plaques were then dispenced into 500 
jsl of SM and incubated at 4°C to allow the phage to elute out of the agar plug. Twenty 
microlitres of chloroform was added to act as a preservative. 
3.2.3 Estimation of insert sizes 
The insert sizes of the selected phage were determined by PCR using Bluescript primers 
(M13 Reverse and M13 Forward) with aliquots of the phage stock as template. A 
number of the clones proved difficult when attempting to determine the insert sizes. In 
those cases a restriction digest was performed on the purified plasmid (see Chapter 2: 
Preparation of plasmid DNA) using the enzymes Xho 1 and Xba 1 (Promega). Of the 
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332 clones picked from the library 66 (19.8%) did not have inserts and were not 
included in any further analysis. Some clones gave an insert size which later turned out 
to be an underestimate of the actual size of the clone when the clone was subsequently 
sequenced. Blue/white screening of the colonies was not carried in the selection of 
recombinant clones as due to the high titre of the library it was deemed somewhat 
unnecessary. 
3.2.4 Excision of phage insert 
Phagemids were excised as outlined in Chapter 2: Materials and Methods. 
3.2.5 Preparation ofphagemid DNA 
Preparation of the phagemid DNA was as outlined in Chapter 2: Materials and 
Methods. 
3.2.6 Dye Terminator Cycle Sequencing Reaction 
The dye terminator protocol used was according to the Perkin Elmer manual, as 
detailed in Chapter 2: Materials and Methods. 
For specific clones, internal primers were required to obtain further sequence data. In 
these cases, the primers used and the positions from which they were designed are 
shown on the nucleotide sequence, in the relevant sections of this chapter. 
3.2.7 Analysis of Sequence data 




The genes identified from the EST project were named following the nematode 
nomenclature proposal as formed by Bird and Riddle (Bird and Riddle, 1994). Thus all 
genes are given a 3-letter name and a number, and the prefix Tc to denote the species 
(e.g. Tc = Toxocara canis). Three sets of interim gene names were used where no 
functional homology exists: Tc-not (= novel transcript), Tc-ant (abundant novel 
transcript, where =7 clones/266 were identical), and Tc-huf (homologue of unknown 
function, where similar sequences had been reported in other nematodes such as C. 
elegans or Onchocerca volvulus). For these interim gene designations, the number of 
the EST clone first sequenced was retained. For cDNAs assigned functional names, 
clones were generally numbered sequentially (e.g. Tc-ctl-1, Tc-ctl-2 for C-type lectins), 
except where numbering was significant in other organisms, principally for ribosomal 
proteins (e.g. Tc-rps-4, -5 and -9 to conform with established nomenclature). 
3.2.9 Database Submission 
Sequences were deposited in NCBI dbEST (Banfi et al., 1998; Boguski et al,, 1993) 




3.3.1 Sequencing and homology searches 
A total of 332 clones were sequenced from the 5' end, of which 266 (80%) contained 
inserts ranging from 128 to 2050 base pairs (Table 3.1). Of these, 223 were also 
sequenced from the 3' end. Five clones were found to be chimaeric, i.e. the 5' and 3' 
ends were derived from separate transcripts with different derivations. All nucleotide 
sequences were subjected to BLASTX searches against the nonredundant (nr) 
database at NCBI (National Centre for Biotechnology Information) GenBank. Where 
no homology was found, nucleotide sequences were also subjected to BLASTN 
searches (at both nr and dbEST databases), and where an unambiguous open reading 
frame could be assigned, the deduced protein sequence was used to search with 
TBLASTN (also with nr). Most homologies were found, or were stronger, with the 
5' sequences, but a significant minority of homology relationships were found only 
with 3' sequence reads. In general, a probability value of 10.6  was sought as minimum 
degree of similarity. 
3.3.2 Clustering analysis 
All sequences were held as MacVector files, and the Align to Folder algorithm used to 
determine similarities between different EST clones. It was noted that in some of the 
larger clusters, identity of the 3' sequences was critical to correctly group differently 
truncated clones with non-overlapping 5' sequences. To some extent this reflected the 
moderate read lengths achieved in this work. 
As a result of these analyses, a total of 129 distinct gene products were identified. Of 
these, only 3 had previously been characterised, namely mucin-1 (Tc-muc-J; (Gems 
and Maizels, 1996)) phosphatidylethanolamine-binding protein (Tc-peb-1; (Gems et al., 
1995)) and the 60S ribosomal protein L3 (Tc-rpl-3; (Moore et al., 1995)). Table 3.2 
gives a gross summary of the number of individual genes, and the total clones isolated, 
which fell into one of four different homology classes. Approximately 50% (65/129) 
of the total number of genes showed significant similarity to genes of known function 
from other species; a further 16 clones had database homologues of unknown function; 
and 48 genes (37%) showed no similarity to known genes: members of this last class 
were designated novel genes. 
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and 48 genes (37%) showed no similarity to known genes: members of this last class 
were designated novel genes. 
Table 3.2. Gross summary of the EST project. 
- 	Genes 	Clones 
Identified Homologues 	(Table 3.6) 65 * 140 
Unidentified Homologues (Table 3.5) 16 20 
Abundant Novel Transcripts 	(Chapter 4) 4 48 
Novel Transcripts 44 53 
TOTAL 129 261 
* Includes 3 genes previously characterised, i.e. Tc-muc-1, Tc-peb-] and Tc-rpl-3. 
Excludes 5 cDNAs found to be chimaeric and so not used in further analysis. 
3.3.3 Abundant Transcripts 
The clustering analysis produced some surprising results, with a small number of 
transcripts being heavily represented in the library. Eight transcripts (6.4% of genes) 
accounted for 106 clones (39.1%) from the cDNA library (Table 3.3), while the 20 
most abundant (all those sequenced 3 or more times) accounted for 145 clones 
(55.1%). Table 3.4 presents the transcripts characterised in order of frequency, with 
the most highly abundant clone being cytochrome c oxidase subunit 11(25/263 = 9.6% 
of clones), and the second most common clone being a C-type lectin (16/263 = 6.1%) 
which in published work was shown to correspond to TES 32, the major surface 
secreted glycoprotein of T. canis larvae (Loukas et at, 1999). 
55 
Table 3.3. Abundant clones 
25 Cytochrome c Oxidase 
16 C-type lectin (TES 32) cd-i 
15 Abundant Novel Transcript (ant) 003 
7 Abundant Novel Transcript (ant) 005 
13 Abundant Novel Transcript (ant) 030 
13 Abundant Novel Transcript (ant) 034 
7 Surface coat mucin (TES 120/rnuc-1) 
5 Phosphatidylethanolamine (PE) Binding Protein (TES 26) 
The 8 most abundant clones identified as part of the EST project. Together accounting for 106 (39.8%) 
of the total clones sequenced from the library. 
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Table 3.4 Frequency of transcripts 
Cytochrome c oxidase, subunit II (cox-2) 25 9.6% 
C-type lectin, TES-32 (al-1) 16 6.1% 
Abundant Novel Transcripts 003 (ant-003) 15 5.7% 
Abundant Novel Transcripts 034 (ant-034) 13 5.0% 
Abundant Novel Transcripts 030 (ant-030) 13 5.0% 
Abundant Novel Transcripts 005 (ant-005) 7 2.7% 
Mucin, TES-120 (muc-1) 7 2.7% 
PE-binding Protein, TES-26 (peb-1) 5 1.9% 
Novel Transcript 095 (not-095) 4 1.5% 
Protein tyrosine phosphate (ptp-1) 4 1.5% 
60S Ribosomal Protein L19 (rpl-19 4 1.5% 
ADP/ATP translocase (aat-1) 3 1.1% 
ASP Homologue-1/Tc-CRISP (vah-1) 3 1.1% 
Mucin-2 (muc-2) 3 1.1% 
Novel Transcript 018 (not-018) 3 1.1% 
Novel Transcript 120 (not-120) 3 1.1% 
60S Ribosomal Protein P0 (rpp-O) 3 1.1% 
Superoxide dismutase-3 (sod-3) 3 1.1% 
Tubulin alpha-3 chain (tua-3) 3 1.1% 
14 transcripts present as two clones * 28 10.7% 
96 transcripts present as single clones 96 36.7% 
Total Clones Sequenced 	 261 
* The 14 genes present as 2 clones are aki-1, ash-2, cap-], huf-001, irp-1, muc-3, not-069, not-126, 
ofin-1, pam-1, pcc-1, rpl-7a, rpl-9 and sod-4. Details of these, apart from the ants and nots are given in 
Table 3.6 
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3.3.4 Abundant Novel Transcripts 
Interestingly, the 4 next most abundant clones were all novel, with no similarities in the 
database or to each other, but occurred with frequencies between 2.7 - 5.7% of all cDNA 
clones randomly selected. These 4 transcripts, which together account for more than 
18% of the library (Figure 3.1), have been designated ant (abundant novel transcript) 
genes, and retain the number of the EST clone from which they were first isolated (ant-
003,005,030, and 034). 
Abundant Novel Transcripts 
19.17% 
Remainder of EST Project 
80.83% 
Figure 3.1. Pie chart showing the percentage of the EST project devoted to the Abundant 
Novel Transcripts (ants) versus the rest of the clones 






3.3.5 Homologues of Genes of Unknown Function (huf) 
Ten clones showed significant similarities to C. elegans sequences with no assigned 
function (Table 3.5, lines 2-12). These were all designated as huf genes, retaining the 
number of the corresponding EST clone. One clone, Tc-huf-1 contained a tandem array 
of 3 blocks of 36 amino acids each containing 6 cysteines in identical alignment, and 
one block containing 5 cysteines. This novel domain, termed NC6 or SXC (nematode 
cysteine 6 or six cysteine) domains (Blaxter, 1998; Gems et al., 1995), has been found 
in T. canis and C. etc gans proteins, particularly those associated with nematode 
surfaces, but no insight into the function of the array has yet been gained. 
The pie chart in Figure 3.2 shows the percentage of ESTs that was devoted to these 
genes of unknown function. 
Figure 3.2. Pie-chart showing the percentage of the EST project inhabited by the Homologues of 
Unknown Function (huf) and the Venom allergen/ASP homologues (va/i). 
Remainder of EST Projec 
92.8% 
Table 3.5 T. canis ESTs classified as homologues of nematode proteins of Unknown Function (huf) (16 genes). All the clones were isolated as single transcript 
except vah-1 (3 clones), vah-2 and huf-001 (2 clones each). 
Gene Name Similarity p value EST Name Insert Size 
(bp) 




 Tc-huf-001 NC6ISXC motif Tc-EST-001 800 764 666 AA683457 AA683458 
 Tc-huf-012 Caenorhabditis elegans R53.5 gene 3.8EM6 Tc-EST-012 850 599 381 AA563573 
 Tc-huf-052 C. elegans yk284h6 cDNA 5.OE-18 Tc-EST-052 420 395 602 AA610968 AA610969 
 Tc-huf-053 C. elegans C13A1O gene 2.8E-38 Tc-EST-053 1000 589 521 AA610971 AA610972 
 Tc-huf-062 C. elegans F41139.1 gene 4.3E-42 Tc-EST-062 760 482 288 AA612566 AA907959 
 Tc-huf-159 C. elegans C56E6.5 gene 7.6E-15 Tc-EST-159 1850 387 393 AA836705 AA836706 
 Tc-huf-169 C. elegans K02E10.6 gene 6.2E-17 Tc-EST-169 1050 466 558 AA874757 AA874758 
 Tc-huf-252 C. elegans Y57G1 1C.12 gene 7.7E-30 Tc-EST-252 1150 547 444 AA684533 AA684534 
 Tc-huf-264 C. elegans B0034.3 gene 1.4E-25 Tc-EST-264 1420 589 416 AA684531 AA684532 
 Tc-huf-287 C. elegans K12H4.5 gene 5.3E-23 Tc-EST-287 452 429 491 AA875794 AA97971 1 
 Tc-huf-296 C. elegans T24F1.6 gene 1.9E-11 Tc-EST-296 2300 259 578 AA875806 AA875807 
 Tc-huf-316 C. elegans T24138.5 gene 3.7E-21 Tc-EST-316 720 542 351 AA87471 1 AA874712 
 Tc-huf-325 Onchocerca volvulus L3CAN05CO8SK 7.4E-47 Tc-EST-325 1250 370 590 AA879368 AA879369 
 Tc-vah-1 C. elegans T05A10.5 venom allergen/ 4.6E-15 Tc-EST-269 1870 459 699 Al 083044 Al 083045 
Ancylostonia secreted protein (ASP) homologue 
 Tc-vah-2 Brugia malayi Venom allergen/ASP homologue 1.OE-13 Tc-EST-303 1600 550 512 Al 083048 Al 083049 
 Tc-vah-3 Brugia malayi Venom allergen/ASP homologue 4.7E-16 Tc-EST-249 650 507 Al 083050 Al 083051 
3.3.6 Venom Allergen Homologues (vah) 
In addition to the aforementioned huf genes, three genes were found to show similarity to 
Ancylostoma secreted protein (ASP), which is associated with larval reactivation and 
development in other nematode species (Hawdon et al., 1996; Schallig et al., 1997). This 
gene family shows similarity to hymenopteran venom allergens, and in common with 
members reported from B. inalayi and 0. volvulus, has been designated vah (venom 
allergen homologue). Figure 3.3(a) shows an alignment of predicted proteins of vah-] and 
-2 together with partial predicted sequence for vah-3. The full-length sequence for vah-1 
was obtained as part of the EST project, whereas vah-2 was obtained by Janice Murray 
(pers. comm.). Identical residues are shaded in dark grey, while similar residues are in 
lighter grey boxes. Each vah gene has one N-linked glycosylation site - this is an 
assumption with vah-3 as the full-length sequence has not yet been obtained - which is 
highlighted on the figure in green. Tc-vah-1 has previously been reported as Tc-CRISP 
(Cysteine-rich secreted protein) by Leo Liu (pers. comm.), and is remarkable for 
containing four NC6/SXC domains in tandem with a vah-homology domain (Figure 3.3 
(a)). vah-2 does not possess any NC6ISXC domains, a feature which is as yet unknown 
for vah-3. Figure 3.3(b) shows a schematic of the vah genes and highlights their relation 
to each other. The conservation that exists between the NC6 domains in vah-1 is detailed 
in Figure 3.3 (c). Both Figures 3.3(a & b) show that these cysteine rich domains are 
separated by a conserved 13 amino acid gap showing a significant degree of homology 
with each other. This homology is highlighted in Figure 3.3 (d). Also of interest, is the 
observation that NC6 domains 1 and 3 of vah-1 are shorter by one amino acid than the 
NC6 domains of domains 2 and 4. The difference between the two domain pairs extends 
further in that there are amino acid differences common to domains 1 and 3 but not to 
domains 2 and 4 (Figure 3.3 (c)). NC6 domains 1 and 3 show a 50% difference to 
domains 2 and 4. Domains 2 and 4 in turn show a 36.4% amino acid divergence to 
domains 1 and 3. These differences are emphasised in Figure 3.3(c) in green for domains 
1 and 3 and pink for domains 2 and 4. 
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Figure 3.3 (a). Amino acid pileup of the vah genes. The boxed sections outline the NC6/SXC 
domains of vah-1. The dark green underlined sections show the conserved 13 amino acid gap that separates 
the NC6/SXC domains. 
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Figure 3.3 (a) continued N-glycosylation sites are highlighted in bright green. 
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Figure 3.3 (b). Schematic representation of the venom allergen homologue (vah) genes isolated from the 
EST project. The grey portion of vah-3 represents the fact that this conception is derived from a partial 
sequence. 
vah-1 NC6/SXC 1 3 	[DVDFflH S IVDNKQLGAAKRH ..flRK SflHfl 	63 
vah-1 NC6/SXC 2 77 CMDIDRDDICENAFY I--  EYPQFAACIK Q TE *1 108 
vah-1 NC6/SXC3 122 	DjE VRFICIHSVVDHG 	LNAAKR_IRKS 34I 154 
vah-1 NC6/SXC4 168 199 
Figure 3.3 (c). Amino acid pileup of the four NC6ISXC domains from vah-1. Conserved cysteines are 
shown in red. The conserved aspartic acid is shown in blue. Residues common to both NC6ISXC 1 and 3 
only are shown in green. Whereas those residues common to both NC6ISXC 2 and 4 only are shown in 
pink. 
va/i-i 13 aa gap 1 	64 S E P - K P P Q P T P - S P D 	76 
vah-i l3aa gap 2 	119 G Q P E R P P - P T P G S G 	121 
vah-1 l3aa gap 3 	155 E 71 P - V P A L P T P - T D G 	167 
Figure 3.3 (d). Pileup of the three 13 amino acid stretch that separates the four NC6/SXC domains of 
valz-1. Residues common to all three domains are highlighted in blue. 
3.3.7 Other Novel Genes 
A total of 44 additional transcripts were found to have no significant similarities to any other 
sequences deposited in the GenBank nonredundant (nr) protein and dbEST databases. 
These were present at between 1-4 copies in the 261 member data set from 
T. canis, and were designated not genes (novel transcripts) (Figure 3.4). Further studies are 
ongoing on selected clones, such as not-018, for which antibodies to the protein product 
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Figure 3.4. Pie chart showing the proportion of the EST project devoted to the Novel Transcripts (nots) 
versus the remainder of the project. 
able 3.6 Table of the novel transcripts (not's) identified as part of the T. canis EST project 
Clone number Gene Name Identification Closest Sibling overlaps Related Insert size 5' Read 3' Read 5' EST 3' EST Clone Number 
Species GenBank GenBank 
I Tc-EST-009 Tc-not-009 Novel Transcript 009 None None No 480 554 522 AA563571 AA683462 Tc-EST-009 
2 Tc-EST-018 Tc-not018 Novel Transcript 018 None 018,031,136 Yes >1270 600 671 AA683463 AA683464 Tc-EST-018 
3 Tc-EST-031 Tc-not-031 Novel Transcript 031 None 018,031,136 Yes 1000 382 555 AA568095 AA568096 Tc-EST-031 
4 Tc-EST-136 Tc-not-136 Novel Transcript 136 None 018,031,136 Yes 1000 620 565 AA835621 AA835622 Tc-EST-136 
5 Tc-EST-028 Tc-not-028 Novel Transcript 028 None None No 607 588 600 AA568091 AA568092 Tc-EST-028 
6 Tc-EST-039 Tc-not-039 Novel Transcript 039 None None No 450 360 360 AA583 103 AA583 104 Tc-EST-039 
7 Tc-EST-042 Tc-not-042 Novel Transcript 042 None None No 377 377 AA603959 Tc-EST-042 
8 Tc-EST-052 Tc-not-052 Novel Transcript 052 None None No 420 395 381 AA610968 AA610969 Tc-EST-052 
9 Tc-EST-056 Tc-not-056 Novel Transcript 056 None None No 750 630 400 AA6 10962 AA907597 Tc-EST-056 
10 Tc-EST-068 Tc-not-068 Novel Transcript 068 None None No 370 370 370 AA728630 AA728631 Tc-EST-068 
ii Tc-EST-069 Tc-not-069 Novel Transcript 069 None 069,071 Yes 295 294 283 AA888748 AA888749 Tc-EST-069 
12 Tc-EST-071 Tc-not-071 Novel Transcript 071 None 069,071 Yes 332 332 332 AA728647 AA728648 Tc-EST-071 
13 Tc-EST-073 Tc-not-073 Novel Transcript 073 None None No 400 396 393 AA68 1626 AA728638 Tc-EST-073 
14 Tc-EST-095 Tc-not-095 Novel Transcript 095 None 095, 145. 293, 321 Yes 350 315 AA820018 Tc-EST-095 
15 Tc-EST-145 Tc-not-145 Novel Transcript 145 None 095, 145, 293, 321 Yes 314 314 AA836694 Tc-EST-145 
16 Tc-EST-293 Tc-not-293 Novel Transcript 293 None 095, 145, 293, 321 Yes 320 311 300 AA875800 AA875801 Tc-EST-293 
17 Tc-EST-321 Tc-not-321 Novel Transcript 321 None 095, 145. 293, 321 Yes 300 300 300 AA879363 AA883053 Tc-EST-321 
18 Tc-ESTM98 Tc-not-098 Novel Transcript 098 None None No 800 528 501 AA820022 AA820023 Tc-EST-098 
Table 3.6 continued 
Clone Name Gene Name Identification Closest Sibling overlaps Related Insert size 5' Read 3' Read 5' EST 3' EST Clone Number 
Species GenBank GenBank 
19 Tc-EST-099 Tc-not-099 Novel Transcript 099 None None No 310 250 258 AA820024 AA820025 Tc-EST-099 
20 Tc-EST-103 Tc-not-103 Novel Transcript 103 None None No 640 432 538 AA824218 AA824219 Tc-EST-103 
21 Tc-EST-107 Tc-not-107 Novel Transcript 107 None None No 1200 528 516 AA824226 AA824227 Tc-EST-107 
22 Tc-EST-120 Tc-not-120 Novel Transcript120 None 120, 236, 240 Yes 630 580 AA825139 Tc-EST-120 
23 Tc-EST-236 Tc-not-236 Novel Transcript 236 None 120, 236, 240 Yes 500 480 463 AA874742 AA874743 Tc-EST-236 
24 Tc-EST-240 Tc-not-240 Novel Transcript 240 None 120, 236, 240 Yes 500 501 481 AA874744 AA874745 Tc-EST-240 
25 Tc-EST-126 Tc-not-126 Novel Transcript 126 None None No 570 552 568 AA835594 AA835595 Tc-EST-126 
26 Tc-EST-127 Tc-not-127 Novel Transcript 127 None None No 1000 562 645 AA835596 AA835597 Tc-EST-127 
27 Tc-EST-132 Tc-nor-132 Novel Transcript 132 None None No 1430 493 653 AA835615 AA835616 Tc-EST-132 
28 Tc-EST-135 Tc-not-135 Novel Transcript 135 None None No 300 292 300 AA835619 AA835620 Tc-EST-135 
29 Tc-EST-138 Tc-not-138 Novel Transcript 138 None None No 614 591 590 AA835625 AA835626 Tc-EST-138 
30 Tc-EST-139 Tc-not-139 Novel Transcript 139 None None No 605 355 505 AA835627 AA835628 Tc-EST-139 
31 Tc-EST-154 Tc-not-154 Novel Transcript 154 None None No 1300 615 416 AA836701 AA836702 Tc-EST-154 
32 Tc-EST-l73 Tc-not-173 Novel Transcript 173 None None No 530 328 395 AA873913 AA873914 Tc-EST-173 
33 Tc-EST-l95 Tc-not-J95 Novel Transcript 195 None None No 237 237 218 AA873902 AA873903 Tc-EST-195 
34 Tc-EST-198 Tc-nor-198 Novel Transcript 198 None None No 498 495 498 AA873893 AA911816 Tc-EST-198 
35 Tc-EST-204 Tc-not-204 Novel Transcript 204 None None No 1000 463 432 AA874709 Al 080931 Tc-EST-204 
Table 3.6 continued 
Clone Name Gene Name Identification Closest Sibling overlaps Related Insert 	ize 5' Read 3' Read 5' EST 3' EST Clone Number 
Species GenBank GenBank 
36 Tc-EST-216 Tc-not-216 Novel Transcript 216 None 218 No 314 314 296 AA911817 AA911818 Tc-EST-216 
37 Tc-EST-218 Tc-not-218 Novel Transcript 218 None 216 No 311 311 302 AA911819 AA9I 1820 Tc-EST-218 
38 Tc-EST-224 Tc-not-224 Novel Transcript 224 None None No 300 278 284 AA874727 AA874728 Tc-EST-224 
39 Tc-EST-225 Tc-not-225 Novel Transcript 225 None None No 830 520 461 AA911821 AA911822 Tc-EST225 
40 Tc-EST-230 Tc-nor-230 Novel Transcript 230 None None No 1010 436 616 AA874732 AA874733 Tc-EST-230 
41 Tc-EST-231 Tc-not-231 Novel Transcript 231 None None No 240 240 240 AA874734 AA874735 Tc-EST-231 
42 Tc-EST-243 Tc-not-243 Novel Transcript 243 None None No 430 351 369 AA874761 AA874762 Tc-EST-243 
43 Tc-EST-272 Tc-not-272 Novel Transcript 272 None None No 550 399 463 AA875779 AA875780 Tc-EST-272 
44 Tc-EST-276 Tc-not-276 Novel Transcript 276 None None No 460 409 421 AA87582 AA875783 Tc-EST-276 
45 Tc-EST-289 Tc-not-289 Novel Transcript 289 None None No 700 462 620 AA875795 AA875796 Tc-EST-289 
46 Tc-EST-302 Tc-not-302 Novel Transcript 302 None None No 760 283 621 AA879342 AA879343 Tc-EST-302 
47 Tc-EST-307 Tc-nor-307 Novel Transcript 307 None None No 258 258 258 AA879344 AA879345 Tc-EST-307 
48 Tc-EST-310 Tc-not-310 Novel Transcript 310 None None No 700 589 625 AA879348 AA879439 Tc-EST-310 
49 Tc-EST-311 Tc-not-311 Novel Transcript 311 None None No 394 394 368 AA979717 AA979718 Tc-EST-311 
50 Tc-EST-313 Tc-not-313 Novel Transcript 313 None None No 750 564 669 AA879352 AA879353 Tc-EST-313 
51 Tc-EST-317 Tc-not-317 Novel Transcript 317 None None No 123 123 119 AA879356 AA803052 Tc-EST-317 
52 Tc-EST-327 Tc-not-327 Novel Transcript 327 None None No 550 397 528 AA879370 AA879371 Tc-EST-327 
53 Tc-EST-329 Tc-not-329 Novel Transcript 329 None None No 250 237 249 AA879372 AA879373 Tc-EST-329 
3.3.8 Homologues of Known Genes 
Table 3.7 shows a compilation of all the genes for which significant homologues of known 
function existed in the database. This includes 62 new genes together with 3 previously 
characterised sequences. Of the identified genes, there are 23 metabolic and respiratory 
enzymes, but remarkably few structural proteins (only actin, calponin and ct-tubulin) and no 
products involved in DNA replication. This finding is consistent with the developmentally 
arrested state of the parasite. The identified genes have been categorised under distinct 
headings, and the findings are summarised in Figure 3.5 and Table 3.7 below. The pie-
chart in Figure 3.5 shows a diagrammatic representation of the EST project and is also 
likewise categorised. The ants and nots have been omitted from this grouping. 
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Figure 3.5. Pie-chart showing a summary of the EST project categorised by genes with homologues of 
known function only. 
Table 3.7. Summarised table of the clones identified by homology searching 
Gene Identification Closest Species p (n) Clone Number Insert 5' 3' 5 EST 3' EST 
Name (. = Longest Clone) Size Read Read GenBank GenBank 
MUCIN 
1 Tc-,nuc-1 Mucin-1, Surface coat TES-120 Toxocara canis 6.3E-104 Tc-EST-087 810 557 539 AA583105 AA907963 
2 Tc-rnuc-2 Mucin-2 T. canis 3.8E-49 Tc-EST-130 990 612 694 AA583106 AA583107 
3 Tc-muc-3 Mucin-3 T. canis 2.6E-36 Tc-EST-162 1010 603 555 AA583111 AA583112 
4 Tc-muc-4 Mucin-4 T. canis 1.6E-45 Tc-EST-186 560 553 586 AA583108 AA583109 
LECTINS 
5 Tc-crl-1 C-type lectin/TES-32 glycoprotein Tc-EST-209 830 615 393 AA874713 t AA874714 
6 Tc-ctl-2 C-type lectin-2fVariant of TES-32 Tc-EST-036 780 596 618 Al 078880 Al 078881 
7 Tc-ctl-3 C-type lectin-3/Variant of TES-32 Tc-EST-155 610 590 737 Al 080917 Al 080918 
PROTEASES AND PROTEASE INHIBITORS 
8 Tc-aep-1 Asparaginyl Endopeptidase Horno sapiens 3.5E-28 Tc-EST-262 1300 520 648 AA825 116 AA875769 
9 Tc-api-1 Aspartyl proteinase inhibitor Caenorhabditis elegans 1.5E-09 Tc-EST-096 650 570 638 AA820019 AA820020 
10 Tc-cpl-1 Cathepsin L cysteine proteinase C. elegans 2.3E-40 Tc-EST-013 1150 604 390 AA563518 t Al 078878 
11 Tc-cpz-1 Cathepsin Z proteinase precursor Onchocerca volvulus 1.2E-73 Tc-EST-205 1000 568 701 Al 080921 Al 080922 
TRANSPORTERS AND RECEPTORS 
12 Tc-aat-1 ADP/ATP translocase C. elegans 1.9E-69 Tc-EST-041 750 515 663 AA603955 AA683466 
13 Tc-acr-1 Acetylcholine Receptor (tar-I) T. colubrforrnis 1.2E-35 Tc-EST-121 1300 529 547 AA835586 AA835587 
14 Tc-peb-1 Phosphatidylethanolamine binding protein (TES- T.canis 6.1E-76 Tc-EST-164 1200 406 459 AA864177 fAA864178 
26) 
STRUCTURAL PROTEINS 
15 Tc-act-1 Actin C. elegans 1.3E-81 Tc-EST-097 1450 524 AA820021 
16 Tc-cap-1 Calponin M.javanica 4.2E-21 Tc-EST- 620 462 537 AA875799 AA907961 
17 Tc-tua-1 Tubulin alpha-3 chain C. griseus 1.5E-69 Tc-EST- 1500 400 439 AA979712 AA907952 
Table 3.7 (continued) 
Gene Identification Closest Species p (n) Clone Number Insert 5' 3' 5' EST 3' EST 
Name (. 	Longest Clone) Size Read Read GenBank GenBank 
PROTEIN SYNTHESIS AND MODIFICATION 
18 Tc-efa-I Translation elongation factor la C. elegans 3.5E-84 Tc-EST-300 1600 498 572 AA879374 AA879375 
19 Tc-eJb-I Elongation Factor Beta-I C. elegans 3.1E-42 Tc-EST-081 830 355 756 AA888759 AA888760 
20 Tc-pain-1 Peptidylglycine alphahydroxylating D. melanogaster 1.1E-07 Tc-EST-200 420 385 357 AA874705 Al 080786 
monooxygenase 
21 Tc-pdi-1 Protein disulphide isomerase Gallus gallus 5.9E-18 Tc-EST-235 474 445 468 AA874740 AA874741 
22 Tc-ppi-/ Peptidyl-prolyl cis-trans isomerase M. musculus 3.2E-15 Tc-EST-019 1200 319 AA563572 
23 Tc-ptp-I Protein Tyrosine Phosphatase M. niusculus 5.9E-49 Tc-EST- l 18 1590 589 628 AA820013 AA820014 
GLYCOLYSIS, RESPIRATION AND MODIFICATION 
24 Tc-aca-I Acetyl-00A Acetyltransferase C. elegans 9.8E-33 Tc-EST-059 626 626 560 AA610965 AA907958 
25 Tc-aki-I Adenylate kinase isoenzyme I Gallus gal/us 9.2E-39 Tc-EST-328 800 452 505 AA873889 AA873920 
26 Tc-ald-1 Aldehyde dehydrogenase Bos bovis I.3E-45 Tc-EST-299 1700 559 360 AA979715 AA979716 
27 Tc-ata-1 Alanine aminotransferase C.elegans 4.OE-42 Tc-EST-294 1440 472 357 AA875802 AA875803 
28 Tc-cgl-1 Cystathionine gamma lyase C.elegans 6.4E-54 Tc-EST-090 750 555 685 AA583 117 AA583 118 
29 Tc-cyb-5 Cytochrome b5 H. sapiens 4.5E-10 Tc-EST-032 406 406 AA569419 
30 Tc-Jba-1 Fructose biphosphate aldolase 0. volvulus 2.IE-98 Tc-EST-183 1010 480 533 AA915868 AA915869 
31 Tc-fdh-1 Fumarate dehydrogenase precurs. H. sapiens 1.7E-26 Tc-EST-237 317 317 314 AA285389 AA874746 
32 Tc-frb-I Fumarate reductase, cytochrome b small subunit. Ascaris suum 2.9E-32 Tc-EST-083 1560 452 480 AA888752 AA888753 
33 Tc-gdh-1 Glutamate dehydrogenase H. contortus 4.7E-74 Tc-EST-026 1740 584 331 AA568090 Al 078879 
34 Tc-pcc-I Proprionyl CoA carboxylase C.elegans 8.6E-64 Tc-EST-074 1560 320 399 AA888750 AA888751 
35 Tc-pck-1 Phosphoenolpyruvate carboxykinase Ascaris suurn 4.4E-69 Tc-EST-004 2740 599 AA470327 
36 Tc-pgk- 1 Phospho-glycerate kinase S. ,nansoni 1.8E-41 Tc-EST- 109 1400 576 805 AA825 117 AA825 118 
37 Tc-sdi-I Succinate dehydrogenase iron-sulphur protein Ascaris suu,n 3.OE-73 Tc-EST-166 630 518 AA86418I 
38 Tc-ubo-1 NADH 	ubiquinone 	oxidoreductase 	18 	kDa Bostaurus 1.9E-39 Tc-EST-201 521 501 480 AA874708 Al 080786 
subunit 
Table 3.7 (continued) 
Gene Identification Closest Species p (n) Clone Number Insert 5' 3' 5' EST 3' EST 
Name (. = Longest Clone) Size Read Read GenBank GenBank 
PRESUMED MITOCHONDRIAL PROTEINS 
39 Tc-atp-6 ATP synthase A chain (Protein 6) Ascaris suum 1.9E-68 Tc-EST-064 610 576 557 AA6 12565 AA979708 
40 Tc-cox-2 Cytochrome c oxidase IT Ascaris suum 7.1E-75 Tc-EST-038 850 496 669 AA569422 AA569423 
41 Tc-ubo-4 NADH-Ubiquinone oxidoreductase chain 41- Ascaris suum 2.6E-29 Tc-EST-163 220 213 216 AA864175 AA864176 
ANTI-OXIDANTS 
42 Tc-sod-2 Superoxide dismutase 2 C.albicans 1.5E-23 Tc-EST-084 850 401 340 Al 078885 Al 078886 
43 Tc-sod-3 Superoxide dismutase 3 Zea mays 2.1E-18 Tc-EST-100 900 449 608 Al 080774 Al 080775 
44 Tc-sod-4 Superoxide dismutase 4 C.elegans 3.6E-40 Tc-EST-143 804 630 520 Al 080778 Al 080779 
45 Tc-sod-5 Superoxide dismutase 5 C.elegans 2.4E-39 Tc-EST-266 900 731 730 Al 080782 Al 080783 
RIBOSOMAL PROTEINS 
46 Tc-rpl-JO 60S Ribosomal Protein L10 C. elegans 8.6E-44 Tc-EST-271 800 321 590 AA875777 AA875778 
47 Tc-rpl-19 60S Ribosomal Protein L19 M.,nusculus 2.IE-60 Tc-EST-244 900 439 555 AA874749 AA874750 
48 Tc-rpl-3 60S Ribosomal Protein L3 T. canis 5.5E-60 Tc-EST-257 500 498 457 AA875762 1A1 080789 
49 Tc-rpl-31 60S Ribosomal Protein L31 H. sapiens 4.8E-49 Tc-EST-072 580 440 491 AA728649 AA728650 
50 Tc-rpl-37a 60S Ribosomal Protein L37 S.,nansoni 3.6E-34 Tc-EST-267 400 372 381 AA875772 AA875773 
51 Tc-rpl-7 60S Ribosomal Protein 1-7A H. sapiens 7.2E-29 Tc-EST-054 750 513 560 AA610961 AA907956 
52 Tc-rpl-9 60S Ribosomal Protein L9 H.contortus LIE-54 .Tc-EST-182 630 396 480 AA873890 Al 080784 
53 Tc-rpp-0 60S Ribosomal Protein p0 C. elegans 4.4E-35 Tc-EST-122 1100 476 552 AA835588 AA835589 
54 Tc-rpp-2 60S Ribosomal Protein P2 B. rnalayi 3.6E-08 Tc-EST-088 288 288 275 AA907964 AA907965 
55 Tc-rps-4 40S Ribosomal Protein S4 C.griseus 4.1E-61 Tc-EST-006 750 582 AA563574 
56 Tc-rps-5 40S Ribosomal Protein S5 C. elegans l.4E-70 Tc-EST-215 610 571 675 AA874719 AA874720 
57 Tc-rps-8 40S Ribosomal Protein S8 H. sapiens 7.4E-66 Tc-EST-277 640 481 600 Al 080929 Al 080930 
58 Tc-rps-9 40S Ribosomal Protein S9 R. non'egicus 8.6E-38 Tc-EST-270 410 38 AA875776 
Table 3.7 (continued) 
Gene Identification Closest Species p (n) Clone Number insert 5' 3' 5' EST 3' EST 
Name (. = Longest Clone) Size Read Read GenBank GenBank 
OTHERS 
59 Tc-gep-1 Granulin/epithelin precursor M. musculus 8.4E-31 Tc-EST-14l 1000 654 625 AA836692 AA836693 
60 Tc-hili-4 Histone H4 C. elegans 3.5E-60 Tc-EST-174 250 444 459 AA557121 AA873915 
61 Tc-lah-I Lupus Autoantigen Homologue C. elegans 1.5E-22 Tc-EST-177 450 607 520 Al 083048 Al 083049 
62 Tc-nips-1 Metailopanstimulin (=rps27) S. ratti 8.3E-41 Tc-EST-178 1430 367 400 AA873918 AA979709 
63 Tc-of,n-1 Olfactomedin (F11C3.2) C.elegans 1.6E-54 Tc-EST-079 1870 479 628 AA728643 AA728644 
64 Tc-pth-1 PC4/TIS7/"Interferon-related" M. inusculus 4.1E-20 Tc-EST-075 1440 616 299 AA6 18627 Al 078882 
65 Tc-rlp-i Tubby-like protein H.sapiens 1.6E-42 Tc-EST-242 1530 506 585 AA874759 AA874760 
Notes : Numerous sequences for which "closest species" listed is not a nematode show a higher BLASTX score with a C.elegans sequence for which there is either no assignation, or which 
described as similar to the non-nematode sequence given here. Full species names are as follows : B.malayi = Brugia tnalayi; C.albicans = Candida albicans; C.griseus= Cricetulus grisew 
H.contortus = Haenzonchus contortus; M.javanica= Meloidogynejavanica; O.volvulus= Onchocerca volvulus; S.mansoni= Schistosorna inansoni; T. co1ubrforniis = Trichostrongylus colubriformi 
S. ratti = Strongyloides ratti. 
1 Denotes that a full-length, verified sequence has been deposited in GenBank. Accession numbers : Tc-cpl-J, U53172; Tc-ctl-1,AF041023; Tc-muc-1, 039815; Tc-peb-J, U29761; Tc-rpl-
P49149. 
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Figure 3.5 and Table 3.7 show a breakdown of the EST project into categories and as 
such manage to highlight the relative absence of developmental and reproductive genes. 
Structural proteins make up 6.3% of the isolated clones and only 4.6% of the identified 
genes from the project. In stark contrast to this is the percentage of the library made up of 
enzymes classified as glycolytic, respiratory and other metabolic enzymes, which account 
for 23%, representing the largest segment of identified genes from the library. 
3.3.9 Mucins 
Three new genes were discovered which bore similarity to a known T. canis mucin, Tc-
muc-]. This gene was reported to be abundant both in mRNA prepared by amplification 
with SL and oligo-dT primers (Gems and Maizels, 1996), and in the conventional cDNA 
library described here. Consistent with this, 7 clones of Tc-muc-] were recorded. Three 
new genes with similarity to Tc-muc-1 were found, each of which contain similar mucin 
domains and flanking NC6/SXC domains (Blaxter, 1998; Gems et al., 1995; Gems and 
Maizels, 1996). The mucins differ in the composition of repeats within the mucin domains 
(serine/threonine content), and in the number of NC6/SXC domains. A separate analysis 
of these mucins with respect to the family of TES-120 glycoproteins associated with the 
parasite surface coat is in progress (Loukas et al ms in preparation). Chapter 5 deals with 
those clones isolated from the EST project that possessed NC6 domains. 
3.3. 10 C-type Lectins 
One of the most abundant transcripts (16/263) was found to correspond to the peptide 
sequence obtained from TES-32, a prominent secreted glycoprotein, and the full-length 
sequence showed homology to C-type lectins. The clone designated ctl-1 represented 
6.1% of the clones isolated as part of the EST project. The similarity exhibited by the 
clone through database searching to asialoglycoprotein, a mammalian C-type lectin, was 
only weakly apparent when initial EST sequences were analysed, and the significance 
threshold of 106  only achieved once full-length sequence was available. A detailed 
analysis of the functional lectin properties of TES-32/Tc-al-J is shown in (Loukas et al., 
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1998). Two variants of this sequence have since been identified and assigned Tc-ctl-2 and 
Tc-ctl-3. 
Confirmation of the sequences' relation to TES 32 came from peptides obtained from 
tryptic digestion of the TES 32 native protein, which were found in the sequence. Due to 
the modest length of the clone, full-length sequence was obtained from the EST project 
using the universal primers M13 R!F and T3/T7. Sequence data was later confirmed by a 
postdoctoral investigator, Alex Loukas, who carried-out some elegant experiments to 
define this molecule (Loukas et al submitted). Essentially, the recombinant protein, derived 
from the pET 29-T vector cloned Tc-ctl-] was used to immunise Balb/c mice. The resultant 
antibody was then used to probe Western blots to confirm the presence of TES 32 in TES 
(Loukas et al., 1998). 	Later, experiments were carried out in which different 
monosaccharides were bound to beaded agarose in order to determine the ligand(s) 
concerned. Although the physiological ligand of TES 32 is yet to be determined, modelling 
predictions with its closest homologue mannose binding protein (MBP) have suggested that 
Tc-ctl-1 would be capable of ligating Gal-type of man-type sugars. Further work, in 
particular site directed mutagenesis, would be required to confirm this hypothesis (Loukas 
et al., 1998). 
As can be seen from Figure 3.6, the three lectin clones, Tc-ctl-], -2, and -3, share a high 
degree of similarity but with significant levels of variation. From the Figure it can be seen 
that ctl-2 appears to be the most divergent of the two lectins at the aa level. Although the 
carbohydrate recognition domain, QPD, is identical in all three lectins, so too is the Ca"  
ligation site. It is not yet known whether these differences are due to allelic polymorphisms 
within the parasite population, or represent distinct gene products. 
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Figure 3.6. Amino acid pileup of the 3 C-type lectins isolated from the EST project. The arrow 
identifies the start methionine. N-linked glycosylation sites are identified in green, and conserved cysteine 
are in red; those cysteines bearing an asterix are those involved in forming the conserved Ca' ligation site 
in mannose binding protein. The blue lines identify the C-type lectin domain, whereas the black lines 
show the tryptic peptides obtained via an sequencing of cti-1 (Loukas et al ms. submitted). The 
carbohydrate binding motif, QPD is highlighted in purple. 
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3.3.11 Proteases 
Proteolytic enzymes have been prominent in most studies of parasitic helminths at the 
biochemical (Healer et al., 1991) and molecular (Lustigman et al., 1996) levels. Three 
transcripts, with strong similarities to cathepsin L (Loukas et al., 1998) and cathepsin Z 
(Lustigman et al., 1996) and asparaginyl endopeptidase (Chen et al., 1997), were each 
present as single clones. Full-length sequences of the cathepsins L (Loukas et al., 1998) 
and Z (Falcone et al ms.in preparation) have been determined. A protease inhibitor, similar 
to the aspartyl protease inhibitor of Ascaris and Brugia (Bm33) (Dissanayake et al., 1993) 
was isolated as a single clone. 
3.3.12 Asparaginyl endopeptidase (Legumain) 
The identification of clone Tc-EST-262 from the Toxocara EST Project - designated Tc-
aep-1 (GenBank accession nos :5' EST : AA825 116 & 3' EST : AA875769) - represents 
the first such peptidase isolated from a parasitic nematode and only the second identified in 
parasitic helminths to date; sequence homologous to asparaginyl endopeptidase has also 
been identified as part of the C. elegans genome project. An EST from the Filarial Genome 
Project (FGP) representing partial sequence with homology to AEP has also been 
identified, and was partially sequenced as part of the analysis of this clone (gift from 
Giuliano and Blaxter). 
Asparaginyl endopeptidase, or legumain (EC 3.4.22.34), is a member of a novel family of 
cysteine peptidases first isolated from leguminous plants. Abe (1993) purified an 
asparaginyl endopeptidase from Canavalia ensiformis (Jack bean), and Takeda et al (1994) 
isolated and analysed cDNA encoding the legumain precursor. Legumain is classified as 
belonging to the C13 family of peptidases, a characteristic of which is the strict specificity 
that they show for the hydrolysis of aparaginyl bonds (Barrett and Rawlings, 1996); Abe et 
al (1993) found exceptions to this specificity exist when the asparagine is located at the 
NH,-terminus, the second position from the NH,-terminus or where it is glycosylated. 
Members of this group differ from papain in their ineffective inhibition by cystatin and EM 
(Kembhavi et al., 199 1) and also by their rapid inactivation by iodoacetamide in preference 
to iodoacetate (Csoma and Polgar, 1984; Kembhavi et al., 1991). 
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The best characterised of the animal asparaginyl endopeptidases is that derived from 
Schistosoma mansoni, Sm 32. Sm32 has had something of a labyrinthine route to 
discovery. Evidence for the presence of a proteolytic enzyme with a pH optimum of 3.9 in 
extracts of S. mansoni had previously been shown (Dalton et al., 1995a). Again in 1979 
an important advance in the characterisation of this elusive peptidase came from Dresden 
and Deelder (1979). A purified form of the cysteine peptidase was isolated by Lindquist et 
at (1986). Later clones were obtained, through immunological screening using human and 
mouse infection sera, of two antigens, termed 5m3 1/32 (Klinkert et al., 1989; Klinkert et 
al., 1987). Davis et al first cloned the gene in 1987 (Davis et al., 1987) but it was not until 
1994, when Takeda eta! (1994) isolated their jack bean legumain and carried out database 
searches that they found their sequence to be homologous to the S. mansoni 
hemoglobinase. 
The enzyme is thought to be located in the lysozomes of the animal and has been implicated 
in the digestion of host haemoglobin (Brindley et al., 1997; Dalton et al., 1995b; Davis et 
al., 1987; Wasilewski et al., 1996). Sm 32 was originally identified as a minor component 
from adult parasites capable of eliciting a potent immune response, but was later found to 
show similarity to an asparaginyl endopeptidase from Jack bean (Canavalia ensiformis) 
(Takeda et al., 1994). An asparaginyl endopeptidase has been cloned and sequenced from 
humans and one has been isolated and characterised from pig kidney (Chen et al., 1997); 
more recently an asparaginyl endopeptidase has been cloned and sequenced from mouse 
and the recombinant protein expressed and characterised (Chen et al., 1998). 
Figure 3.7 	Nucleotide and deduced amino acid sequence of the Toxocara canis legumain (Tc-aep-1) 
1 GTT CAC TTG GTA CTC ATT CTG CTC TCT CTT CTC TAT AAC TCC TGT GAA TCG AAA CGA TTT CTT CAC TAT AGA CCG 75 
V 	H 	L 	V 	L 	I 	L 	L 	S 	L 	L 	Y 	N 	S 	C 	E 	S 	K 	R 	F 	L 	H 	Y 	R 	P 
76 TTA AGG ATA AAT AAA GAA CTG AAC GAA CCA AGC GAA AAT CAT CCA CGA ATA TGG GCT CTG- CTT GTG GCC GGT TCA 151 
L 	R 	I 	N 	K 	E 	L 	N 	E 	P 	S 	E 	N 	H 	P 	R 	I 	W 	A 	L 	L 	V 	A 	G 	S 
152 AAC GGC TGG TTC AAT TAC CGA CAC CAG GCT GAC ATT TGT CAT GCG TAC CAT ATA TTG AGA AGG CAT GGC ATT CCT 227 




CAA GAA CAC ATT ATA ACG ATG ATG TAC GAT GAT GTT GCC AAC AGT AAG GAG AAT CCA TAC CCC GGC AAG TTA TAC 303 
Q 	B 	H 	I 	I 	T 	H 	H 	Y 	D 	0 	V 	A 	N 	S 	K 	B 	N 	P 	Y 	P 	G 	K 	L 	Y 
304 AAT AAA CCA CAT GGA GAA GAA GTG TAT CAT GGA GTG AAG ATC GAT TAC AGA GGG GTT GAT GTC ACA CCC AAA AAC 379 
N 	K 	P 	H 	G 	E 	E 	V 	Y 	H 	G 	V 	K 	I 	0 	Y 	R 	G 	V 	0 	V 	T 	P 	K 	N 
380 TTT CTT GCA GTG CTG CAA GGA AAT GCG AAC GCG GTT GAG GGT GGA AAC GGA CGG GTC ATA AAA AGC AAT GCA CAT 455 
F 	L 	A 	V 	L 	Q 	G 	N 	A 	N 	A 	V 	B 	G 	G 	N 	G 	R 	V 	I 	K 	S 	N 	A 	H 
456 GAC CAC ATA TTT GTC TAT TTC AGC GAT CAC GGC GCT ACT GGA TTG ATC GCT TTC CCT GAT GAT ATT TTG AGT GCT 531 
D 	H 	I 	F 	V 	Y 	F 	S 	0 	H 	G 	A 	T 	G 	L 	I 	A 	F 	P 	D 	D 	I 	L 	S 	A 
532 AGT GAT CTA TAC ATG GCA TTG AGG AAC ATG CAT AGA AGA AGA CAC TTC GGT CAA CTC GCC TTC TAT TTA GAA GCG 607 
S 	D 	L 	Y 	H 	A 	L 	R 	N 	M 	H 	R 	R 	R 	H 	F 	G 	Q 	L 	A 	F 	Y 	L 	B 	A 
608 TGT GAA AGC GGT TCT ATG TTC AAG GGA ATT CTT CCA AAA GAC ATA GGC GTC TAT GCG ATG ACG GCA GCG AAC GAT 683 
C 	B 	S 	G 	S 	N 	F 	K 	G 	I 	L 	P 	K 	D 	I 	G 	V 	Y 	A 	H 	T 	A 	A 	N 	D 
684 CAC GAG AGT TCA TAT GGT TAC TAC TGC GAC AAC GAT ATG AGC CTT CCA TGC ATG GGT GAT CAG TTT TCG ATA AAC 759 
H 	B 	S 	S 	Y 	G 	Y 	Y 	C 	D 	N 	0 	H 	S 	L 	P 	C 	M 	G 	D 	Q 	F 	S 	I 	N 
760 TGG ATG GAG GAT TCA GAC GTT GAG CAA CTC AAT AAG GAG CTC ATC GAA TGG CAA TAT GAG ATT GTC AAG ACA AAG 835 
W 	M 	E 	D 	S 	0 	V 	E 	Q 	L 	N 	K 	E 	L 	I 	B 	N 	Q 	Y 	E 	I 	V 	K 	T 	K 
836 
11 
ACC AAT CTG AGT CAC GTG ATG CAA TAC GGC AAC CTA TCG ATC GGG AA CAG TTC GTT GCC GAC TTT CAG GGA TGG 911 
T 	N 	L 	S 	H 	V 	M 	Q 	F 	G 	N 	L 	S 	I 	G 	K 	Q 	F 	V 	A 	D 	F 	Q 	G 	W 
912 AAA AAA GCA TCG CAA CGC AAA GTT TCC AAT TAC CCT GAA TCG CCA GTA TCA GCA TGG CCT GTT CGA GAC ATT CCA 987 
K 	K 	A 	S 	Q 	R 	K 	V 	S 	N 	F 	P 	E 	S 	P 	V 	S 	A 	W 	P 	V 	R 	D 	I 	P 
988 ATG TTA ATG CTT CGC AAA CAG CTA AGT CAA GAA GAA AGC ACA GAC AAA CGA ATC GAA ATT ATC AAC AAA CTC AGA 1064 
H 	L 	M 	L 	R 	K 	Q 	L 	S 	Q 	B 	E 	S 	T 	D 	K 	P. 	I 	B 	I 	I 	N 	K 	L 	R 
1065 AAA CTT CAG CGA AAG CGC GAA TAC CTG GAC AAC TTT ATG ATG GGT TTG GTT GAG GCG ATC ATT CAT GAC CCA GTC 1140 
K 	L 	Q 	P. 	K 	R 	E 	Y 	L 	D 	N 	F 	N 	M 	G 	L 	V 	E 	A 	I 	I 	H 	D 	P 	V 
1141 AAC CAA CTG CGT GCC CTC AAC AGC CAT CCT CGG GCG CTT ACC AAT TTG AAG TGC CAT GAT AGG CTT GTC AAA GCA 1216 
N 	Q 	L 	R 	A 	L 	N 	S 	H 	P 	R 	A 	L 	T 	N 	L 	K 	C 	H 	0 	P. 	L 	V 	K 	A 
Ff_  1217 T  CAT CGG CAC TGT TTC AAC TTC AGT CAC AAT CCT TAC GCA TTG AAG TAT GCG TTC GTT TTG GCT AAA AAA TGT 1292 
F H R H C F N F S H N P Y A L K Y A F V L A K K C 
NE 	 iii 
1293 GAG GAA CGA ATC GAT GCT GAA ATT GTT ATT AAC AAA CTG ATA GAA CAC TGT TAC GAT ATT CAA ATA ACT GCT ATA 1368 
E B R I D A B I V I N K L I E H C Y D I Q I T A I 
1369 fHC TAA TTG TCT TTT TGT AAA GTT GTT AAT TTT GGA AAA AAA AAA AAA AAA AAA 1423 
Y * 
A Tc-EST-262 R 5' CAG TGC CGA TGG AAT GCT TTG AC 3' 
B Tc-EST-262 R 5' CCG GGG TAT GGA TTC TCC PTA CTG TTG GC 3' 
C Tc-EST-262 F 5' CAT GGA GTG AAG ATC GAT TAC AGA GGG 3' 
i P0-262-pET 15b F 5' CGG CGC GGA TTC AGC GAA AAT CAT CCA CGA ATA TGG GCT CTG 3' 
ii Tc-262-pET 15b R 1 5' CGG CGC GGA TCC TTA CCA TCC CTG AAA GTC GGC AAC GAA CTG TTT 3' 
iii Tc-262-pET 15b R 2 5' CGG CGC GGA TCCTTA AGT ATA TAG CAG TTA TTT GAA TAT CGT AAC A 3' 
The translated sequence shows the primers designed to obtain the full-length clone from the cDNA library. Also indicated are the pET 15b (Novagen) primers 
designed for future expression of the AEP in the bacterial system. The arrow indicates the predicted cleavage sites and the underlined segment refers to the putative 
leader peptide. The potential N-glycosylation sites are shadow underlined. 
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Figure 3.7 shows the deduced amino acid sequence of Tc-aep-1. The full-length sequence 
as determined from the insert from the cDNA library was obtained as outlined in Chapter 2: 
materials and methods. Two 3' primers were designed (Tc-262 pET 15b RI and R2) 
based on the cleavage patterns highlighted in (Takeda et al., 1994). The full-length cDNA 
sequence comprises 1423 bp (inclusive of poly A tail) with an open reading frame of 455 
amino acid residues. Amino acid translation of Tc-aep-1 showed that the 5' end of the 
cDNA was missing albeit by one amino acid (Figure 3.8). PCR was performed using the 
gene specific primer Tc-EST-262 R with vector primers to amplify the remaining fragment 
from the cDNA library, but this proved unsuccessful. 
The pileup in Figure 3.8 shows Tc-AEP-i with six of the highest ranking homologues as 
determined by database searching. As can be seen from this figure, the Toxocara canis 
AEP shares a high degree of homology with species as diverse as mammals and plants. At 
present no active site domains have been elucidated for this novel family of cysteine 
peptidases. Chen et al (1997; 1998) showed the presence of an RGD motif in both mouse 
and human AEP, a similar sequence appear in those of the flukes as a KGD motif. The 
amino acid sequence QGN appear in Tc-aep-1 which may represent a divergent member of 
the RGD sequence motif. This motif may be involved in processing of the mature enzyme. 
RGD or Arg-Gly-Asp is a motif present in cell adhesive proteins and allows binding to 
their respective receptors. It has been shown that a mutation of this motif results in a loss 
of processing activity of intracellular proprotein convertase (PC 1) (Lusson et al., 1997). 
The clone Tc-aep-1, as shown in the pileup of Figure 3.8 bears strong homology to 
asparaginyl endopeptidases (AEP) from a number of different species, including those 
from Schistosoma japonicum and S. mansoni. In schistosoma, AEP is thought to be a 
factor involved in host blood digestion (Dalton et al., 1995a; Dalton et al., 1995b; Davis et 
al., 1987) . This clone was isolated only once out of the initial 332 clones picked, 
suggesting that it is not a major product of this lifecycle stage. Sequence analysis shows 
that significant differences exist between the species. In terms of N-linked glycosylation 
the T. canis clone has three potential glycosylation sites, whereas the C. elegans, S. 
japonicum, S. mansoni and Vicia sativa (vetch) all have two. In contrast both known 
mammalian AEPs have 5 N-linked glycosylation sites. The function of AEPs is still 
somewhat unknown. In flukes it is thought to function as a haemogiobinase in digesting 
host blood. In plants these novel enzymes are thought to play roles in the processing of 
II 
seed storage proteins (Bottari et al., 1996; Jung et al., 1998; Scott et al., 1992) and also in 
the processing of lectins (Min and Jones, 1994) (Sheldon et al., 1996). 
Through a collaboration with Dr. Andrew Dowd (Dublin City University) AEP activity has 
been confirmed in somatic extracts (TEX) of larval T. canis. Further work is presently 
being carried out to determine the presence of AEP activity within TES material. 
Figure 3.8. 
Toxocaracanjs 	 I F111  L 	L I L L S L L 	N S C E S K R F ----- 20 
Ce. T28H10.3 I 	 M R P L A L L I =I VIL FV T EER  V ----- 21 
MiAsmusculus 	 I MTWRVI\IVLLSLVILGAGAVpVG ----- 21 
Homo sapiens 1 	 MVWKVAVFLSVALGIGAVPI ------ 20 
Schisiosomajaponicum 	1 M FY s  F F II L 	IV L 	D[N ------ 19 
S.niansoni 	 I 	 MMLFSLFLISI LHILLVKCQL ----- 21 
Vicia saliva I M G S S Q L S T L L F F T I V V T F L T \' V S S G R D L P G 30 
Toxocaracanjs 	21 - - - - L 	Y R P L R I N K 	L NP S EN H P R I WA I, L 46 
C.e.T28H10.3 22 	---NPRKGLAAGR RKHKYQDEGE-\1VVL 47 
Miss musculus 	 22 - - - - V - - - - - - - - - - - - -D D P E D H G K H 	V V I 35 
Homo sapiens 21 - - - - - - - - - - - - - - - - - -DDPEDGGKHWAVI 33 
Schislosomajaponicum 	20 - - - - - - - - - - - - - - 
nF 
V S E E N 
V
V D D N H K W A V L 35 
S.mansoni 	 22 - - - -D - - - - - - TNYVSDETSDNNKWAvL 41 
Vicia saliva 31 D V L R L P S E T S R F F RP K '41 D D D F E G T N W A I L 60 
Toxocaracanis 47 V A G S N G W F N Y R H Q A D I C H A Y H I L R R H G I PIQ 	76 
C.e.T28H10.3 48 VAGSNGWYNYRIIQADvAHAyflLRNflGIpE 77 
Masmusculus 36 VAGSNGWYNYRHQAD\CHAYQI IHRNGIPD 65 
Homo sapiens 34 VAGSNGWYNYRHQAD-  \CHAYQI IHRNGIPD 63 
Schislosomajaponicum 36 V A G S N G F E N V R H Q A D V C H A Y H V L I. S K G V K P 	65 
S.,nansoni .12 VAGSNGVPNYRHQADVCHAYHVLRSKGIKP 71 
Vicia saliva 6/ LAGSNGYWNYRHQSDVCHAYQLLRKGGSKID 90 
Toxocaracanis 	77 H H I I T MM Y D D V A NIS KL
DN 
V P G K L V N K P H G F 106 
C.e.T28H10.3 78 EI I TMMYDDVANNP YKGKL FNRPHGK 107 
Mus ,nuscuius 	 66 E Q I I V M M V D D I A N S F I P G \' V I N R P N G T 95 
Homo sapiens 64 H Q I V V M M Y D D I A Y S F I PG I V I N K P N GI 93 
Schislosomajaponicum 66 EH I I T F M Y D D I A H N KF P G K I F N I) VN H K 95 
S.rnansoni 	72 EH II TMMYDD I AYNL P LGKL FNDY NHK 101 
Vicia saliva 91 	f1UTMV D D I A S N FN P G V LIJ I IN K P D G D 120 
Toxocaracanis 	107 E V Y H G V I I D Y N GIVID V T P K N F L A V L Q GINN 	136 
C.e.T28H10.3 10.8 D L V K G L K I D Y K G A S V T P F. N F LV L K 	 G 137 
Musmusculus 	 96 DVYKGVLL
DY'Lj 
EDVTPENFLAVLRGDAE[X125 
Homo sapiens 94 DV Y Q G V P E DV T P Q N F LA V L N H I) A HAl 123 
Schistosomajaponicnnz 96 DflY K G V V 	K K V N P K T F L[V L H I)K RIAI 125 
S.nzansoni 	 102 DJY F G V V K K VN S K T F L K V L U I) K S 	131 
Viciasalii'a 121 DVVAG VIP 	 AEVHADNFYAALLG\KS150 
Toxocaracanis 	137 FV1E[1- fN G R V I K S NIA HID B I F V Y F S D HGA T 	fl 165 
C.e.T28H10.3 138 I D G - G N G R V LT NIDD R V F V Y F T 0 H G AIV GM 166 
Musmusculus 	126 V K G KG S G KY L K S GIPJJD H V F I Y F T D H GAIT G I 155 
Homo sapiens 124 V K G r G5 G K V L K S GIP[D H V F I Y F T D HG SIT G 1 153 
Schislosomajaponicum 126 G - - - - - -G K V L K S G K N D F V F I V F T D H G Al  P G 1 150 
S.nzansoni 	 132 U - - - - - GKVLKSGKNDDVFIYFTDHGJPGL 156 
Vicia saliva 151 	T- 	S G K V V I) S GP N D H I F V V V T D H GIG PIG V 179 
MacVector amino acid alignment of legumain sequences. Regions of identity are shown in bold capitals; 
regions of change are shown in capitals. The N-glycosylation sites are highlighted in green. The RGD 
sequence is indicated in brown with the conservative change in orange. The arrow indicates the putative N-
terminal G1y26 as hypothesised in ref (Chen et al., 1997). 
Figure 3.8 (continued) 
Toxocaracanis 	166 II A F P D DI- i[1s11sffly NIIA L RINIMH R R R 	FIG[fl 194  
Ce. T28H10.3 167 1 S F P D G - I LT V K Q L N I) V LE.JM_H K N K K Y  Q L 195 
A8.smusculns 	156 LFPND - DLHVKDLNLTIRYM YE HK[flYIQK\1 184 
Homo sapiens 154 L[JFPNE -DLHVKDLN} TIHYMYKHKJYIRKM 182 
Schisloso,n ajaponiculn 151 L A F P D D - D L H A K P F I N T L KY L R Q H R R Y S K L 179 
S.rnansoni 	 157 1AFPDD - ELYAKEFMSTLKYL H I S HKRYISKL 185 
Vicia saliva 180 LGNIPVGPYLY 	DLN AS k 	 H \LKKKASGTjKSL2l 
Toxocaracanis 	195 A 	V L K A C K S G S M FIR 6 I I L PIKID I 0 V Y AINIIT A A NI 224 
C.e.T28H10.3 196 IjF V I. K A C ES G S MJL I 	LSID NIDI Y AjJS A A NI 225 
lvmas,nuscuius 	185 V F V I E A C E S G S MINI N - JIlL P 1) ID I N V V A T T A A NI 213 
Horno sapiens 183 V F Y I E A C K S G S MINI N - FIlL P D1I N V V A T T A A NI 211 
Schistosornajaponicum 180 V I V V E A C K S G S M A CJ 	L P 1 fl I N I V A T T A A 	200 
S.mansoni 	 186 V I V I E ADC S G S M F Q Q I L P S 	J.I Y AT T A A 215 
Vicia saliva 210 V F Y L E A C E S G S I F F F L L P H D F N V A T T A S NI 239 
Toxocara can is 	225 DHESSY(;YYCDIN - - - - - --DMSLPCMGDJT 	248 
C. e. T28H10.3 226 S H K S S NV C T F C KIN -------D NI N L P C L G D L F S 249 
Musmusculus 	214 PKESSYACYYDI - - - - - - - -EERGTYLGDWYS 236 
Homo sapiens 212 P R ES S V A C V Y DI - - - - - - - -E K R S T Y L G D NV V S 234 
Schislosomajaponicwn 210 ~PD] E S S V A T F CJD ------P R IS S C LRD L Y S 233 
S.'nansoni 	 216 	K C S Y S T F C G D ------- --- I T T C LJI) L V S 239 
Vicia saliva 24(3 	E S S I\ 	Y Y C1 11 C D K P P P P P E V S T C L G D L V S 269 
Toxocaracanis 	249 1 N W  K D S D V E L N K EL I C W Q Y I I V K1 K T N L 278 
C.e.T28H10.3 250 V N WMDD S DDE 1 lL 	T L C I Q Y F L V K K F T C 279 
Musn2usculus 	237 V N W  K D S D V K DIL T K K T L II K Q V 1-I L  KS II T N I 266 
How sapiens 235 V N W M K D S I) V E DI C T K E T L II K Q V H L V K S I! T N I 261 
Schistosoinajaponicum 234 V DWIflDS L Is 11 QILTQPflTL D Q Q Y KP1V K F E TN! 263 
S.mansoni 	 240 YI N W I  [JD S Q T II 1-LILT Q KI T L D Q Q V KUV KR F. T D L 269 
Vicia saliva 270 I A WM E D S E VI I, NUJQ TIE S LIT1Q Q Y K L V K 	-. I I S 299 
Toxocaracanis 	279 S - - 	- H V M Q V GS I G K Q F V A D F Q G NV K K A 	301 
C.e.T28H10.3 280 S - - 	- H V M Q F G  KID I A K E A V A L F Q G  K  D R 305 
Has ,nusculus 	267 S - - 	 - H V M Q Y G N K I S TM K V NI Q F Q G NI K H R A 292 
Homo sapiens 265 S- - -  HVMQYGN Eli 
SK
290 
Schistosomajaponicum 264 S - - - - H V Q R V G DJK M G K L V C S E F Q G S R K K A 289 
S.mansoni 	270 S----- HVQRYGDTRMGKLYVS EF GSRDKS 295 
Vicia saliva 300 K P V G S H V M F Y G D I C L S K N D L V Q V F G T N P A N 329 
Toxocara canis 	305 - - - - - - - Q R K V S N V 	P V S 	wll v lR 5ipsil F 327 
C.e.T28H10.3 306 K ----------- ---------329 
Musmusculus 	293 - - - - - - - -S S P I S L PFTVT H L D L T P S P D V P L T 315 
Ho,nosapiens 291 - - - - - - - -SS PV PLPPVTHLDLTPS PDV PLT 313 
Schistosomajaponicum 290 - - - - - - - - r E H D E P P M K P K D S I P 5 R U I P L H 312 
S.mansoni 	 296 - - - - - - - -STENDESPMKPRHSIASRDIPLH 318 
Vicia saliva 330 DNNSFVDETEN5LKLRTPSAAVNQRDADLI 359 
The GenBank accession numbers are: Tc-aep-1 (5': AA8251 16 & AA875769; full-length sequence has not 
yet been deposited), C. e1egws T28H10.3 (Z75551), Mus rnusculus (legumain) (AJ000990), Homo sapiens 
(Cysteine protease) (D55696) 
Figure 3.8 (continued) 
Toxocaracanis 	328 XI L R K Q LISE - F S T D KI EriflN1flRFL Q R[ 	356 
C. e. T28H10.3 330 H LQ 11 RJK S - N D L L S S N K L F Y K I N R I K E I R 358 
Musnzusculus 	316 1 LKRKLLRT -NDVKESQNLIG 	IQQFLDAR 3.14 
Homo sapiens 314 IMKRKLMNT -NDLEESRQLTEIiIQRHLD\R 342 
Schislosomajaponicum 313 I L H R R I M NI A - N N M N D K T L L M K I L G L K L K R R 341 
S. Inansoni 	 319 T L H R Q I M NI I - N N A F D K S F L M Q I L G L K L K R R 347 
Vicia saliva 360 I1FWEJ1:RKAPEGSSQKNE.NEK 	V L E A M S H R 389 
Toxocara canis 	357 F Y L D N F hi NI D FL V E A 0 I H D P V N - Q L R A L - - N S 383 
C.e.T28H10.3 359 RN I KR N V H M I V Q K F FDGS ED LI SRV 	- L 	386 
MJAsnusCu1Us 	345 H 	I E 	SVHK IVS LLAFG FT 	- A E R H - LS 370 
Homo sapiens 343 H L I E K S V RIKI I V S L LA A SA F -E Q 	- L S 368  
Sc/zislosomajaponicurn 342 DLIKDTMLVIIDQFIMFNVKQP - - - - - - - - NS 363 
S.mansoni 	 348 DLI EDTMKL IVKVMNN EEl P - - - - - - - - NT 369 





VKAFHRHCFNIX --HN 411 
C. e. T28H10.3 387 Q T R P V L H I-I I V II K
DKC 
N F N - - E Y 414 
Mus musculus 	371 E R 
A~EP 
L I N Q K V I H F N NV I-I S V T Y 4) 
Homo sapiens 369 F R 	L I Y P EL I. H F NW H S P T Y 398 
Schistosomajaponicum 364 N A D F I F V V N K E F K I Q -- Q A 391 
S. mansoni 	 370 K A T I I) Q I E S V Y K Q 	F I L 	- - Q A 397 
Viciasativa 420 H S P LV D I. KT NI V K T C; S L S - - - - 445 





IlV1I NKflI LH 441 
C. e. T28H10.3 415 	A M K V V K V I NY R R I KI V L - A L P D 1 443 
Mus musculus 	401 E A L R Y K Y V L A 	A P Y P 1 	I F NI A NI I) K V 430 
Homo sapiens 399 EYALRHLYVLV KPYPLHRIKLSMDHV 428 
Schislosomajaponicu,n 392 PEITGYLST LY KGYSAENINGVIRKV 421 
S.,nansoni 	 398 PEVGGHFSTLY DGYTAETLNFAI 1K! 427 
Vicia saliva 446 	GHR S F A 	A G I P N LEJ P M A F A S A Q A 475 
Toxocaracanis 442 [Y D I Q I T A I V 451 
C. e. T28H10.3 434 C NI I) I D I E Q E V A I R L E K E F L 462 
Mus tnusculus 431 C L 	S 1-I V 435 
Homo sapiens 429 C K G H Y 433 
Schistosomajaponicum 422 C H 423 
S. ,nansoni 428 C H 429 
Vicia saliva 476 ICIA S I P A N P W S S L Q H H F S A 493 
Schistosoma japonicum/SJ32 (Hemoglobinase) (X70967), Schistosoma mansoni/SM32 (Hemoglobinase) 
(M21308) and Vicia sativa (Cysteine proteinase) (Z34899) 
3.3.13 Transporters and Receptors 
One clone homologous to the acetylcholine receptors from other nematodes (C. elegans, 
0. volvulus and Trichostrongylus colubriformis) (Fleming et al., 1996) was isolated. A 
relatively frequent transcript (5/263) encodes Tc-PEB-1, a previously identified 
phosphatidylethanolomine-binding protein (Gems et al., 1995) which was present in 
parasite secretions as a 26-kDa protein (TES-26). 
3.3.14 Structural Proteins 
Few structural proteins were identified in the EST dataset, probably reflecting the arrested 
state of the parasite stage from which the cDNA library was constructed. Actin (Zeng and 
Donelson, 1992) and calponin (Irvine et al., 1994) from parasitic nematodes have 
previously been characterised. For nematode tubulins, most attention has focused on the 
13-tubulins (Guenette et al., 1991), with which benzimidazole resistance is associated. Tc- 
tua-1 has similarity to C. elegans and S. japonicum ct-tubulins but no sequence from a 
parasitic nematode appears yet to have been reported. 
3.3.15 Protein Synthesis and Modification— 
Two genes essential for protein synthesis (elongation factors la and lb) were identified, 
as well as peptidyl-glycine alpha-hydroxylating monooxygenase, which modifies the C-
terminus of peptides. Protein disulphide isomerase (PDI) is a well-known requisite for 
protein folding and correct formation of disulphide bonds and a homologue from 0. 
vovulus has been characterised (Wilson et al., 1994). Peptidyl-prolyl cis-trans-isomerase 
is similarly essential for correct protein conformation; the Tc-ppi-] however is not related 
to the multi-gene cyclophilin family of PPIs described from C. elegans (Page et al., 
1996). Interestingly, although 4 clones were found to encode a protein tyrosine 
phosphatase, all correspond to the same transcript. No protein kinases were found by 
homology searches. 
M11 
3.3.16 Glycolysis, Respiration and other Metabolic Enzymes and Citric Acid Cycle_ 
Some 18 distinct metabolic enzymes were found to have high levels of similarity 
(p = 10 25  or higher) to T. canis ESTs, and to represent the major metabolic pathways of 
glycolysis and aerobic respiration, as well as essential processes such as amino acid 
synthesis and degradation. Particularly prominent among these is cytochrome c oxidase 
subunit 11(25/263 = 9.6% of all clones). It is difficult to account for the extremely high 
level of this transcript, but it may be connected with the imperative for nematodes to 
minimise oxidative stress. 
3.3.17 Anti-oxidants:-Superoxide Dismutases (SODs) 
Oxidative stress is known to have highly detrimental effects on both parasitic (Ou et al., 
1995) and free-living (Ishii et al., 1998) nematodes. In tissue-dwelling parasites, reactive 
oxygen intermediates are likely to be released by aggressive granulocytes, and expression 
of anti-oxidants such as glutathione peroxidase (GPX) and/or superoxide dismutase (SOD) 
is to be expected. In previous work, a SOD (Tc-sod-J) was obtained via a degenerate PCR 
from T. canis cDNA, although no GPX activity was detectable in parasite extracts 
(Matzilevich et al unpublished). The EST dataset contained 7 clones encoding SOD 
isoforms, all quite distinct from Tc-sod-1 (approximately 66% divergence in amino acid 
sequence) and showing more similarity to C. elegans gene F55H2. 1. Moreover, the 7 
clones fall into 4 consensus sequences, each showing 10 - 20% divergence in nucleotide 
and deduced amino acid sequence, including two codon insertion/deletions (indels). 
Although sequence data is still incomplete for one of the clones (Tc-EST-084 = Tc-sod-2), 
this level of divergence led us to designate these 4 isoforms as separate genes, namely Tc-
sod-2, -3, -4 and -5. Figure 3.9 shows an amino acid pileup of the 5 SODs. From the 
pileup it can be seen that all the T. canis clones share the same catalytic and metal ion 
binding sites as those as those shown for a number of helminths in (Liddell and Knox, 
1998). The cysteine involved in intrachain disulphide binding is also highlighted. 
Both Tc-sod-1 and -sod-3 have 2 potential N-linked glycosylation sites, whereas Tc-sod-2, 
-sod-4 and -sod-5 have three such sites. The results of the BLASTX database survey are 
suggestive that all five SODs are probable extracellular proteins. These results also serves 
to highlight the level of variation existing between each SOD. Tc-sod-1 has 72% (121/168 
amino acid) identity to the copper/zinc (Cu/Zn) extracellular SOD precursor from Brugia 
pahangi; the partial sequence for Tc-sod-2 and Tc-sod-5 show a 40% (54/133 amino acid) 
and 44% (80/182 amino acid) identity respectively, to an SOD-4 isoform from the free-
living nematode C. elegans; Tc-sod-3 shows a 42% (77/182 amino acid) identity to a 
Cu/Zn SOD from the bacterium Candida albicans; Tc-sod-4 exhibits a 47% (86/182 amino 
acid) identity to the predicted Cu/Zn extracellular SOD from C. elegans. Both Tc-sod-2 
and -sod-5 have been sequenced a sufficient number of times to significantly reduce the 
possibility of sequencing error. Also from the blast result the regions of homology are 
significantly different to suggest that although both homologous to the same protein they 
are in fact different genes. 
Confirmation of this assignation will require full-length sequencing and hybridisation of 
i soform- specific probes to Southern blots of T. can is DNA. 
eke 
	
sod-] 	1 KTOL LLAF ILA IF IL ITYA - QN PH SI11_ --1 	26 
sod-2 1K I G A T - SLLLLCP I N L S _ASQNAAVRIGRAT 28 
sod-3 	1K bAT - SLLLLCF IHLS - ASQKAAVRIGRAT 	28 
sod-4 1 	I G A T - SLLLLCF I11LS _ASQKAAVRIARAY 28 
sod-5 	IN bOAT - SLLLLCF I N L S -ASQMAAV1ARAT 	28 
sod-I 	27 -Y D S ITDR R1IV TK T PA IVV LK-[1[]GVG I 52 
sod-2 29 LFRAQNNNNA - 	PFNLAGMVDFRQDSLN 54 
s
0 
d-3 	29 LFjJAQNDPNA - -- -PFKPAO IVDFRQDSLS 54 
sod-4 29 LFRAQNLN SA - - - -PFT LAOMVDFRQE SLN 54 
sod-5 	29 LFRAQNDTIA - ---PPM PAG IVDFRQDSLS 54 




HG L 	50 -  - -  -  -  -  -  - -FSVH 75 
sod-3 	55 	IVNGSVROLTA -HAL -50 ---------FVH 	75 
sod-4 55 	IVNGSVI_ - _ISG LAAG P110 - ------- -FSVH 74 
sod-5 	55 LVVNGTVRGLTAG L -- -G ---------FHVH 	74 
sod-] 	QYGDT 
if  	
I S A G PIIFNPY IlL 	GAP - - -T 107 
sod -2 76 H 100 IONS TAAAGS YHPFORN 	G A P A LMF 105 
sod-3 	76 P B 0 0 I 0 N jJ L A A L 0 Fl I N P F 0 H H 0 A P 5 L K F 105 
sod4 75 1 V 0 0 I 0 N G 	G A A M 0 IF I N P F 0 R N 	0 A P A L K F 104 
sod-5 	75 A N V 0 I 0 N N G A A L 0 Ii I N P F 0 H N 	G A P 5 L A F 104 
sod-i 	108 DIS  IRRJJTfrH - IX LP - - - - - - - G PflS I IGR 128 
sod-2 106 1VT  I H H V 0 L 0 H I Q A D 5 
KV 
I S 0 T i - - - H 132 
sod-3 	106 PT IR H V G 	L G H IQ AD G 	ISJT FL - - H 133 
sod4 105 P T I H H V 0 L 0 H I Q A D A I S G H F - - - H 131 
sod-5 	105 P T v H H V o 	L G N I Q A N A 	I S 0 H F - - - H 131 
sod-] 	.129 SEV El H A D Q D DILO_KIGEG  A El K Q _ES El ------ 151 
sod-2 133 	 132 
sod-3 	134 -V 3 L 	OP F S I TORT L IV H ANN DO L 0 L 0 GA P 162 
sod-4 132 G V 0 L V 0 P F S I I 0 H T L I V H E K P D 0 L 0 L 0 N D D 161 
sod-5 	132 G VOLVO P F S 110 R A L 	V H AN AD DL G L OHM 0 161 
sod-] 	152 - -El- IT 0 N A 0 IN IR V A C 0 I V IA S S G A P 	 171 
sod-2 133 	 132 
sod-3 	163 D S T T T 0 N A 0 N K V A 	0 I I 0 L L 	 182 
sod4 162 G SR A TO N A OS K VA 	0 110 L L 182 
sod-5 	162 5 S N T H 0 N A 0 G H F A 0 I I 0 V M 	 181 
Figure 3.9. Amino acid sequence alignment showing the level of divergence between the 5 superoxide 
dismutases (SOD). The putative N-glycosylation sites are indicated in green. The arginine (R) highlighted 
in purple may represent an alternative start. 
3.3.18 Ribosomal Proteins 
Twenty ESTs (comprising 13 different genes; 8.4%) encoded ribosomal proteins. This is 
within the range found with EST projects of other nematodes; for example, 8.5% 
(1,339/15,811) Brugia malayi ESTs deposited are ribosomal (Blaxter, M. pers. comm.), as 
are 5.0% (11/218) of Necatoramericanus ESTs (Blaxter, M. pers. comm.). 
3.3.19 Other Proteins 
Some ESTs had homology to mammalian proteins for which a function in nematodes is not 
obvious. Five particularly interesting findings were noted: 
3.3.20 Granulin/epithelin precursor (Tc-gep-1) 
Granulins are synthesised as large (500 - 600 aa) precursors from which typically are 
derived 7 small (-S  60 aa) 12-cysteine peptides with growth-factor-like activity (Bhandari et 
al., 1992) (Belcourt et al., 1993) (Zhou et al., 1993). Figure 3.10(a) shows these domains 
outlined on the amino acid pileup based on Plowman et al (1992) Mammalian and fish 
kidney epithelial cells are all rich sources of these peptides (Belcourt et al., 1993) 
(Plowman et al., 1992), as are human and rodent leukocytes, suggesting that granulins 
may fulfil cytokine-like functions (Bateman et al., 1990). If so, the synthesis of a 
granulin-like homologue by T. canis larvae may be important in the interaction between 
parasite and the host immune system. 
Mohammed Shoyab et al (Shoyab et al., 1990) isolated a pair of cysteine-rich growth 
regulators which they termed epithelins 1 and 2; epithelin 3 was later identified using the 
same purification protocol (Culouscou et al., 1993). These proteins were found to be both 
heat and acid stable (Plowman et al., 1992). The epithelins were first isolated from 
purified rat kidneys by their ability to inhibit the growth of a human epidermal carcinoma 
cell line (A431). Both epithelin 1 and 2 were structurally related but exerted antagonistic 
effects on each other (Shoyab et al., 1990). Epithelin 1 was shown to stimulate the 
proliferation of murine keratinocytes, whereas epithelin 2 inhibited the action of epithelin 1 
Ell 
on these cells. At around the same time Bateman et al (Bateman et al., 1990) isolated and 
characterised a family of novel cysteine rich peptides, of approximately 6 kDa, purified 
from leukocytes of the bone marrow of rats and humans. This family was composed of 
four peptides termed granulins or gm- A, B, C and D; partial sequence for four more 
granulin domains (grn-E, -F, -G and paragranulin) were also sequenced (Bateman et al., 
1990). By virtue of being the most abundant, granulin A was selected for a detailed 
sequence analysis. It was later found that both the rat granulins and epithelins were in fact 
identical, a fact alluded to by Bateman et al (Bateman et al., 1990) and later by Bhandari et 
al (1992). 
The pileup in Figure 3.10(a) shows the T.canis clone, designated Tc-egh-1, with its six 
closest homologues. The seven granulin domains as defined in (Plowman et al., 1992) for 
mouse, rat and human have been outlined. 
Due to the high cysteine content (approximately 20%) of these molecules it is suggested 
that the secondary structure of these growth factors may be an essential component with 
regards to their biological function. Evidence which is borne out by the evolutionary 
conservation shown in their sequence structure (Bateman et al., 1990; Hrabal et al., 1996; 
Shoyab et al., 1990). The structure formed by this concentration of cysteines has been 
termed the hairpin stack fold. This is a novel protein architecture unique to the 
epithelin/granulins. The structure also contains a subdomain shared by small toxins, 
protease inhibitors and the epithelin growth factor-like protein modules (Hrabal et al., 
1996). 
To further characterise the epithelin/granulin family of growth molecules Culouscou et al 
(1993) utilised the human breast carcinoma cell line, MDA-MB-468 in order to determine 
whether the epithelins had specific cell surface receptors. Using '251-epithelin in a 
competitive binding it was shown that the three epithelins were capable of binding the same 
receptor on the MIDA-MB-468 carcinoma cell line. Despite the binding of all three 
recombinant epithelins to the same receptor this did not preclude the possibility of each 
naturally occurring epithelin having its own specific receptor (Culouscou et al., 1993) as 
has been demonstrated for insulin growth factor I and II (IGF-1 & -II) in (Casella et al., 
1986). Apart from a unique subdomain shared with transforming growth factor-e (TGF-e) 
(Hrabal et al., 1996), the epithelin/granulins showed no strong sequence homology with 
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other molecules, growth factors or otherwise, in the database. Yet Shoyab et al (1990) 
showed that epithelin 1 elicited identical biological responses to epithelin growth factor 
(EGF), such as the stimulation of Balb/MK cells and the induction of anchorage 
independent growth of rat kidney cells in a dose dependent manner. 
To date the epithelinlgranulins have been identified from the rats, humans (Shoyab et al., 
1990) (Bateman et al., 1990) (Bhandari et al., 1992) (Belcourt et al., 1993), carp 
(Cyprinus carpio) (Belcourt et al., 1993) and locust brain (PMP-D1) (Nakakura et al., 
1992) and now in Toxocara canis. The precursor for the epithelin/granulin was isolated by 
Bhandari et al (Bhandari et al., 1992) and was shown to be a 593-residue prepropeptide 
containing seven tandem repeats of 12-cysteine epithelinlgranulin domains (Bhandari et al., 
1992). Figure 3.10(b) shows a schematic representation highlighting the presence of these 
domains in both Toxocara canis and C. elegans compared to those previously identified in 
rats (Plowman et al., 1992). A definitive function is still to be elucidated for these 
candidate growth factors. Xu et al (1998) demonstrated that the epithelinlgranulin peptide 
was capable of stimulating growth in a R- 3T3 cell line. R- 3T3 are cells deficient in the 
insulin growth factor receptor, and therefore incapable of growth in serum-free media 
supplemented with growth factors that would ordinarily facilitate growth in 3T3 cells 
without the disruption (Xu et al., 1998). The results of these findings suggest that 
epithelinlgranulins are able to bypass the insulin receptor substrate-i (IRS-1) mitogenic 
pathway, rejoining at a point common to many growth factors and mitogenic stimuli (Sale 
et al., 1995; Schlaepfer and Hunter, 1998; Whitmarsh et al., 1995). The significance of 
this finding is as yet difficult to ascertain due to the complexities of the mitogenic signalling 
pathways. More so in light of the fact that as yet no receptor for the granulin precursor has 
been identified (Xu et al., 1998). 
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Tc-e8h-1 	 290 L S S -Q IRRSQQARQ lEAK FLVCPDHR - TK 	56 
T22H22 53 V - TA - - - - SQ - - - - - - - - - - 	C _DA[i_TE 	63 
Granulin(rat) 	60 Y - T T 0 L M T K L P G Y P V N E - - - 	S C - D L B V S - 	83 
Acrogranin (mouse) 60 Y - TTD LLTS L P G Y P V K E 	- - VS C - DM BV S - 	83 
Granulin(human) 	60 NA T T D L L T K L P A H T V G D 	-- 	SC - DM 8 	S - 84 
PMP-DI(lccust) I 	 S C T - - B S T - 	6 
eNAP-1 (horse) 	1 - 0 
Carp Gran ulin2 1 	 0 
Carp Gran uhn 1 	1 0 
Carp Gran ulin3 1 	 0 
Figure 3.10 (a). Partial amino acid pileup of Tc-egh-1 with 9 relevant homologues as determined by 
database searching. Conserved cysteine residues are highlighted in blue. The red boundaries mark the 7 
epithelin domains as determined by sequence comparison from human, rat and mouse (Plowman et al., 
1992). The aspartic acid and histidine residues in green are found in all epithelins/granulins. Sequences 
used in the pileup were obtained from GenBank and SwissProt. 
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Tc-eg/i-1 	 87 	- Q E R G A Fl - - P1W W ifl 114 
T221-12.2 	 A D H K H 	P - 	- 	Ic I 120 
Granulin(rat) 	114 	 G V 0 Q -V lxi— —Ix I 140 
Acrogranin (mouse) 114 G I L Q - IV I w 	- - IX I 140 
Granulin (human) 	115 	 G P H Q - lj w - 	142 
PMP-D1(locust) 37 54 
eNAP-1 (horse) 	2 	 - 	 - 	 0 
Carp Gran ul)n2 1 0 
Carp Gran ulinl 	1 	 0 
Carp Granulin3 1 0 
Tr-egh-1 	 115 	K Q H A A K I G 0 K A A V N T K - - - P A $ N I C T D '1 T K 141 
T22U2.2 121 K K K - - - - - P A K K T V S K N Q F N E V V - C P D K A 5 144 
Granulin (rat) 	141 	K V T S. S 0 S L P 0 P Q I 0 - K N 0 V P - - - - C D D F S S 165 
Acrogranin (mouse) 141 K V I A P 0 K 0 P D P Q I L - K S 0 T P - - - - C 0 D F F K 165 
Granulin (human) 	143 	A - P A H 0 S L P 0 P Q A L - K R 0 V P - - - - C D N V S S 166 
PMP-Dl(locust) 55 54 
eNAP-1 (horse) 	1 	 0 
Carp Gran ul in 2 1 0 
Carp Gran uiml 	1 	 0 
Carp Granulin 3 1 0 
Tc-eg/-I 	 142 	 170 
T22112.2 145 174 
Granulin (rat) 	166 	 194 
Acrogranin (mouse) 166 194 
Granulin (human) 	167 	 195 
PMP-Dl (locust) 85 - -- 	- 	54 
eNAP-1 (horse) 	1 	 0 
Carp Granulin2 1 0 
Carp Gran ulinl 	1 	 0 
Carp Granulin3 1 0 
Tc-e8h-1 	 171 	- 188 
T221-12.2 175 F A - M I ----- 196 
Granulin (rat) 	195 	 G 0 K M V A S L S K 222 
Acrogranin (mouse) 195 0 0 7 M V A G L S K 222 
Granulin (human) 	196 	 0 S H I V A G L B K 223 
PMP-Dl (locust) 55 54 
eNAP-) (horse) 	1 	 0 
Carp Gran ul in 2 1 0 
Carp Gran ulin) 	1 	 0 
Carp Gran ulm3 1 0 
Tc-egh-1 	 189 	--------------188 
T22H2.2 197 -P -H ----------198 
Granulin(rat) 	223 	N P V K Q T T 0 L Q H 0 0 I C C 0 Q H T 5 C P V 0 Q F C C P 252 
Acrogranin (mouse) 223 SPAR OTT P L 	I 	DIG C DQ H F SC PVG 0 TC C P 252 
Granulin (human) 	224 	M P A R R A S 0 S H P N 0 I S C 0 Q H T S C P V G G F C C P 253 
PMP-Dl (locust) 55 54 
eNAP-1 (horse) 	1 	 0 
Carp Gran ul in 2 1 0 
Carp Gran ulinl 	1 
Carp Gran ul in 3 1 	 0 
XccPIE[T ROD V 55GM CNS 
XCCPT OT TOO PQ GAR C IG 
XC CPA GPO C NT E TG TO EL 
XCCPAGF OCR TEED TOEM 
8CC? AOF TCO TQKG TOE Q 
NC CPSG TV CD ED H RN C 10 
-CT A TN K C CE A EDO ES C C P L K G LC C K GA 
K C FOG S TC CL 0 00 DCC P V P A V C C A GM 
-C P SN N TC CR L S SO OW DCC PM PEA V CCL OH 
-CF TN N TC C K ON SO DR G CC P 5 PEA V C C S ON 
-C PS SD TC COLT SO ERG CC? I P E AV C Cs ON 
Q, FCCPROYK C -D EGO - CYRD 
LN C C PSO FTC N - -GO FC SQ N 
I DCC?  Q OF K CMOS 0 Y -C -Q K 
I NC C P00 FTC LAQ OF -C -Q  K 
I N C C? 00 FT CV A EGO -C -QR 
Figure 3.10 (a). continued. GenBank Accession numbers: Tc-egh-1 (5': AA836692 & 3': 




Gran uim (rat) 311 
Acrogranin (mouse) 311 
Granulin (human) 314 
PMP-Dl (locust) 55 
eNAP-1 (horse) 2 
Carp Granulin2 2 
Carp Granulin l 2 
Carp Granulin 3 2 
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Tc-egh-1 	 189 	 188 
T221122 	 199 	 - L R K FAST S INS K 210 
Granulin(rat) 	253 S L K S SW AC C Q LPN AV CC E D R Q H CC P A G V T 	282 
Acrogranin (Mouse) 253 S L K S S S A C C Q L P N A V C C E C S Q H C C P A G V V C 282 
Granulin(human) 	254 5 L S S S W A C C Q L P H A V C C H C S Q H C C P A 5 1 V C 283 
PMP-Dl (locust) 55 	 54 
eNAP-1 (horse) 	1 	 0 
Carp Gran ul in 2 1 	 0 
Carp Gran ulinl 	1 	 0 
Carp Granulin3 1 	 0 
7c-egh-1 	 189 - - - - - - C K 	V V V S K L A I K T S P A S S C T C S C S 212 
T22H12 311 5 A V S F L S K 5 5 C C C C S S S V S S 5 0 P 8 S C V C P 240 
Granulin (rat) 	283 N V K A H I C K K C A S S V Q P S M C C T F S S K V S N - - 310 
Acrogranin (mouse) 283 N V K A S T C K K 0 V C F I Q P P V L C T L S P K V G N - - 310 
Granulin (human) 	284 N V K A N S C K K K V V S A Q P A T F C A S S P N V S V K C 313 
PMP-D1 (locust) 55 	 54 
eNAP-1 (horse) 	1 	 0 	1 
Carp Granulin 2 I 	 V 	I 
Carp Granulin 1 	1 	 V 	I 
Carp Granulin 3 	1 V 	I 
Tc-egh-1 243 C H K G_V C C 	- S 	- H 	C C 	R 01 Q C - A 	E 0 0 XC V 	F 269 
T22HZ2 271 PC 	S N A 	I C C 	- E N - 	C C P A 0 1 H C - V C 0 G K C E K 297 
Granulin(rat) 337 PT]v C C R 0 0 5 H C C P 	I 0 F H C S A K 0 V K C C 5 366 
Acrogranin (mouse) 337 L- V P 	 C C 8 0 G S N C C P G 0 F H C S A 5 0 1 K C C R 366 
Granulin(human) 340 C_Cl5]R_H C C P A 0 F S C A A S U V K C C 8 359 
PMP-D1(locust) 55 1 54 
eNAP-1(horse) 28 0 V C L2J 	L~j H C C PV 0 F 46 
Carp Granulin 2 28 LO C C C S 0 0 8 H C CrH 0 5 5 C 0 	S I S T C C L 5 57 
CarpGranulinl 28 
RPF 
SM 	U Q C C S D GH C C S H 6 1 H C 0 	S 	T S K H C C R 57 
CarpGranulin3 28 LW U Q C C K D U K H C C S H G S H C C S TS sJTlc L R 57 
Tc-egh-1 270 N Q 	K L Q 	T T T S 	S 	L F N 	F 283 
T22H2.2 298 HAS TM 5 T S FM 	N V K CD 	ED 	ED Q 	I 318 
Granulin(rat) 367 K K T P 5 5 0 	I L L H C 	P A P N P L L 385 
Acrogranin (mouse) 367 K K 	I P 5 W C N F C R C P V 	P S 	P C C 385 
Granulin(human) 370 5 15 A P 5 5 D A P L R C 	P A C S Q 	C C 388 
PMP-D1(locust) 55 54 
eNAP-1 (horse) 47 46 
Carp Granulin 2 58 57 
Carp Granulin 1 58 57 
Carp Granulin 3 58 - 57 
Figure 3. 10 (a). continued. SwissProt Identification Numbers: Homo sapiens (Granulin) (sp1P28799), 
Locust (PMP-D1) (sp1P80059), Horse (eNAP-1) (sp1P80930), Cyprinus carpio (Granulin 2 - partial) 
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Figure 3.10 (b). Schematic representation of the aligned granulin sequences obtained from rat (accession 
no. M97750), T. canisi Tc-egh-1 (accession nos. 5' AA836692 and 3' AA836693) and C. elegans 
/T221-12.2 (accession no. Z81595) 
3.3.21 Lupus autoantigen homologue (Tc-lah-1) 
The autoimmune disease systemic lupus erythrematosus (SLE) is characterised by high 
levels of autoantibodies to DNA and nucleic acid-associated proteins (Kotzin, 1996). The 
Lupus Autoantigen (also known as Sjogren Syndrome type B antigen, or SS-B) is a 
ribonucleoprotein which shows a high degree of conservation between animal phyla. 
Autoimmune responses can be initiated by infectious agents (Oldstone, 1987), and in a 
related example, the RAL-1 product of Onchocerca volvulus, which is homologous to the 
Sjogren Syndrome type A antigen, has been shown to stimulate high levels of antibody 
(McCauliffe et al., 1990). 
3.3.22 Olfactoinedin (Tc-ofm-1) 
A T. canis homologue of the olfactomedin gene family was found. The prototype gene 
was found to encode a 57 kDa glycoprotein in the extracellular mucous matrix of the 
olfactory neuroepithelium of frogs (Yokoe and Anholt, 1993), but additional homologues 
are now known to be widely expressed in mammalian brain (Karavanich and Anholt, 
1998). An olfactomedin homologue has been found in C. elegans, and Tc-ofin-] shows 
maximum similarity to this sequence (Figure 3.11). As T. canis larvae produce high levels 
of mucins, including those constituting the surface coat (Gems and Maizels, 1996; Page et 
al., 1992b), Tc-ofin-1 protein may be involved with the mucous layers in this parasite. 
Analysis of the primary structure of olfactomedin has linked the glycoprotein with 
extracellular matrix proteins of which include the neural cell adhesion molecule 
(N-CAM), laminin, fibronectin and proteoglycans. These extracellular proteins have all 
been implicated in adhesion, maintenance, migration, growth, or differentiation of 
neurones (Reichardt and Tomaselli, 1991), thus by analogy it could be suggested that 
olfactomedin may be able to function in a similar manner to the olfactory epithelium (Yokoe 
and Anholt, 1993). Recently, Nguyen et al (1998) showed the presence of a glycoprotein 
in the trabecular-meshwork-inducible glucocorticoid response gene (TIGR) of the eye that 
showed significant homology to olfactomedin. Mutations in these olfactomedin related 
domains have been linked closely with a large number of cases of primary open-glaucoma, 
a disease responsible for blindness in 1 out of every 100 individuals over the age of 40 
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(Stone et al., 1997). Kubota et al (1997) described the identification of a protein they 
termed "myocilin" as a result of its homology to myocin and its preferential localisation to 
the ciliary rootlet and basal body of the connecting cilium of photoreceptor cells. Myocilin 
was shown to have significant homology with myosin in the N-terminal region and with 
olfactomedin in the C-terminal region, a characteristic not seen in the frog olfactomedin 
(Yokoe and Anholt, 1993) or the rat related olfactomedin (Danielson et al., 1994); it was 
however found in the non-muscle myosin of Dictyostelium discoideum. The myocilin 
cDNA sequence differs from TIGR by only a 2 base pair GA insertion at nucleotides 104-
105 (Kubota et al., 1997). 
The olfactomedin homologue isolated as part of the EST project bears little similarity to 
myocillin or TIGR. The homology obtained is due to the fact that both the aforementioned 
proteins have an olfactomedin like domain within their sequence. From the pileup in 
Figure 3.11 it can be seen that there is significant similarity between the C. elegans clone at 
the 5 prime end of the gene. This similarity extends to encompass similarities with both the 
frog olfactomedin and the rat AMZ protein (see Chapter 1: Introduction). The pileup of the 
conserved sequences in Figure 3,12 show this level of homology more clearly. As can be 
seen from both Figures 3.11 and 3.12 there are 7 domains found in C. elegans, frog and 
rat. Of these 7, Domain 1 is absent from the T. canis sequence. The reason for this 
absence could be attributable to the fact that the T. canis sequence is 5' truncated. This 
suggestion seems somewhat unlikely as there is a putative start methionine present, 
although this is yet to be confirmed. The more likely explanation would be that the loss of 
Domain 1 was an evolutionary modification of the parasites protein. Perhaps this domain 
had no relevant function in terms of allowing the parasite to colonise a host or in parasite 
survival within the host. Identification of olfactomedin homologues from other parasitic 
nematodes bearing similar evolutionary changes would support the likelihood of this event 
having occurred. 
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Tc-O FM-i 	 1 	 0 
C.e.F11C32 I H V A T P K E P S L T N W T L S N N L I V A 0 E I 0 N V F L 30 
Frog olfzctomedin 	1 	 0 
Rat AMZ protein i 0 
Tc-OHM-1 	 1 	 PILLLRCIIEK PV 13 
C.e.F1JC3.2 31 I G V L Y L H A 1 1W L N T L H C N I S S F K N P 	S P p L 60 
Frog o1cto,nedin 	1 	 H I I C L L T L V L 10 
Rat AMZ protein 1 H Q 	A N K L L S L L V L L V 15 
Tc-ORvl-1 	 14 1 LR Q RN DVI Q Q F POD F 0 QM
IL 
- N DIII 42 
C.e.F11C32 61 S PA F V IR EN K KM PV DL ED - Q D TX I 69 
Frogol/Icto/nedin 	11 IRAAAAFVAQNATG - - - -  	 - KDIH --31 
Ra%AMZprotein 15 MG T K LTQ V L P TN- _EJS A QDT]_ - 41 
Tc-OFM-1 	 43 P K N V F B K B CIK N V H R I C A KIT G - H K L H 0 F Q 0 P 71 
C.e.F11C32 90 P N I V L 0 N B C S Q V H Q I C S K K S - Q N L T 0 F P 0 V 118 
Fmgoljiclomedin 	32 - - - - - - - - -C - -----VCDVLL__PD S S F P A K 46 
Rat AMZprotein 42 - - - - -I!IGRC ------ ICTVVAP ITQ 75 T 	C SRDP. 61 
Tc-OFM-1 	 72 R  P PG V Q 0 V AOL P OR RO 	OK VO PT G  nGN 101 
C.e.FJ1C3.2 119 K 0 S P G D Q 3 P V G P P 0 K K o p H 0 I V 0 P I 0 L 	148 
Fmgolctoinedin 	47 RVGALED --E---TIRL 	 65 
RatAMZprotein 52 R:PPLPQ__D_EKV0I; ----SQIE 	84 
Tc-OFTvl-J 	 102 V GE EO P
[PG fRD 
RC H C rIFP DLIV Q R V T V POP 131 
C.e.F11C32 149 H 0 I L 0 E K C H C P FPDLIV Q R V P I P 0 P 178 
Frogol7&ctomedin 	55 M ------ --EQD IILDTYSEKuN PIN 88 
RatAMZprotein 55 ------- D LQ I V EN M EN QM K GE S - 105 
Tc-OFM-i 132 'P V 	I Q i1jilT FV P V P V V V V H B V H V I N L V P F H P' 151 
C.e.F11C32 179 IP V I K X 	B KIMIV 208 
Frog olfactomedin 59 IN VI 	flL 
P V P V V V V K B 	I B V I KIfl
XM 
V P F HP' 
H K L1jI
Q 
K 	N E1I1RIE 	L EI 118 





Tc-OFM-i 162 TA PG P 0 p p p 	w S PG H G N 	PD L SR I RLJL P K FT 191 
C.e.F11C32 209 T P P 0 F 0 P P D 0 H A P 0 N 
PEN  
P K P - 0 N 	T R K 	L P N I 	S 235 
Frogolfactoinedin 1191 ISAMRVK SVQVE T 	L Y 138 
RaiAMZprotein 135 LIPVLEEYK -- 	- - 	- - 	- - 	- - - ADAKLVLK 154 
Figure 3.11. Amino acid pileup following that as outlined by Karavanich and Anholt in (1998). N-
glycosylation sites are highlighted in green. The purple bars mark the conserved regions as defined from C. 
elegans, frog, rat and mouse (Karavanich and Anholt, 1998) that are shared by T. canis. Sequences 
were obtained from GenBank as referenced in (Karavanich and Anholt, 1998): Tc-oftn-1 (Tc-EST-(Y70: 
5'AA728641 & AA728642; Tc-EST-079: AA728643 & AA728644), C.e. F1 11-13.2 (Z81499), Frog (Rana 
catesbeiana) (1-13595), Rat (Rattus norvegicus) (U03416) 
Me 
Tc-OFM-1 	 192 
QT 
A P T T N T N T v P T T I N E I A F E L[N S T F A N N 221 
C.e.F11C32 237 	p p p N P K H K T N Q S P I H V V P TjK N I T N 0 D 2
Frogolfactomedin 	139 	 KNM SF TVG - -QLETLDKNNLQAKRN I 165 
RatAA4Zprotein 155 	ON L N S V L 	E L 	SRI GAY DJY[JE L 	SR VS 184 
Tc-O EM-I 	 222 F 
MRL 
p p p T 5 p i T 0 p p 1 L 0 1 N R H 	249 
C.e.FJJC3.2 267 M 	- - - -x p yx op p T LOT ER KIG E 292 
Frogolfactoniedin 	157 V - -E K N LEA K PS LM VP LG 	191 
RatAMZprotein 185 - 	 -----------K L A C 0 K ----- 201 
Tc-OFM-1 	 250 - - - - - - - - - - - - - - - - - - - - - - - - - - - - SC 251 
C.e.F11C32 293 P L S E L F V K G I L S L E P L K F I D K L G N P T Q K K C 322 
Frogolfactomedin 	192 - - - - - - - - - - - - - - - - - - - - - - - - - -SCQHQ 195 
Rat AMZprotein 202 ------------------------------201 
Tc-O FM-I 252 V L N A V G I P V L H A N S Q 1 0 - - 	- A'V 0 SW M R D S MI 278 
Ce. FIIC3.2 323 H S Q 1 0 - 	-1i1 v o N N K R 0 A L' 349 
Frog olfactomedin 197 AHINKPNLMQLI;KG N A Y 'K 	1 0 A N F1 K D A 225 
Rat AMZ protein 202 I ND PV T 	-V K 	S S 	S - - 	
- 
F 10 S N - 224 
Tc-OFM-I 	 279 MY N EJM A FR R N L N D[JT A S - - - - VL
MYN 
304 
C.e.FIIC32 350 	N SM K TAKRRW VT DO FAN - - - _IPVL 	375 
Frog olfactotnedin 	225 A N N T T K K S L Y N V A P L N T D S S V L E S I 255 
RatAMZprotein 225 	L A PG D NV N Y M 0 0 1 H N N - - - R F V 	251 
Tc-O FM-i 	 305 E R Q L K N K K Q Q 
~SILI 
V D N L A S ----------- 324 
C.e.F11C32 376 E R Q L L .1-.171 Q K 	V D 7 L A N ----------- 395 
Frog olfactomedin 	256 U S D L 5 N P K N P L S M L I K N K L N N T F A 0 0 285 
Rat AMZ protein 252 K V D F K N T D N F 	0 P H P N ----------- 271 
CONSERVED REGION 2 
Tc-OFM-1 	 325 
FTG 
N I I I P1 5 S N F N S H H 0 S S F L V R N 0 L B S T D 354 
C.e.FJJC3.2 396 	N V V N H 0 S I N N H K H 0 T T S LV R N E LB T 0 V 425 
Frogolfactornedin 	286 DV VN NTN N Nfl , S H D MRL T S 0 - 314 
Rat Aii4Zprotein 272 	0 V V N MG 8111T F N KF 	I I PR F D L K T - - 299 
Tc-O FM-I 	 355 %
~'~ 
G 	SF- -1,   L S C A 
E 
H N F N K C N F P E 383 
C.e.F11C32 426 	 OP EM SH ID C S 	 HI FEE C ilK TO 455 
Frogoifactoinedin 	315 P - - - - - - - - - - - -ALFNNRF 330 
RatAMZprotein 300 	 IK -----T--- --YAGYNNMY 317 
CONSERVED REGION 3 
Tc-OFM-1 	 384 E LND R P H N I v S Y A T 0 H N G L W V V TR - A 412 
C.e.F11C32 455 	 L N D R P H N I V 0 F A V D B N 0 LW A I NT_ A 484 
Frog olfactornedin 	331 T - - - 14 F 5DNDFSS0N 	OLWV I F T iE K 357 
RatAMZprotein 318 	 G - - - G H 5 0 I_DIrflV_0 B N 0 L W A V N A_TN Q 344 




A T B 441 
C.e.FIIC3.2 485 D 	 -- 	P T N 512 
Frogolfactomedin 	358 	 A - K S D 385 
RatAMZprotein 345 N V - KR 5 373 
Figure 3.11 continued 
CONSERVED REGION 5 
Tc-OHvI-1 	 442 2 A D S P I N C ZWY L K S A TID ED I V I S F A I D L 471 C.e.F11C32 513 IADSFIXC LKSANNLQTQ ITHAIDL 542 
Frogolfacro,nedin 	387 A S N A PM I C 	 R_S L G PEN  K K V F I N F D 1 416 
Ra1AWprotein 374 AG RA P11 C jLjTN G V SD N IS V Hi A ID T 402 
CONSERVED REGION 4 	 CONSERVED REGION 6 
Tc-OFM-I 	 472 1 
PSTYEYEIDX 
1 I D 	K IN I N P 1 jJo V T N L H I N P I 3 G R 501 
C.e.FJJC3.2 543 F 	1' XP SW! N PlQ OLIN LX! N P L 	A 	572 
Frogolfactornedin 	417 K KG H 	M N 5 KM A K K VL S I N S N D N K 446 
Rat AMZ protein 403 N 	 P F Q N K I S S I S N L D I NP K 3 NA 432 
CONSERVED REGION 6 
Tc-OFM-1 	 502 L 	P F 	 L L S yIN V N M ND D 	D NP F D P A D F 5 531 
C.e.F11C32 573 L  F F D1STL L S VN V N I NE DI1P NY ID D 	 598 
Frog olfactomedin 	447 L I H F S ]O I L LI I 	I A L K P 	 464 
Rat A!itZprotein 433 L  AK N[IG_N 0 T L N V T L F H 11 
	
VR S - -L 	 457 
Figure 3.11 continued 
CONSERVED REGION 1 CONSERVED REGION 4 
Toxocaracanis Toxocara canis Q T I D V N I K W 
Caenorhabditis elegans A R V K R E N K K M P Caenorhabditis elegans S L F V V N I W W 
Frog (Rana catesbeiana) N R V E D E N Q K L E Frog (Rana catesbeiana) T F T V V N I W I 
Rat (Rat/us norvegicus) A R T K Q L R Q L L E Rat (Rat/us norvegicus) S L Q I L Q T W N 
CONSERVED REGION 2 CONSERVED REGION S 
Toxocara canis G T G N I I Y N G S Y 	Y  Toxocara canis SF1 KC G V F Y G L 
Caenorhabditis elegans G T G N V V Y N G S Y Y Y H Caenorhabditis elegans S F I H C G V W Y G L 
Frog (Rana catesbeiana) G A G V V V H N N N L Y Y N Frog (Rana catesbeiana) A F H I C G V L Y V I 
Rat (Rat/us norvegicus) G T G Q V V Y N G S I Y F N Rat (Rat/us norvegicus) A F I I C G T L Y V T 
CONSERVED REGION 3 CONSERVED REGION 6 
Toxocara canis Y V D Y A T D E N G L Y V V Y V Toxocara canis YNPIDGRLYFFDSKRLLSVNVRM 
Caenorhabditis elegans Y V D F A V D E N G L W A I Y A Caenorhabditis elegans Y N P L D A R L Y F F D N S S L L S V N V R I 
Frog (Rana catesbeiana) D M D F S S D E K G L W V I F T Frog (Rana catesbeiana) Y N S N D R K L Y M F S E G Y L L H Y D I A L 
Rat (Rattusnorvegicus) DI D L M V D E N G L W A V Y A Rat (Rat/usnorvegicus) YNPKDRALYAWNNGRQTLYNVTL 
Figure 3.12. The six conserved domains identified in olfactomedin and the respective homologues. Residues highlighted in red are those found in all the aligne 
members. Those highlighted in green refer to aa found in three of the four aligned sequences of which T. canis is one. Residues highlighted in blue are those amino acid 
shared by T. canis and C. elegans only 
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3.3.23 PC4/TIS7 "Interferon-related protein" (Tc-pth- 1) 
A T. canis gene has been isolated which is similar to a mammalian product variously 
described as PC4 or TIS7, induced in cell lines by activators such as nerve growth 
factor or phorbol esters (Tirone and Shooter, 1989). The same mammalian gene has 
also been designated interferon-related protein, due to an erroneous deposition of this 
sequence in 1985 as murine beta-interferon (accession no J00424). We have named the 
T. canis gene, which bears no similarity to mammalian beta- or gamma-interferon's, 
Tc-pth-1 (PC4/TIS7 homologue). 
3.3.24 Tubby-like protein (Tc-tlp- 1) 
Recently, a new multigene family related to the mouse gene tubby has been recognised 
(Kleyn et al., 1996). Mutations in tubby in the mouse result in obesity and 
degenerative changes in adult life; however the existence of conserved homologues in 
nematodes (including C. elegans) and in plants indicate that this gene encodes a protein 
which fulfils a fundamental function in all higher organisms. 
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3.4 Discussion 
This chapter deals with the small scale analysis of expressed genes from a Toxocara 
canis cDNA library. The hypothesis behind this investigative approach was to identify 
cDNAs encoding abundant primarily surface and secreted proteins that were represented 
as abundant mRNAs from this immunologically important parasite lifestage. In this 
regard the project has realised its aim by identifying numerous clones encoding many 
genes of hypothetical immunological importance. 
3.4.1 ESTs generated from serendipitously selected clones 
The cDNA library used in this study was derived from the infective larval stage of 
Toxocara canis , which is reproductively and developmentally arrested, yet is very 
much metabolically active. Reflecting this, very few clones relating to developmental 
genes were identified. 
Of the 332 selected clones, 266 were found to contain inserts and so were used in 
subsequent analysis. Detailed analysis on these clones showed that 5 of the 266 clones 
were in fact chimeric. That is to say, a number of the clones possessed internal Eco RI 
sites which ligated to each other prior to packaging within the phage. 
To conclude the outcome of this small-scale EST strategy suggests that it may be 
applicable to any metazoan organisms which have relatively large genome sizes (=101  
bp) and in which interest is focused on genes expressed at moderate to high levels. In 
addition, genes restricted to life-cycle stage can be identified in this manner. Further 
evidence for the success of this approach is seen in the Filarial Genome Project which 
in three years has deposited over 15,000 sequences in dbEST, which are estimated to 
represent some 5,000 separate gene transcripts, or around 33% of the total gene 
complement of B. malayi. The availability of the full genome sequence of C. elegans 
lends an exceptional opportunity to compare free-living and parasite gene sequences and 
structure, with the potential to identify adaptations requisite for parasitism at the 
molecular level. 
Although this project is a modest effort compared to the wealth of genome projects 
presently being undertaken. Many of the genes identified by database homology 
searching proved to be novel not only to parasitic nematodes but also to parasitic 
systems as a whole. This work has also made the first step towards a comprehensive 
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gene catalogue of a biologically intriguing and clinically significant parasite, providing a 
resource and springboard for future studies. 
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4.1 Introduction 
A significant proportion of genes identified in genome projects turn out to be novel. 
That is to say, they have no homologues in any of the existing databases. 
Approximately 40% of the genes isolated as part of the Toxocara EST project were 
found to be novel genes. Ascaris, hookworm (Necator) and Trichuris ESTs have all 
been found to contain 16% (22.56/141), 42% (86.1/205) and 51% (75.99/149) novels 
genes (Daub J and Blaxter M. L. pers. comm.). 
This chapter deals with the identification of four abundantly represented gene clusters 
termed abundant novel transcripts (ants) 3, 5, 30 and 34 (see chapter 3). Tables 4.1-A 
shows the clones that comprised each gene cluster (also included (Table 4.5) are the 
clones representative of the novel transcript (not) 018 which in the original classification 
was termed an abundant novel transcript). These clones were somewhat unexpected, 
because although hyper abundant within the library - occurring at a frequency of 
between 2.6 - 6.0% of all cDNA clones randomly selected - their sequences showed no 
homology with any known proteins in the database. It would appear that whatever 
proteins these clones encode are novel. The abundance of these clones, which together 
made up 18% of the library - not-018 accounts for 1.1% -, suggest an important role 
in parasite survival. 
Described here is the characterisation of these antigens and subsequent attempts to 
assign putative functions to these families and thus to hypothesise putative roles with 
regards to survival at the parasite/host interface. 
ant 005 
ant 003 	 ant 030 
JJ - - 	 ant 034 
- 
not 018 
Remainder of EST Project 
Figure 4.1. Pie-chart showing the abundance of the ant genes and the not 018 gene with relation to the 
remainder of the EST project. 
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4.2 MATERIALS AND METHODS: 
4.2.1 Identification of clones. 
The clones relating to the T. canis ant genes were initially isolated as part of the T. 
canis EST project (chapter 3). The procedure employed is as outlined in Chapter 2: 
Materials and Methods. 
4.2.2 Sequencing of the Ants 
Double stranded DNA templates for the following members of the abundant novel 
transcripts (ant 003: Tc-003; Ant 005: Tc 228; ant 030: Tc 128 and ant 034: Tc 315) 
were sequenced using the universal primers M13 forward and reverse and subsequent 
gene specific internal primers (see figure 4.2 to 4.6 for primer design). Clone were 
selected based on the initial analysis of the gene clusters. Later, more detailed analysis 
of the clusters identified longer clone members, but it was deemed prudent to complete 
analysis on clones selected (Tables 4.1 to 4.5). Sequencing was performed as outlined 
in the materials and methods of chapter 2. Initial analysis of the ant clusters, EST 
clones Tc-EST-003, 228, -128, and -315 were selected for analysis. Analysis of the 
nucleotide and deduced amino acid composition and database searches were performed 
as outlined in chapters 2 and 3. Sequence analyses of the members of each ant cluster 
were performed using the MacVector software (Oxford Molecular) in order to determine 
open reading frames (ORFs). Contigs for each cluster were created using the 
AssemblyLign software (Oxford molecular). 
± 	 A - 
1 T GTG CTC GCC GTG GTT TAC GGT TTG AGC TAT ACC ATT GGG GAT ATT GAC GGG AGA GTG TTG GCG AGA TAC TAC 73 
V 	L 	A 	V 	V 	Y 	G 	L 	S 	Y 	T 	I 	G 	D 	I 	D 	G 	R 	V 	L 	A 	R 	Y 	Y 
74 TGT TTT AAC GCA CCT AGA GAG CTG AAA GAA GAG TGC ATA TCT GGT TAC TTG TAT TCG AAG TAT ACC AAC GAG ATA 148 
C 	F 	N 	A 	P 	R 	E 	L 	K 	E 	E 	C 	I 	S 	G 	Y 	L 	Y 	S 	K 	Y 	T 	N 	E 	I 
149 AGG GAA GGA AAG CTG TCA GGG CTT AAA TAT GAA GAT CAA GTC GCT GTC TTC CGA AAA ACT CAG GAA AGG GCT ACG 223 
R 	E 	G 	K 	L 	S 	G 	L 	K 	Y 	E 	D 	Q 	V 	A 	V 	F 	R 	K 	T 	Q 	E 	R 	A 	T 
224 AGG AGG GCG TAT GAC GAA GCC GAA GAG ATG ATT ACA ACC ACA ATT AGC GCT GAC AAC GTG AAC TAC TGG TGG TTT 298 
R 	R 	A 	Y 	D 	E 	A 	E 	E 	M 	I 	T 	T 	T 	I 	S 	A 	D 	N 	V 	N 	Y 	W 	W 	F 
F 
299 TTA AAA TAT CCA GCT CAT CTC GGG ATA GGC TTT TTG TTT TCA GCT CTT TTC TTG GGC TTC CAT CTT GAT GAC ATC 373 
L 	K 	Y 	P 	A 	H 	L 	G 	I 	G 	F 	L 	F 	S 	A 	L 	F 	L 	G 	F 	H 	L 	D 	D 	I 
F C 
374 TAC GCC AAG ATG GTATG TTG GGC GAC GCG AGA GCT AAG CAT GGC GAC AAG TTT GAG AGC ATG TTG TCA TTT CAT 448 
Y 	A 	K 	N 	V 	V 	L 	G 	D 	A 	R 	A 	K 	H 	G 	D 	K 	F 	B 	S 	N 	L 	S 	F 	H 
449 GCT AGT ATC CGA GGA 	ACT 	ATG GTT TTGAGCCTG TTC A 	GGG TTC GGA CCA ATT ATT TCA GTT GTC 523 
A 	S 	I 	R 	G E L 	T G H 	V 	L 	S 	L 	F 	N G F 	G 	P 	I 	I 	S 	V 	V 
D 
524 TCT GTC GGT ATA TAT GTG TAT GAC ATT CCA ACT CAA GGC ATC ATG CTA CTC ACA ATT GTG GGA TTT TGT GTT G?C 598 
S 	V 	G 	I 	Y 	V 	Y 	0 	I 	P 	T 	Q 	G 	I 	M 	L 	L 	T 	I 	V 	G 	F 	C 	V 	G 
0 
599 CTG GTT GTG AAC ACT GGC ATA ATA GTT TAT GCA TAT ACA GCT GAT GCT AAC AGA GTC GCC AAC TCC CTT TAT GAA 673 
L 	V 	V 	N 	T 	G 	I 	I 	V 	Y 	A 	Y 	T 	A 	D 	A 	N 	R 	V 	A 	N 	S 	L 	Y 	B 
674 GTC AGC GGC ATG GCT CGA GTT GGG TGT GTC GTT AAG CCT AAC ATC GAA AAG GTG GAT AAA GGT CTA TTT ACG GTA 748 
V 	S 	G 	M 	A 	R 	V 	G 	C 	V 	V 	K 	P 	N 	I 	E 	K 	V 	0 	K 	G 	L 	F 	T 	V 
Figure 4.2 Nucleotide and deduced amino acid sequence of abundant novel transcript (ant) 003. The reverse and forward pCDNA3. 1 (+1-) (Invitrogen) (see later) 
primers are indicated by green arrows, pET lSb primers (see later) are shown by the blue arrows. Restriction sites are highlighted in bold and the stop codon is 
indicated by the asterix. Internal primers are shown by the red arrows. The sequence for ant-003 was derived from clone Tc-EST-003. (Figure continued over page) 
E 
749 	TTC TGC GTC ATT AAC CTC GCC CTA ACC CTA TGC CTT TAC ATC TCG AGT GCT ACA CCT AGA CAT 	ATA ACT GTA 823 
F 	C 	V 	I 	N 	L 	A 	L 	T 	L 	C 	L 	Y 	I 	S 	S 	A 	T 	P 	R 	H L I 	T 	V> 
E H 
824 	GCG CTG GCA TTG GGC GGA TTG CTA AAG GAA GTA GTC AAG GTT GAG AAC AGA GCG GAA GAT tcT GTA GCG CGA TGG 898 
A 	L 	A 	L 	G 	G 	L 	L 	K 	E 	V 	V 	K 	V 	E 	N 	R 	A 	E 	D 	A 	V 	A 	R 	W> 
899 	 ATT AAC TGG AGT ATT TAC AGT TGG GCG TTT CTG GTA TTG CCC GTC ATG 973 
A 	I 	y 	H 	G 	T 	V 	H 	L 	I 	N 	W 	S 	I 	Y 	S 	W 	A 	F 	L 	V 	L 	A 	V 	M> 
B 
974 	ATC GTT TCG ACA GAT GCA AGG AAC AAT TTC ACA CGC TTT TAT AG 	AGA GAA AAA ACC CCT GAT GAC GTC ATT GCT 1048 
I 	V 	S 	T 	D 	A 	R 	N 	N 	F 	T 	R 	F 	Y 	R R 	E 	K 	T 	P 	D 	D 	V 	I 	A> 
ii 
1049 	T GTC GTC ATC TAA TTC AAA ATT TCC TTC TAA ACT TGT TGC TTT TTA TTT CAT TTT GTT TGT AAC AGA AGC TTA 1123 
N 	V 	V 	I 	* 
1124 	AAA AAG CCC AAG TTA GGT CTT GAG AGA GGA CCC TTC AAG GAG GAC CAG CGT AGC TAA GAG GGG CTT GTA GCC CCC 1198 
1199 TCA TTG AAG CTT AGT GAG ACT AGT CGG AGT CTG GCT TCT CTT GAA AGG TCA AGC GAG GGA ACC AAA AAA AAA AAA 1273 
1274 	AAA AAA AAA 1282 
i ANT 3 PcDNA3.1(-) F: 	5' GAA TTC GCC ACC ATG GTG CTC CCC GTG GTT TAC GGT 3' 
ii ANT 3 pcDNA3.1(-) R: 5' GAA TTC TTA GAT GAC GAC ATT AGC AAT 3' 
A ANT 3 pET 15b F: 	5' CGG CGC CAT ATG TAC GGT TTG AGC TAT ACC ATT GGG GAT ATT GAC 3' 
B ANT 3 pET 15b R: 5' CGG CCC CAT ATG TTT TCA AGA AAC ACC TTT GAG AGG AAT TAT 3' 
A Tc-EST-003/323 F 	5' AAC TTA CTG GAA TGG TTT 3' 
B Tc-EST-323 R 	 5' AGG TGA ACC GTA CCC ATG 3' 
C Tc-EST-281 (gc) R 	5' GCT TAG CTC TCG CGT CGC CCA ACA C 3' 
D Tc-EST-281 (gc) F 5' GTT TGG CCT GGT TGT GAA CAC TGG C 3' 
E Tc-EST-281 R 	 5' CCC CCC AAT GCC AGC GCT ACA GTT ATG AG 3' 
F Tc-GC/003 380 R 	5' CCC CTA CAT GTC ATC AAG ATG GAA CCC C 3' 
G Tc-GC/003 479 F 5' CGT TTT GAG CCT GTT CAA TGG GTT CGG ACC 3' 
H Tc-GC/003 109 R 	5' CCC ATG TAT ATC GCC CAT CGC GCT ACA GC 3' 
Figure 4.2 (continued). N-linked glycosylation sites are indicated in green. 
I AT CAG GTG AGA GAG AAC GTT ATC CAG TAT TTA AAT GGT GAC TCA GCT GTT GCG ATG ATG GTT TCA GGT GAT GAT 74 
Q 	V 	R 	E 	N 	V 	I 	Q 	Y 	L 	N 	G 	D 	S 	A 	V 	A 	M 	M 	V 	S 	G 	D 	D 
75 A T GTG GTC ATC TTG AAT AAA GAA GAG AGT AAA GCG TTC TCC AAG GCA TTT TGG TTC AAT AAT GAG ACA GGT AAG 223 
S 	V 	V 	I 	L 	N 	K 	E 	E 	S 	K 	A 	F 	S 	K 	A 	F 	W 	F 	N 	N 	E 	T 	G 	K 
224 ATC CGG AAG GAT GTT GCA GAG AAT TTA CCA TCT GTA GTC GAA GAG GAC ATA GAG AAT GTG AGT TTT TGC TCA AAT 298 
I 	R 	K 	0 	V 	A 	E 	N 	L 	P 	S 	V 	V 	E 	E 	0 	I 	E 	N 	V 	S 	F 	C 	S 	N 
B 
299 TTT TAT GTG TCC ACG AAG TTT GGA GGA AGT GTG CGC ATG ATG CCG ATA At AGC GTT GAG GAA GTG CTT AGC AAG 373 
F 	Y 	V 	S 	T 	K 	F 	G 	G 	S 	V 	R 	M 	M 	P 	I 	R 	S 	V 	E 	K 	V 	L 	S 	K 
374 GCG AGT CTT ATG TTG GGG TAT GCT AGG GAT TTC ACT ACG TCT GAG GCT TGG GCG CGA GCT CAG GGT TTC ATG ATG 448 
A 	S 	L 	M 	L 	G 	Y 	A 	R 	0 	F 	T 	T 	S 	E 	A 	W 	A 	R 	A 	Q 	G 	F 	M 	M 
449 GTA TGT TGT TAT CCT CAT GTG GCG GAA ATA AAA CTT CTG GGG CTT GCT TTG TTA ATT GCT ACA AGG GCC AAT ATT 523 
V 	C 	C 	Y 	P 	H 	V 	A 	E 	I 	K 	L 	L 	G 	L 	A 	L 	L 	I 	A 	T 	R 	A 	N 	I 
524 GTA CTC GAA GGG CTG TTG AAC CCC GGT CGG GTC CAA AAG GAA CCG TGG CTT GGG AAG GCT ACA CTC GAA AAG GCA 598 
V 	L 	E 	G 	L 	L 	N 	P 	G 	R 	V 	Q 	K 	E 	P 	W 	L 	G 	K 	A 	T 	L 	E 	K 	A 
599 TTT CGG CAT TGT TAT GGA GTG AGC TCG AGA TAC CCT ATC AAT GTT GGG CTG GAC GAT GTC CAG GTG CTA CAT CTA 673 
F 	R 	H 	C 	Y 	G 	V 	S 	S 	R 	Y 	P 	I 	N 	V 	G 	L 	0 	D 	V 	Q 	V 	L 	H 	L 
674 
C 
AGT AGG TAT AAT ATA CAG GGA GGA TGT GCA AGG CAT AGA TAT GGA AAA CCA CGC TTA GGA TGT ATG CTC AAG CTA 748 
S 	R 	Y 	N 	I 	Q 	G 	G 	C 	A 	R 	H 	R 	Y 	G 	K 	P 	R 	L 	C 	C 	M 	L 	K 	L 
749 TCA GAA GAT GGA TCC ACC AAA GGT ATC AAG ATA GAA CGA TTT GTG AGT TTG AAG ACT GCC TCA GTA ATG AGG TTG 823 
S 	K 	D 	G 	S 	T 	K 	G 	I 	K 	I 	K 	R 	F 	V 	S 	L 	K 	T 	A 	S 	V 	M 	R 	L 
824 
A 
AiT GGA ACA GAT GGG AAG CAG GAG TTA CTG A 	
__ 
AG TAC 	T CCA TTG GGC TCC TAG AGT CCA GTT TTG CCA GAG CTT 898 
I 	G 	T 	0 	G 	K 	Q 	K 	L 	L 	K Y R 	P 	L 	G 	S 	* 
899 AGA AAT CAA AAA ACA TTT GCC TGA GCC CGA CAG GTA AGA GAG GGC AAA ATA TGG CAT TTT TGT TGA ATT CAA ATT 973 
974 TTT TCT TGT TTG TAA CAG ATG AAG TTT AGA AAA GCC TGA GTT GGG TCT TGA GAA GGG AGC TCT CAA GGA TGA ATA 1048 
1049 GCG TAA CTA AGT GGG GTT TGT AAC CCC GTT ATT GAT GCT TAG CGA GAC TAA TCG GAG TTC GGC TTC TTT TGA AAG 1123 
1224 ATC AAG CTT GGG AAC CAA AAA AAA AAA AAA AAA 1156 
ANT 5 pcDNA3.1 (-) F: 	 5' GGG CCC GCC ACC ATG GTT TCA GGT GAT GAT AGT GTG 3' 
ii ANT 5 pcDNA3.1 (-) R: 5' GGG CCC CTA GGA GCC CAA TGG ACG GTA 3' 
A ANT 5 pET 15b F: 	 5' CGG CGC CAT ATG ATG ATG GTT TCA GGT GAT GAT AGT GTG GTC 3' 
B ANT 5 pET 15b R; 5' GCG CAT ATG CTA GGA GCC CAA TGG ACG 3' 
A Tc-GC/005 115 R: 	 5' CCC ATC TGT TCC AAT CAA CCT CAT TAC TGA GG 3' 
B Tc-228 F 245-275: 5' GGA GGA AGT GTG CGC ATG ATC CCG ATA AGG 3' 
C Tc-228 R 111-82: 	 5' GCC TTG CAC ATC CTC CCT GTA TAT TAT ACC 3' 
Figure 4.3 Nucleotide and deduced amino acid sequence of abundant novel transcript (ant)-005. pcDNA3. 1 (+1-) primers are shown by the green arrows for both the 
5' and 3' ends. pET 15b primers are shown by the blue arrows. Internal primers are shown by red arrows with N-linked glycosylation sites in green. 
1 GT TGG AGT TTC AAG CAC AGG GCT GAC AAT TTC TTT GAT TGT CTG GCA TCA GAT GGT GTT GTG ACA TGC AGT TGT 74 
W 	S 	F 	K 	H 	R 	A 	D 	N 	F 	F 	D 	C 	L 	A 	S 	D 	G 	V 	V 	T 	C 	S 	C 
75 GTG CAA CTG AAG AAG TTC CCT CGC AGT ATG TTT GTG GTT GAG AGA AAG GAA TCG GCT TTG GAA ATT GAA GTG GAA 149 
V 	Q 	L 	K 	K 	F 	P 	R 	S 	M 	F 	V 	V 	E 	K 	K 	E 	S 	A 	L 	E 	I 	E 	V 	E 
T 
150 GAT GTT TTT GGG AAA AAG GAA CGT AAC TCC ATT TTT CGT GAT GAG AAA GGT CAA GTT GAA GAG ATG AG 	ATG AGO 224 
D 	V 	F 	G 	K 	K 	B 	R 	N 	S 	I 	F 	K 	D 	B 	K 	G 	Q 	V 	B 	B 	B 	K M 	R 
—i--- 
225 GCA GTA GAT CTT CAA GAT CAT TGG GAG TAT GGA TTC TAT GAT CTT GGG GAA GGT GCC ATC AAT GTG AAA GAT AGC 299 
A 	V 	0 	L 	Q 	D 	H 	W 	B 	Y 	G 	F 	Y 	D 	L 	G 	E 	G 	A 	I 	N 	V 	K 	D 	S 
300 TCT CTT GCT GGG TTG ATT GCT CG AGA GGA GCA ACT TTA GAG TTT CGA AAA GGA GAG TGG CAG CTT GTG AGA AGC 374 
S 	L 	A 	G 	L 	I 	A 	Q 	K 	G 	A 	T 	L 	E 	F 	K 	K 	G 	E 	W 	Q 	L 	V 	K 	S 
375 AGA GTT AAG ACC AGG TTG GTG TCA GAA AAC AGA GTG GAG TAT TCC TAT GAC TGG TAT GGC ACG CCT CTT CGA GAG 449 
K 	V 	K 	T 	K 	L 	V 	S 	E 	N 	R 	V 	B 	Y 	S 	Y 	0 	W 	Y 	G 	T 	P 	L 	R 	B 
450 CAT TTT GAG AAG GCT GAG ATC AAG AGA ACG GGT GAT GAG GTT GTG TTT TGG GTG GCA CTA AAA CAC GCC ATG ATA 524 
H 	F 	E 	K 	A 	E 	I 	K 	K 	T 	G 	D 	E 	V 	V 	F 	W 	V 	A 	L 	K 	H 	A 	M 	I 
525 GCG TAT GAT ATA TCT AGA GAG GTA TGC GCC ACG CAA GCC GTC TGT GAA TGT ACT GCG CAC TCT GTT AGA AGA GCT 599 
A 	Y 	D 	I 	S 	R 	B 	V 	C 	A 	T 	Q 	A 	V 	C 	E 	C 	T 	A 	H 	S 	V 	K 	K 	A 
600 GTG ACT CTG CTT GAT GGG AGC TTT AGA GTT GTT GTG TCG TTA TAT TGT ATA AAA TAT ACG GCA TGT AGA GTT CAT 674 
V 	S 	L 	L 	D 	G 	S 	F 	K 	V 	V 	V 	S 	L 	Y 	C 	I 	K 	Y 	T 	A 	C 	K 	V 	H 
675 GTC ACC ATC AAA GAA GAA GGA GAG AGA GCT GTC GTT ATC CTC AGA GAG ATA GAT TCT GAA CAT CGA GTG GTA GTA 749 
V 	T 	I 	K 	E 	E 	G 	E 	K 	A 	V 	V 	I 	L 	R 	E 	I 	D 	S 	E 	H 	R 	V 	V 	V 
750 CTC CCC TAC ACT TAT AAA GAA ACG CTT TAT GTG ATT GGA AAT AGG ACA GTG AAG TTG GGA GCT GAT CGT ATG GCT 824 
L 	P 	Y 	T 	Y 	K 	E 	T 	L 	Y 	V 	I 	G 	N 	R 	T 	V 	K 	L 	G 	A 	0 	K 	B 	A 
B 
825 AGT TCC ATT OTT GAT GAG AGT CAT TTT TCA CAC GGA GCC AAG GTA GGG TTT GAT CCT AAA GAC TTT TAT GAG CTG 899 
S 	S 	I 	V 	D 	E 	S 	H 	F 	S 	H 	C 	A 	K 	V 	G 	F 	D 	P 	K 	D 	F 	Y 	E 	L 
C 
900 GAG GGT GAA GOT ATA GAT GTG CTG GGG AAC ATC AAG GAT GTT TTC TTG CAT GTA GAG AAA TGG ATA CCA GCT CTT 974 
E 	G 	B 	C 	I 	D 	V 	L 	G 	N 	I 	K 	D 	V 	F 	L 	H 	V 	B 	K 	W 	I 	P 	A 	L 
975 ATT GTC GGG ATT ATT ATC TTA ATG AGA CCT ACC ATC TTG GCT GAG CCT ATT TTT TGG GTT TTG TGT CTC GCC GTG 1049 
I 	V 	G 	I 	I 	I 	L 	B 	R 	P 	T 	I 	L 	A 	E 	P 	I 	F 	W 	V 	L 	C 	L 	A 	V 
Figure 4.4 Nucleotide and deduced amino acid sequence of abundant novel transcript (ant) 030. Internal primer sites are highlighted in red. The stop codon is 
shown in italics. The N-linked glycosylation sites are in shown in green. 
1050 GTG TTT TAC CCT ATG GTT TTG GGG GTA AAA ACA GCT GGA GTT GGA GTC ACA GAT CCT GAA TTG CTA TCA GCT TGT 1124 
V 	F 	Y 	P 	H 	V 	L 	G 	V 	K 	T 	A 	G 	V 	G 	V 	T 	D 	P 	E 	L 	L 	S 	A 	C 
1125 GTG TTC TAT CTC GTT GAC GTT GGC ATC AGT CAC GCA GCA GGA GAG GCC GGA AGC GTG GTA AGT TTT CTT ATC ATA 1199 
V 	F 	'1 	L 	V 	D 	V 	G 	I 	S 	H 	A 	A 	G 	E 	A 	G 	S 	V 	V 	S 	F 	L 	I 	I 
1200 GTT ATC TGG TGG TTT AGT TTA ACA CCA AGA TCG AGG GTG AGG GCT TTT CCA TTC ACT TTT GCT AGT ATG GTG ACA 1274 
V 	I 	W 	W 	F 	5 	L 	T 	P 	R 	S 	R 	V 	R 	A 	F 	P 	F 	T 	F 	A 	S 	M 	V 	T 
1275 GCG GCA AGC CCT TCC AGG AAG GAG ATC ATG GCA GCA GGA CTT GTG GCC ATG ATT CTT GAC ATC ACT GGA AAC GAA 1349 
A 	A 	S 	P 	5 	R 	K 	E 	I 	M 	A 	A 	G 	L 	V 	A 	M 	I 	L 	D 	I 	T 	G 	N 	E 
1350 GTT GAG AAG CTC TAT CAT GCG CTT GAT GAT TGG CTT GGT CAA TAT CTT GTG CAA GCT AGT GGT TGC TGG AGA AAA 1424 
V 	K 	K 	L 	Y 	H 	A 	L 	D 	D 	W 	L 	G 	Q 	Y 	L 	V 	Q 	A 	S 	G 	C 	W 	R 	K 
A 
1425 CAC GCT TCG ACC ATT TAT TCA TGG ATG GAA CCT GGG GGC TAT GTT GTG CAG ACT TTG AAC CTG ACA GGG GTT TTT 1499 
H 	A 	S 	T 	I 	Y 	S 	W 	M 	E 	P 	G 	G 	Y 	V 	V 	Q 	T 	L 	N 	L 	T 	G 	V 	F - E F 
1500 
-
G TAT AAT 	'rC TGG G
1
AGA GAG GTC GAG CAT AAA AGA CCA CGC AAG CCC CAC CTC ATG AAT GTG AAG AAG AAT CCT 1574 
Y 	N L W 	G 	R 	E 	V 	E 	H 	K 	R 	P 	R 	K 	P 	H 	L 	N 	N 	V 	K 	K 	N 	P 
H 
1575 GGT TGG AGA ACT TCT TTT TCG ATT CAG AGA AGG TAAGG TGA ACG CTA GCT GGT GCA CAT TGA AGC CAA TTG AGC 1649 
G 	W 	R 	T 	S 	F 	S 	I 	Q 	R 	R 	* 
1650 GCG CTA AGT ATG TGA AGA AAG GAC TGC CGA AGA CTG GGA GAG AGG AAG GTG ATC TTG GAT TCT ACG AGG AAT GGC 1724 
1725 TGA GAA CGA CGA ATA TGA AGG CAT TCA AGA AGT ACG CGT ACT TGG AAG GTG ATC CCT CTT TCT GAA ATT CCG GAA 1799 
1800 CAG CGA TTT TCG AAT TGT GAG TTT GAA ACT TGT TGA ATT AGA AAA AAT TTT GGG AAT AAG GTG TGG ACT GCT TGG 1874 
1875 CTC AAG TTT ATG GTG TAG CGT AGC CGA AAG AGG CAT GTT GCC TCG ACA TTG ATG TTC GGT GAG ACT AGA CTG AGA 1949 
1950 TAC GAG CTG GGC TGA CGT GCC GAG TTC TTA AAA AAA AAA AAA AAA AAA AAA A 2001 
A 	Ant 030 AR 143-108: 	 5' CCC CTG TCA GGT TCA AAG TCT GCA CAA CAT AGC CC 3' 
B Ant 030 BR 151-125 5' GGA TCA AAC CCT ACC TTG GCT CCG TGT G 3' 
C 	Ant 030 BF 215-243: 	 5' CTT GCA TGT AGA GAA ATG GAT ACC AGC TC 3' 
D Tc-050 (Ant 030) 262 F: 	5' CTT AAT GAG ACC TAC CAT CTT GGC TGA GC 3' 
E 	Tc-050 (Ant 030) 	124 R: 5' GCT CGA CCT CTC TCC CCC AGA G 3' 
F Tc-110 R 100-71: 5' GCG TGG TGT TTT ATG CTC GAC CTC TCT CCC 3' 
G 	Ta-110 F 201-230: 	 5' GAG AGG TAT GCG CCA CGC AAG CCG TCT GTG 3' 
H Tc-199 (132-106) R: 5' TCA ATG TGC ACC AGC TAG CGT TCA CCC 3' 
I 	Tc-199 (140-114) R: 	 5' GAT CTT GAA GAT CTA CTG CCC TCA TTC 3' 
J Tc-199 (194-220) F: 5' AGC TCT CTT GCT GGG TTG ATT GCT CAG 3' 
Figure 4.4 continued 
1 AA ATA ATG CAG TCA CCT GGA ACT GGG AAG ACA AGA CAA CAT GTT CCA AGA ATG GCT TTC CAA GCT CTC CAG GCA 74 
I M Q S P G T G K T R Q H V P R M A F Q A L Q A 
75 GGA ATT CAG GTA GTA GTG TCA CCT CCT ACG CGA GTT ATT TGC GGA GAG GTT GCC ACG TTG CTT GAT GAG ATC CCG 149 
G I Q V V V S P P T R V I C G E V A T L L D E I P 
150 GGA GCG AGA GTT ACT CGG AAT TGG CGA GGA GGT TTG AGA AGG AGA GAT TGG AAT ATC ATG GTT ACC CCG CAT GCT 224 
G A R V T R N W R G G L R R R D W N I M V T P H A 
225 GTC CTT TTC AGA CTG CTC TAC TTG AGA TCA GGA ATG TTG AAG AAG CAG ACT GTC TTC TTT ATA GAT GAG GCC CAT 299 
V L F R L L Y L R S G M L K K Q T V F F I D E A H 
300 TTC TCA GAT ACG AAG ACG ATA CA CTC TGC AAG TTT CTG AGG CAC AGA GTG GAA GAA ACG CTT GAT ACT GCT ATA 375 
F S D T K T I A L C K F L R H R V E E T L D T A I 
376 TTT TTG ACA GCC ACA GGA AAA GAT TGG AAA ACT GGT CAA GAT AGG ATA TGT GAC ATC AGC AAT TAT CCT ATT GCA 450 
F L T A T G K D W K T G Q D R I C D I S N Y P I A 
451 GAT CAT GAT ATT CCA AGT CAC AAT GTT GTT CAA TTT GTT GAA GAC CAT TTG CGC AGT TGG ATG GGA AAG AAG GTG 525 
D H D I P S H N V V Q F V E D H L R S W N G K K V 
526 APT GTC TTC TGC AAT TCA GTA GGA GGC GAA GGC CTT TCT ATA AGA ACA TTT TGG AGA AAG TTG CGC AAT AAT CCA 600 
I V F C N S V G G E G L S I R T F W R K L R N N P 
601 GCA GCT GAC GTC ATA GCT TTT TCA AGA AAC ACC TTT GAG AGG AAT TAT CCT CTG GTG AAG AAG GAT CCT GAG ATG 675 
A A D V I A F S R N T F E R N 
C 
Y P L V K K D P K M 
676 GAT AAG GCA ATG ATT GTG TTG ACG ACC AAC ATG TCA GAA TGC GGC ATA AAC ATC AAT GCT GAC ATA GTG GTG GAC 750 
D K A N I V L T T N N S E C G I N I N A D I V V D 
751 ACA GGT CAG CAA GTT GCT TTT AAG GTT AAG AAT GGT TGT GTT GTC AGA AGT ATG GAA AGG ACA ACT ATG GCC CAG 825 
T G Q Q V A F K V K N G C V V R S N K R T T N A Q 
826 CAA GTC CAA CGA AGA GGA AGA GTT GGA AGA AGA AAG CCA GGA GAC TAT TAT AAG GTG GTT AGT CAT GAA fCA CAG 900 
Q V Q R R G R V G R R K P G D Y Y K V V S H K P Q 
901 T T ACC ATC AGC AGA CCT ATG GAG ATT GAA GAG ATA GAA GCT CTC GTA TTG TGT GAC AAG GCT GGC ATA CCT TTG 975 
Y T I S R P N K I K E I E A L V L C D K A G I P L 
Figure 4.5 Nucleotide and deduced amino acid sequence of abundant novel transcript (ant)-034. The internal primer sites are shown by red arrows. The N-linked 
glycosylation sites of ant-034 are shown by the green arrows. 
976 ACC CAT CTT GAG AAA TGC AAG GTT GAT GCT CTC GGT CTT GTG GTA ACT GAT AGC CAG ATT GTT AGG TGG CTT GAT 1050 
T 	H 	L 	E 	K 	C 	K 	V 	D 	A 	L 	G 	L 	V 	V 	T 	D 	S 	Q 	I 	V 	R 	W 	L 	D 
1051 GGT GAA ACA CAG AGC TTG ATA GGA GCA ACT GTT GTC TAT GAC ACG GAA GGT AAC ATC AGG ACG GCT AGT GGG AGA 1125 
G 	E 	T 	Q 	S 	L 	I 	G 	A 	T 	V 	V 	Y 	D 	T 	E 	G 	N 	I 	R 	T 	A 	S 	G 	R 
B 
1126 GCA GCC TTG ATC AAC AGC TGG AAA tT CGT GGT GAG ATT GTC AAC TTT GGC AGC AGG AAA GTG AGA CTC CGT TAT 1200 
A 	A 	L 	I 	N 	S 	W 	K 	D 	R 	G 	E 	I 	V 	N 	F 	G 	S 	R 	K 	V 	R 	L 	R 	Y 
1275 TAT GAT GCA AGA GAT CGT GAG TTG TTT GTA AAA GCG CTC AAA CTT GGG GGT ATC AAA GAT GAG GAG CAT GAG GAA 1350 
Y 	D 	A 	R 	D 	R 	B 	L 	F 	V 	K 	A 	L 	K 	L 	G 	G 	I 	K 	D 	E 	E 	H 	E 	E 
1351 GAA CAT CAG GAC AAA TGT GAA GCG TGT GGA ACA CTT TGG TAC CAT CAT TTT GAT GGA AGA TCG TGT AGA AGT AAA 1425 
E 	H 	Q 	D 	K 	B 	A 	 G 	T 	L 	W 	Y 	H 	H 	F 	D 	G 	R 	S 	R 	S 	K 
1426 TGT CCT ACT TGT GTG TGT GAG GAG GTT GAA GCA GCC GAA CTA GCG AAG ATA GCC GAT GAC GTA GAG TAG ATG AAT 1500 
P 	T 	V 	E 	E 	V 	E 	A 	A 	B 	L 	A 	K 	I 	A 	D 	D 	V 	B 	* 
1501 CGT ATG ATC CGA GGC CGA CAG GTA AGA GAG GCC AGA AAG ATC TAT GTT TGT TAA CAT TAT GAT AAA AGG AGA TTG 
A 
1575 
1576 CGA GGG AGC CGG AGG GGG CTC TGC AGT ATC TCA AGA CAG ATG GAG CGT AGC TAC TAG AGG ATT GAA TCC TCG CAA 1650 
1651 TTG ATT GGT AGT GAG ACT ACA CTG GTT GAG GTC AAG CAG GGC TCT TGA AGC CTC AAG CAT GAT CTA AAA AAA AAA 1725 
1726 AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA 1773 
A 	Tc-GC/034 279 R: 	 5' GTC TTG AGA TAC TGC AGA GCC CCC TCC GG 3' 
B Ant 034 AR 142-110: 	 5' CCT GCT GCC AAA GTT GAC AAT CTC ACC ACG ATC 3' 
C 	Ant 034 BR 131-102: 5' GCA TTG ATG TTT ATG CCG CAT TCT GAC ATG 3' 
D Ant 034 BR 291-321: 	 5' CCA CAG TAT ACC ATC AGC CGA CCT ATG GAG 3' 
E 	Tc-315(Ant 034) 364 F: 	 5' GGC CCA TTT CTC AGA TAC GAA GAC GAT AGC 3' 
Figure 4.5 continued 
I TC ACA ATG CTG TCT GCT CGA CTG COT TTT CTT TTT TTC ATT GCT GCC CTA COG TGT GTT CO TCG CAA ACT ACA 74 T 	M L 	S A 	R L 	R F 	L F 	F I 	A A 	L R 	C V 	Q 	S 	Q 	T 	T A 75 C GTG TAT GGA TAT GGA TCA AAC TAC AGC CCC AAC TAC AGC ACA GGA TAT AAT GCG CAA TGC TGC TCG AAT CTT 149 S 	V Y 	G Y 	G S 	N Y 	S P 	N Y 	S T 	G Y 	N A 	Q 	C 	C 	S 	N L 
150 GGT TAC GTG GGG GAC TGC TGC ACG CTA GGT GTT ACC CAG TGC TGC AAC TAC AAC GCA AAA TGC TGT ACT AGC CTC 224 0 	Y V 	G D 	C C 	T L 	G V 	T 	Q 	C 	C 	N Y 	N A K C C 	T S 	L C - 
225 GGC TAT ACG GGA GAC TGT TGT GCA CAA GGC GTA AGT CAA TGC TGT AAT GCA GGC TG ACT TAT GGA ATG AGC TCG 299 
0 	Y T 	G D 	C C 	A Q 	G V 	S 	Q 	C 	C 	N A 	G S 	T Y 	C M 	S S B 
300 GCA TAT GOT ACG GGC TAC AAG TCG A'fO TAT AGC CCA CAG TGT TGC ACT AAT CGA GOT TAC ACT GGA AAC TGT TGT 374 
A 	Y G 	T G 	Y K 	S M Y S 	P Q 	C C 	T N 	R 0 	Y T 	G N 	C C 
375 GCG CTA GOT GTA ACT CAA TGC TOT ACC AGC GGA AGC ACT AAT GTT TAT CAG GGA TAC GGA TAC GGA AGG AAT TAT 449 
A 	L G 	V T 	Q C 	C T 	S C 	S T N V 	Y Q 	G Y 	C Y 	G R 	N Y 
450 AAT CAG TAC GGA TAC GGT TCC AGC TAT CCA TAT GGG TTT AGT GGA AGC GGC AAC AAC AAT CCA AGC AAT CCA TAT 524 
N 	Q 	Y 	C 	Y 	G S 	S Y 	P Y 	G F 	S C 	S G N N 	N P 	S N 	P Y D 
525 GTT ACT GGG TAC GGC AGC ACA TAC AAC TAC AAC TCA CCT TAT SA TAT GGC TAC AGO ACT AAC ACG TAC AGT AAC 599 
V T G Y 	G S 	T Y 	N Y 	N S 	P P 	C Y 	C Y 	R T 	N T 	Y S 	N 
600 CCT TAC GGC GCT TAT GGA GGT AGT TAC GGT GCT CAG TAC GOT TCC GGA AGT GOT TAT GGC TCA TCA GGC ACA CAA 674 
P 	P 0 	A Y 	G 0 	S Y 	0 A 	Q 	P 	C 	S 	G S 	C Y 	G S 	S 0 	T Q 
675 TAT TAC GGC AGC AAC CAG TAC GOT 000 ACA ACA OCT TAT CCT GGA TAC AGT TAC GGA OTT AGC GGC AAA CGA AAC 749 
P 	Y G 	S N 	Q Y 	0 0 	T T A Y P 	0 Y 	S Y 	C V 	S 0 	K R 	N 
750 
11 
GCG AAC AAT OCT ACT GCA GTG GAO GCA T T GCG TTO AAO TCG TAA ATC GAA TGC AAA GTC TTC ACA ATT TAT AAC 824 
A 	N N 	A T 	A V 	E A 	S A 	L K 	5 * 
825 GAA GAA CTT ATT GTA CTA TTO TCT ACA OAT AGC AAA CAT OAT TAG COG AAA CAT CAT TCT TCA TCA ATT TTT CGG 899 
900 CTG CTG TAT TTT GCA CAA TAA AGA OAT COT TTC OTT GGA AAA AAA AAA AAA AAA AAA 956 
ANT 18 pcDNA3.1 (-) F: 	5' GAA TTC 0CC ACC ATG CTG TCT OCT CGA CTG COT 3' 
ii ANT 18 pcDNA3.1 (-) R: 5' GAA FTC TTA CGA CTT CAA CCC AOA TGC 3 
A ANT 18 R 136-102: 	5' OAT CCA TAT CCA TGC ACG OAT GTA OTT OTC GAC TC 3' 
B ANT 18 F 340-368: 5' COO CAT ATG GTA COO OCT ACA ACT CGA TO 3' 
C Tc 31 F 252-280: 5' GGC GTA AGT CAA TGC TOT AAT GCA GGC CTC 3' 
D Pc 31 R 100-71: 	5' ACT GTA COT OTT AGT CCT GTA 0CC ATA TCC 3' 
Fu gu r e 4.6 Nucleotide and deduced amino acid sequence of novel transcript (not)-018. pcDNA primers are shown by green arrows and internal primers are shown 
in red. The N-linked glycosylation sites are shown in green 
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Clone Gene Name Identification Insert 5' 3' 5' EST 3' EST 
Number Size Read Read GenBank GenBank 
1 Tc-EST-003 Tc-ani-003 Abundant Novel Transcript 003 	- 1300 594 620 AA470326 AA683460 
2 Tc-EST-007 Tc-ant-003 Abundant Novel Transcript 003 330 280 AA563575 
3 Tc-EST-015 Tc-ant-003 Abundant Novel Transcript 003 420 407 416 AA563520 
4 Tc-EST-060 Tc-ant-003 Abundant Novel Transcript 003 2050 456 462 AA888761 AA888762 
5 Tc-EST-067 Tc-ant-003 Abundant Novel Transcript 003 1280 534 695 AA873909 AA873910 
6 Tc-EST-106 Tc-ant-003 Abundant Novel Transcript 003 534 519 492 AA824224 AA824225 
7 Tc-EST-137 Tc-ant-003 Abundant Novel Transcript 003 544 491 537 AA835623 AA835624 
8 Tc-EST-172 Tc-ant-003 Abundant Novel Transcript 003 1700 393 564 AA87391 1 AA873912 
9 Tc-EST-191 Tc-ant-003 Abundant Novel Transcript 003 860 497 460 AA873896 AA873897 
10 Tc.EST.239 Tc-ant-003v Abundant Novel Transcript 003 640 326 477 AA874755 AA874756 
11 Tc-EST-258 Tc-ant-003 Abundant Novel Transcript 003 300 276 276 AA875763 AA875764 
12 Tc-EST-268 Tc-ant-003 Abundant Novel Transcript 003 400 372 395 AA875774 AA875775 
13 Tc-EST-281 Tc-ant-003 Abundant Novel Transcript 003 1200 558 620 AA875786 AA875787 
14 Tc-EST291 Tc-ant-003 Abundant Novel Transcript 003 600 250 443 AA875797 AA875798 
15 Tc-EST-3 18 Tc-ant-003 Abundant Novel Transcript 003 320 290 299 AA879357 AA879358 
16 Tc-EST-323 Tc-ant-003 Abundant Novel Transcript 003 1000 380 726 AA879366 AA879367 
Table 4. 1. Table showing EST clones belonging to the ant-003 cluster. Line 10 is highlighted in 
bold to indicate a variant member of the ant-003 cluster. Line 4 is shown in blue text to indicate the 
longest member of the cluster 
Clone Gene Name Identification Insert 5' 3' 5' EST 3' EST 
Number Size Read Read GenBank Genbank 
1 Tc-EST-005 Tc-ant-005 Abundant Novel Transcript 005 510 426 435 AA470328 AA683461 
2 Tc-EST-065 Tc-ant-005 Abundant Novel Transcript 005 1950 509 543 AA728637 AA728636 
3 Tc-EST-111 Tc-ant-005 Abundant Novel Transcript 005 890 329 562 AA825121 AA825122 
4 Tc-EST-134 Tc-ant-005 Abundant Novel Transcript 005 1100 443 459 AA835617 AA835618 
5 Tc-EST-228 Tc-ant-005 Abundant Novel Transcript 005 1150 570 390 AA874729 AA979710 
6 Tc-EST-234 Tc-ant-005 Abundant Novel Transcript 005 1960 419 496 AA874738 AA874739 
7 Tc-EST-295 Tc-ant-005 Abundant Novel Transcript 005 1150 183 333 AA875804 AA875805 
Table 4.2. Table showing EST clones belonging to the ant-005 cluster. Line 6 is highlighted in 
blue to indicate the longest member of the ant-005 cluster. 
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Clone Gene Name Identification Insert 5' 3' 5' EST 3' EST 
Number Size Read REad GenBank Genbank 
1 	Tc-EST-018 Tc-not -018 Novel Transcript 018 >1270 600 671 AA683463 AA68344 
2 	Tc-EST-031 Tc-not-018 Novel Transcript 018 1000 382 555 AA568095 AA568096 
3 	Tc-EST-136 Tc-not-018 Novel Transcript 018 1000 620 565 AA835621 AA835622 
Table 4.3. EST clones belonging to the not-018 cluster. Line 1 is highlighted in blue to indicate a 
the longest member of the cluster 
Clone Gene Name Identification Insert 5' 3' 5' EST - 3' EST 
Number Size Read Read GenBank GenBank 
1 Tc-EST-030 Tc-ant-030 Abundant Novel Transcript 030 652 652 652 AA568093 AA568094 
2 Tc-EST-045 Tc-ani-030 Abundant Novel Transcript 030 1300 519 652 AA728634 AA728635 
3 Tc-EST -050 Tc-ant-030 Abundant Novel Transcript 030 1200 598 663 AA683467 AA683468 
4 Tc-BST-092 Tc-ant-030 Abundant Novel Transcript 030 490 371 402 AA810507 AA8251 13 
5 Tc-EST-1 10 Tc-ant-030 Abundant Novel Transcript 030 1800 357 693 AA8251 19 AA825120 
6 Tc-EST-128 Tc-ant-030 Abundant Novel Transcript 030 2000 485 419 AA907967 AA907968 
7 Tc-EST-133 Tc-ant-030 Abundant Novel Transcript 030 427 414 381 AA907969 AA907970 
8 Tc-EST-149 Tc-ant-030 Abundant Novel Transcript 030 630 602 AA836698 
9 Tc-EST-165 Tc-ant-030 Abundant Novel Transcript 030 280 279 285 AA864179 AA864180 
10 Tc-EST-199 Tc-ant-030 Abundant Novel Transcript 030 1950 335 483 AA888755 AA888756 
11 Tc-BST-219 Tc-ant-030 Abundant Novel Transcript 030 800 576 663 AA874723 AA874724 
12 Tc-BST-280 Tc-ant-030 Abundant Novel Transcript 030 1200 567 432 AA875784 AA875785 
13 Tc-EST-308 Tc-ant-030 Abundant Novel Transcript 030 800 458 579 AA879346 AA897347 
Table 4.4. EST clones belonging to the ant-030 cluster. Line 10 is highlighted in blue to indicate 
the longest member of the ant-030 cluster 
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Clone Gene Name Identification Insert 5' 3' 5' EST 3' EST 
Number Size Read Read GenBank GenBank 
1 Tc-EST-034 Tc-ant-034 Abundant Novel Transcript 034 230 230 230 AA728632 AA728633 
2 Tc-EST-055 Tc-ant-034 Abundant Novel Transcript 034 1100 543 AA603960 
3 Tc-EST-080 Tc-ant-034 Abundant Novel Transcript 034 400 350 360 AA618629 AA618630 
4 Tc-EST-086 Tc-ant-034 Abundant Novel Transcript 034 630 632 435 AA8200 17 Al 078887 
5 Tc-EST-108 Tc-ant-034 Abundant Novel Transcript 034 1050 543 689 AA824228 AA824229 
6 Tc-EST-148 Tc-ant-034 Abundant Novel Transcript 034 432 432 431 AA836696 AA836697 
7 Tc-EST-151 Tc-ant-034 Abundant Novel Transcript 034 730 517 AA836699 
8 Tc-EST-175 Tc-ant-034 Abundant Novel Transcript 034 >1000 538 664 AA563519 AA873916 
9 Tc-EST-192 Tc-ant-034 Abundant Novel Transcript 034 379 379 374 AA873898 873899 
10 Tc-EST-223 Tc-ant-034 Abundant Novel Transcript 034 414 401 414 Al 080787 Al 080788 
11 Tc-EST-265 Tc-ant-034 Abundant Novel Transcript 034 810 535 657 AA915870 AA915871 
12 Tc-EST-283 Tc-ant -034 Abundant Novel Transcript 034 900 537 618 AA875788 AA875789 
13 Tc-EST-298 Tc-ant-034 Abundant Novel Transcript 034 400 320 395 AA979713 AA979714 
14 Tc-EST-3 15 Tc-ant-034 Abundant Novel Transcript 034 1760 639 520 AA879354 AA879355 
15 Tc-EST-3 19 Tc-ant-034 Abundant Novel Transcript 034 1050 704 529 AA879350 AA879360 
Table 4.5. Table showing EST clones belonging to the ant-034 cluster. Line 14 is highlighted in 
blue to highlight the longest member of the ant-034 cluster. 
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Table 4.6 below summarises the amino acid composition of each gene in terms of 
individual amino acids and the nature of their side groups (i.e. hydrophobic, polar, 
basic or acidic). Immediately, one striking difference that can be seen is between the 
ant genes and not-018. The proportion of neutral hydrophobic amino acids is almost 
exactly half that of the ant genes whereas the situation is almost perfectly reversed in 
the case of the neutral polar amino acids. There are also significantly fewer basic and 
acidic amino acids present in the not-018 sequence. Between the ants these differences 
are more subtle. There is a significantly higher number of valines present in both ant-
003 and -030 compared to ant-005 and -034. The number of isoleucines in ant-030 is 
again significantly less than is found in the remaining three ants. Such differences can 
also be seen in the other amino acid groups. Whereas such differences could also be 
found in randomly picked genes, this level of analysis is required in order to give 
another descriptive parameter to these novel sequences. 
A common feature of each of the ants is the presence of amino acid repeats which 
appeared to have no discernible pattern. Although the proportions of the amino acids 
vary, as would be expected, the presence of single pairs of amino acids, some which 
are repeated as many as 7 times, may be a salient feature of these genes. These amino 
acid pairs, and in the case of ant 030 triplets, are highlighted in blue in Figures 4.2 - 
4.6 above. Also of interest was the fact that ant-034 had a cysteine rich stretch of 
amino acids at its 3' terminal end. These residues are shown in yellow in Figure 4.5. 
One of not 018s key feature was the presence of double amino acid repeats, a feature 
shared with the ants although in this case cysteine was the predominant amino acid 
doublet. Also of interest was the presence of GYG and GS/T motifs which are shown 
in red in Figure 4.6. 
The results of the plaque screening assay enabled us to tentatively categorise the 
transcripts in terms of their possibility of being secreted products. The cloning of ant-
005 and not-018 into the pcDNA3.1 (-) (Invitrogen)DNA vaccine vector (Figure 4.7) 
enabled the further characterisation of the two genes. Both ant-005 and not-018 have 
not only been confirmed, through ELISA, to be TES products but have also been 




side-groups amino acids ant 003 ant 005 ant 030 ant 034 not 018 
Percentage Composition Of Aiiiiiio Acids 
A 8.75 6.36 7.08 6.35 6.06 
V 11.01 8.61 11.56 9.11 3.78 
L 9.60 9.73 7.27 6.56 3.40 
N/H I 7.62 4.86 0.37 5.93 0.37 
P 1.97 2.99 2.98 3.17 2.65 
W 1.41 1.12 2.23 1.48 0.0 
F 4.80 3.74 4.85 3.17 1.51 
M 2.25 3.37 2.23 2.33 1.13 
Percentagéf 
amino 	acids 47.41 40.78 38.57 38.10 18.90 
per group 
G 7.34 8.23 6.34 6.14 16.67 
S 5.36 8.23 6.52 4.02 1.13 
T 5.36 3.37 4.10 6.56 8.71 
NIP Y 5.93 3.37 2.98 1.69 14.77 
C 1.69 2.24 2.05 2.96 1.19 
Q 0.84 2.62 1.49 3.60 4.92 
N 4.23 4.49 2.05 3.38 9.09 
Percentage 	ol 
amino 	acids 30.75 32.55 25.53 28.37 56.48 
per group 
K 3.38 6.36 5.22 5.93 1.51 
B R 5.36 5.24 6.34 7.20 2.27 
H 1.69 1.49 2.79 2.75 0.0 
Percentage 	of 
amino 	acids 10.43 13.09 14.32 15.88 3.78 
per group 
A D 4.51 3.74 4.47 6.35 0.75 
E 5.08 6.74 5.78 6.56 0.37 
Percentage 	of 
amino 	acids 9.59 10.48 10.25 12.91 1.12 
per group 
Table 4.6 Summary table of the percentage amino acid composition of the abundant novel 
transcripts and novel transcript 018. N/H: neutral hydrophobic amino acids; NIP: neutral polar amino 
acids; B: basic amino acids and A: acidic amino acids. 
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Each of the genes obtained so far have lacked a start methionine and a signal peptide 
sequence. This together with the insert sizes, suggests that the full length transcripts 
have not yet been found. As such, there may be more salient features that may be 
present in the missing 5' sequences of the genes; so too may any potential regions of 
homology. 
4.2.3 Production of antisera to ant proteins using pcDNA 3. 1(-) 
Inserts for each of the ants and not-018 were generated from a PCR reaction using the 
pcDNA 3.1(-) primers (Figures 4.3 and 4.5) on plasmid template for ant-005 (Tc 228) 
and not-018 (Tc 031). The PCR products obtained were run on a 1% agarose, excised 
and cleaned of contaminants using the Qiaquick Gel Extraction kit (Qiagen). The 
cleaned products were then subcloned into the pGEM-T (Promega) vector and 
transformed into JM109 competant cells (Promega). The transformed cells were plated 
out onto ampicillin plates and grown overnight at 37°C. Positive colonies were 
screened for using the specific primers ant 5 pcDNA3.1 (-) R and not 18 pcDNA3.1 (-) 
with the T7 vector primer. Plasmid template was prepared from the pGEM-T construct 
and the insert excised from the vector using the restriction enzymes Apa 1 and Eco RI 
(Promega) for ant-005 and not-018 respectively. The excised inserts were then ligated 
into the pcDNA3.1 (-) ( Invitrogen) vector under the control of the T7 promoter using 
the Apa 1 and EcoRl restriction enzyme sites (see Figure 4.7) for ant -005 and not - 
018. Ligation reactions were carried out at 16°C overnight. The ligation reactions were 
then transformed into JM 109 competent cells in the presence of super optimal catabolite 
(S.O.C.) (Gibco BRL) medium and plated out onto LB-amp plates and incubated at 
37°C overnight. Positve colonies were screened for by PCR using the T7 vector primer 
and gene specific primers (see Figure 4.8). Positive colonies were grown o/n in lOmls 
LB-amp media at 37°C and plasmids subsequently prepared and digested with the Apa I 
and Eco RI restriction enzymes to confirm the inserts (Figure 4.9). Upon confirmation 
of inserts, 1L o/n cultures were prepared and plasmid subsequently prepared following 
a modification of the Qiagen Plasmid Mega kit (Qiagen) protocol. Briefly, the protocol 
was adhered to except that plasmid were resuspended in 0.9% sodium chloride solution 
(Sigma) as opposed to the resuspension buffer provided. This was done so as not to 
introduce any contaminants into the immunogen. The purity was ascertained by taking 





Figure 4.7. pcDNA (-) plasmid (Invitrogen) schematic showing the salient features of the vector. Of 
particular note is the multiple cloning site (mcs) the Apa 1 and EcoRI sites of which were used to clone 
ant-005 and not-018. 
Note: The figure was reproduced from the Invitrogen web catalogue (www.invitrogen.comlvectors.html) 
Figure 4.8 (a). 1% agarose gel showing results of a PCR colony screen of pcDNA constructs. Lane 
1: 1kb ladder; Lanes 2-16 ant-005 colony screen. Lanes 6, 7, 10 and 15 are positive for the ant-005 
pcDNA construct in the correct orientation. 
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Figure 4.8 (b) 1% agarose gel showing results of a PCR colony screen of pcDNA constructs 
(continued). Lane 17: 1 kb ladder; lane 18: ant-005; lanes 19-32: not-018. Lanes 28 and 32 are positive 
for not-018. Arrow indicates the 1kb band. 
Figure 4.8.(c) 1% agarose gel showing results of a PCR colony screen of pcDNA constructs. Lane 
33: molecular weight marker; Lanes 34 & 35: not 018. 35 is positive for the not-018 pcDNA 
construct. Arrow indicates the 1kb band. 
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Figure 4.9. 1% agarose gel showing restriction enzyme digest of pcDNA constructs of ant-005 and 
not-018. Lane 1: 1 kd ladder; lane 2: undigested pcDNAlant-005 plasmid construct; lane 3: pcDNA/ant-
005 plasmid digested with Apa 1; lane 4 undigested pcDNA/not-018 plasmid construct; lane 5: 
pcDNA1not-018 plasmid digested with EcoRI. 
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4.2.4 Immunoscreening of transcripts 
The procedure was as outlined in the "Screening Protocols: Plaque Screening" of the 
picoBlueTM Immunoscreening kit instruction manual (Stratagene). Essentially, clones 
composing the ants and nots were dotted onto a gridded LB-amp plate on which a 
bacterial lawn composed of LB-top agar and XL 1-Blue E. coli cells had previously 
been grown. It was determined that a phage dilution of 10' pfu/ml was optimal for this 
assay. The plates were then incubated at 42°C for approximately 4 hours, after which 
time plaques were clearly visible. During the incubation period 88 mm nitrocellulose 
filters were incubated in IPTG diluted to 10mM in H20, and then allowed to air dry. 
The nitrocellulose discs were marked with a soft pencil to aid orientation and 
identification of the discs. The discs were placed onto each plate and incubated at 37°C 
for 3.5 hours. Each plate was labelled appropriately in order to correspond with its 
respective disc. Following the incubation the membranes were removed and washed in 
Tris-Buffered-saline-Tween-20 (TBST), then blocked in 5% skimmed milk for 1 hour 
at room temperature. Membranes were then transferred to 5% skimmed milk blocking 
solution in which had been diluted the o-TES polyclonal antibody (1/100 dilution). 
The serum had been raised by immunising BALB/c mice with 15 jig via the 
subcutaneous route with TES. Incubation was for 1 hour at room temperature followed 
by washing in TB ST. The membranes were incubated in the secondary antibody 
(Biorad: EIA affinity purified goat anti-mouse IgG horseradish peroxidase conjugate) 
diluted in 5% skimmed milk and incubated for 1 hour. Following this period of 
incubation, the blots were washed then developed using chemiluminescent Western blot 
detection system (ECL; Amersham Pharmacia Biotech) 
4.2.5 Immunisation of mice with pcDNA3.1 (-) constructs 
Immunisation of mice followed a modification of methods outlined in (Whalen, 1998). 
Essentially, mice were anaesthetised using 50jil of a Vetalar (Pharmacia & Upjohn) 
Rompun (Bayer plc) mixture in the ratio of 2:1 respectively. Once anaethsised Immac 
(Reckitt and Colman), a hair removing agent, was used to remove the fur from both calf 
muscles of the animal. Briefly, using a 27GX3'4" needle with a polyethylene tubing 
coat, cut such that the bevel of the needle enters the calf muscle and no further, lOOjig 
of each pcDNA3.1(-) DNA vaccine construct was injected into each calf muscle. 
pcDNA3.1 (-) plasmid with no insert (lOOjig/calf muscle) and -galactosidase 
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(50 jig/calf muscle) were also used as immunogens to function as positive and negative 
controls. Both BALB/c and CBAICa mice strains were used as strain variations in 
antibody production are common (Maizels pers. comm.). Following immunisation the 
mice were left for 3 months without boosting prior to being bled. 
4.2.6 Enzyme Linked Immunosorbent Assay (ELISA) 
An ELISA was performed using microtitre plates coated with T. c. excretory/secretory 
(TES) antigen and somatic extract (TEX). The procedure used was as defined in 
[Maizels, 1991 #329]. Briefly, the TES and TEX were diluted in sodium carbonate 
buffer (0.06M, pH9.6) to ljig/ml and added to Nunc-ImmunoTM Plate MaxiSorpTM 
surface plates (Nunc) at 501il/well. The plates were then incubated o/n at 4°C. 
Following incubation the plates were washed three times with PBS-T. Diluted pcDNA 
(in carbonate buffer) derived antibody (1/100 and 1/500) was aliquoted at lOOjiuIwell 
and incubated at 37°C for 1 hour; the plates were then washed as before and lOOjiulwell 
of conjugate diluted in carbonate buffer was added and incubated at 37°C for 1 hour. 
Following this incubation period, the plates were extensively washed and before 
addition of 50jil of the substrate ABTS fluorogenic reagent (KPL). The absorbance 
values of the plates were read at 450nm. 
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4.3 RESULTS 
4.3.1 Sequence analysis of clones 
The identification of all the clones that made up each cluster was made possible by the 
sequencing strategy employed, which was to sequence in both the 5' and 3' directions 
using two pairs of vector primers (M13 R/F and T3/T7) (Chapter 2). Figure 4.10 
shows a schematic alignment of the clones that comprised each ant cluster. As each of 
the clones were truncated, no start methionine was obtained, so the numbers indicated 
in the figure refer to the start of the cDNA and not the real start of the gene. The 
longest member of each cluster can be seen in Table 4.1 - 4.5. Tc-EST-239 is shown 
in bold as this clone appeared to be a variant member of the ant-003 cluster in that 
sequence differences were apparent that were not attributable to sequencing error 
(Table 4.1). 
The sequence analysis of each member of the cluster was performed as outlined in 
Chapter 2 in order to determine putative open reading frames. 
As the clusters were novel no definitive sequence description could be obtained via 
database searching. The exception to this was ant-034 (see Table 4.6). Both the 
BLASTX and BLASTP database search algorithms gave probability values of 1.9 x 
10" and 3.4 x 1012,  which was above the threshold of 106  which was determined as 
significant for the EST project. Figure 4.11 shows an amino acid pileup of ant-034 
and the Japanese encephalitis virus protease. The level of identity between the two 
sequences was 23%. The novel transcript-018, also had no significant homology to 
anything in the existing databases (see Table 4.6). The ProDom protein domain 
homology algorithm was also carried out. Using this method the sequence(s) 
submitted is used to search an automatically compiled database of protein motifs 
derived from SWISSPROT entries. Three of the transcripts, ant-003, -030 and not-
018 gave no result using this method. The ants 005 and 034 both yielded results, 
which are summarised by the ProDom alignments in Figure 4.12 (a) and (b). The fact 
that the results are not the same as those obtained for BLAST searching could be 
attributable to the fact that sequences are deposited into the SWISSPROT database at a 
slower rate than the NCBI databases. Entries into SWISSPROT are also compacted 
such that entries are non-redundant. The result obtained for ant-005 suggested that the 
transcript had an 8 x 10" probability of containing domain characteristics similar to a 
30 member protein family of which the protein envelope genome protein is affiliated 
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suggested that the transcript had a 7 x 10 probability of bearing homology to a 280 
member protein family of which the protein helicase ATP-binding RNA-binding 
protein was a member (Figure 4.12 (b)). 
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Figure 4. 1chematic of the ani clusters highlighting the importance of including 3' reads in the generation of ESTs. In particular the ant-005 gene cluster 
would have been impossible to properly characterise without the inclusion of 3' reads. The number(s) in blue refers to the length of sequence to the Stop 
coon. Unshaded segments refer to regions not yet sequenced; lurk segments indicate 3'UTR. The pink sections refer to sequenced regions. 
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ant-034 	 TOK T 	Q H V PRMAIF 	19 
NS3gene 181 I P N U L K K K Q U T V L 0 L H P 0 S 0 K T P. K I L P Q I 111 210 
ant-034 	20 	A L Q A ILJ I Q V V V N P P T R V I C 0 E V A T L L D E I P 	49 
NS3gene 211 51A I Q Q P. 	L P. T A V flA P T P. V V A A K M A IflA L P. 0 L P 240 
ant-034 	50 	A P. 	
flR N 
[flJL P. P. RID 1W N I U V T P H A V L JflL 7-9 
NS3gene 241 - VP. V C P NA V Q P. E H QFEJTV D VflC HA T L T H269 
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NS3gene 406 V I T P 	I S K N 0 A N F G A S P. V I P C P. K S V K P T I L 435 
ant-034 	260 	- - - 0 C V V P. 5 M 	R - P 1 	A Q Q V Q P. P. 0 P. V 0 P. P. 285 
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Figure.4.11 Pileup showing level of identity between the Japanese encephalitis virus protease 
(Y16245) (NS3 gene) and ant-034. Identities are shown by dark shaded boxes, similarities are indicated 
in the lighter grey. The dashed line marks the break in the sequence alignment. 
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Number of sequences in family: 30 
Most frequent protein names: 	POLG(30) 
Commentary (automatic): 	 PROTEIN ENVELOPE GENONE 
POLYPROTEIN CONTAINS: CAPSID C CORE MATRIX M 
Length = 1427 
Score = 156 	(65.2 bits), Expect = Be-il 
Identities = 45/137 (32%), Positives = 69/137 (49%), Gaps = 4/137 (2%) 
Query: 18 VSGDDSVVILNKEESKAFSKAFWFNNETGKIRKDVAENLPSVVEEDIENVSFCS-NFY 76 
M+VSGDD VV 	K 	F KA +F N+ 	K+RKDV E 	PS+ 	+ E V FCS +F+ 
Sbjct: 3171 MLVSGDDCVV --- KPIDDRFGKALYFLNDMAKVRKDVGEWEPSMGFTEWEEVPFCSHHFH 3227 
Query: 77 VSTKFGGSVRTPIRSVEEVLSKASLMLGYARDFTTSEAWARAQGF'T4VCCYPHVAEIKL 136 
G 	++P K 	-'-E++ +A + 	G 	+ 	++A G N + 	Y H 	+++ 
Sbjct: 3228 ELV4KDGRSLIVPCRDQDELVGRARVSPGCGWSVRETACLSKAYGQMWLLNYFHRRDLRT 3287 
Query: 	137 LGLALLIATRANIVLEG 153 
LGA+ A +V G 
Sbjct: 3288 LGFAICSAVPVSWVPMG 3304 
Figure 4.12 (a). ProDom alignment showing regions and levels of homology exhibited by ant-
005 with sequence for the protein envelope genome. A 30 member protein domain family. 
Number of sequences in family: 280 
Most frequent protein names: 	POLG(44) SECA(20) UVRB(15( 
Commentary (automatic) : 	 PROTEIN 
HELICASE ATP-BINDING RNA-BINDING RNA ATP-DEPENDENT 
NUCLEAR FACTOR ENVELOPE PUTATIVE 
Length = 284 
Score = 193 	(79.6 bits), Expect = 7e-15 
Identities = 79/256 (30%), Positives = 121/256 (46%), Gaps = 27/256 (10%) 
Query: 	5 PGTGKTRQHVPRMAFQALQAGIQVVVSPPTRVICGEVATLLDEIPGARVTRNWRGGLRRR 64 
PG GKTR+ +P++ +A+ 	++ V PTRV+ E+A L +P 	+ 	R 
Sbjct: 1701 PGAGKTRRILPQIIKEAINRRLRTAVLAPTRVWAEMAEALRGLP - IRYQTSAVAREH 1757 
Query: 	65 DWN--IMVTPHAVLFRLLYLRSGMLKKQTVFFIDEAHFSDTKTIALCKFLRHRVEETLDT 122 
+ N + V HA L L + 	+ 	+F +DEAHF+D +I? 	++ RVE 
Sbjct: 1758 NGNEIVDVMCHATLTHRL-MSPHRVPNYNLFVMDEAHFTDPASIAARGYISTRVELGEAA 1816 
Query: 	123 AIFLTATGKDWKTGQDRICDISNYPIAD--HDIPSHNVVQFVEDHLRSWNGKKV-IVFcN 179 
AIF+TAT 	G 	SN PI+D 	+IP 	E + ++GK V V 
Sbjct: 1817 AIFMTAT ---- PPGTSDPFPESNAPISDLQTEIPDRAWNSGYE-WITEYIGKTVWFVPSV 1871 
Query: 	180 SVGGE-GLSIRTFWRKLRNNPAADVIAFSRNTFERNYPLVKKDPEMDKANIVLTTNNSEC 238 
+0 E L ++ 	+K 	VI +R ++E VP K D + D 	V+TT++SE 
Sbjct: 1872 KNGNEIALCLQRAGKK -------- VIQLNRKSYETEYPKCKND-DWD --- FVVTTDISEM 1919 
Query: 	239 GININADIVVDTGQQV 254 
G N A V+D+ ± V 
Sbjct: 1920 GANFKASRVIDSRKSV 1935 
Figure 4.12 (b). ProDom alignment showing regions and levels of homology exhibited by ant-034 
with sequence for the protein helicase ATP-binding RNA-binding protein. A 280 member protein 
domain family. 
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Although conclusive database homology could not be obtained for these transcripts an 
interesting characteristic was shown in the 3' segment of the genes. Figure 4.13(a) 
shows the 3' coding sequence of the transcripts highlighting the low level of sequence 
homology existing between the clusters. This is in contrast to the homology shown 
between the clusters at the 3' UTR (Figure 4.13 (b)). 
Transcript 	Top Hit 	Species/source 	BLASTX Top Hit species/source BLASTP 
Probability Score  Probability 	Score 
ant-003 	I Lactate permease 	Streptococcus iniae i 0.42 74 As for BLASTX As for BLASTX 0.23 	74 
[ant-005 NS5 protein 	Kyanasur forest 	1.1 x 10-09 83 As for BLASTX As for BLASTX 4.7 x 10-10 83 
disease virus  
ant-030 Serine/threonine Homo sapiens 1 0.63 54 Hypothetical ABC Mycoplasma 0.48 73 
protein kinase Transporter ATP- pneuinoniae 
binding protein 
MG467 homolog  
ant-034 NS3 protease Japanese 1.9 x 10-11 I 92 As for BLASTX As for BLASTX 3.4 x 10-12 92 
encephalitis virus 
not-018 Keratin, Oryctolagus 2.5 x 10-06 67 As for BLASTX As for BLASTX 2.9 x 10-06 67 
glycine/tyrosine- cuniculus 
rich of hair  
Table 4.7. Summary of the "top hits" obtained through BLASTX and BLASTP database searching. The scores and probabilities of the each database hit together with 
the description and source of each search result. 
A. 3 coding sequence (250 nt per transcript) 
	
10 
CA r A AT 
I" 
b.  Cl1C I C G C AT G C G C GflA IT G CT A A AGDA A
0()5 	A T A C C C T A T C A A G T T G 	C T G IC IA C G A T G Fr IC C A U G T G C T AC A T C I A AT A
03 cTTTTTcCCATrCc -  A AAIGITTAAGGrT-AAACGCTA-CTGG 	TCA
034 	 C IT T G G C AG ADG A AT GA GA C C C G IT A I TA T GA C CAA G 
60 	 70 	 00 	 90 	 tOO 
mI-0W 	G T A G 	A G G T T G 	A A C 	G A G C G A G 	IGCIGIAGCGC IGGGC 	T 
u,1-005 GGTATA 	TATAC - A GGA GATI1TG 	A CCATAIIATATGG 	AACC G 
A,-0_l0 	CATITAAACCC -. 	T G C 	CGAIGIG IAA:GC-AIGICTGGT CATT 	AS 
1-534 ATCC 	-GTTGTIT T A A AGCIJCTCAAACII GGLJGG TAlC 	A G A T G 
110 	 120 	 130 	 140 	 150 
,-503 	A T A C A 	GOTnOG   T C1C C G A T T A A 	IG A G T A T TA A 	 G G C G T 
mt-O05 CTTAG ATT CTCAIAIGFAICAGA-AGATGGATC 'ACC AAGGT ATC 
m1-03t) 	GCCA --TAGCCGCTAG 	ATGTGA -AGAA AGGAC 	CCC AAGACTGG 
U034 U A G C A 	AU AA A A T C A G G A C A A 	- T T G A A G C G G T G 	C A C I T T 
160 	 170 	 180 	 190 	 200 
-003 	TTCTGGTAT I MGCCG 	A 	T C G TIC 	CAGA 	C AA GAAC 	T T  
-5 AAGFrITAGAACGArn -- TTG C UT T --- - MA TGCC 	AGT - AA GAG 
m,-030 	GAG 	GAGGAA 	GI'GA 	T 	AT 	TAC 	AGGAAT GCT AG - -A 	G A C 
anl-034 GGTACCA TCATT 	TGATG A GA[CGTG - AGA AGTAA ATGTCCTA T G  
210 	 220 	 230 	 240 	 250 
003 	AC C 'TTITAV 	GAAG 	.AA A AC CC '1 GA 	ACG TC I CAA CI 
IGA 	TGGAAAGArCIGCAA 	AGGAG 	IACTGAAGT.ACCCI CATI G 
mt-Ot0 	
nc 
AATA AAG C TTTAAG ACT CGCGTACT 	C-AG- 	G TCT CT 
TGTG 	AGG GGTTGA CCAC CGAACIAGC -- GAAG - ATA CCGATGA 
260 
m-93 	C 	T C A T C I A A 
-005 GJC T C C 	A C 
m1-030 	I ..L.0 I C A 
,,534 C JT A i A CT A G 
Figure 4.13.(a). Pileup of the 3' coding sequences of the four ant gene clusters. Identities are shown 
by the grey shaded boxes, with similarities shown in the lighter grey boxes. 
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B. 3 untranslated sequence (220 - 281 nt per transcript 
10 	 20 	 30 	 40 	 50 
,9-003 
	
,,u-0O5 	TA C A G T CC AG T T T TG CC A GA G C I TA GA A A T CA A A A A AC A T T T G CC T GAG C 
,u-030 
T A C A 
60 	 70 	 80 	 90 	 100 
003 	 T A A T T C A A A A T T T C T
Yi 
T A A A C 	G T T 	- 	T A 
-045 C C GA C A G G TA AG A GA G G G CA A A AT A TG1G C 	i -.. T T T G T T GA AT T - C A A 
,9-030 	 TCA AS TT CCGG AAGCG A 	I 	C 	AA TC G 
u,9-634 TCAATC GTATGATCC GAGGC CC C AG TAAGAG GCC AG AA GA C AT 
110 	 120 	 130 	 140 	 150 
- TTTCATTT GEPTAACA A--- AGC TAAAAAAGC CAA TUATC
905 A TTTT T CT G T AC CATC AAG TT A . AA AGC TGA GT TC 
-630 	 C TTT GA AAC T A T TA CA AA AAA TI iCC GA A---TAA GG G A 
m,-O34 G ITT G TAAC A GA I AA AA CC AGA TG CCA GG G A G C G  AG C I 
160 	 ________ 1 70 	 160 	 90 	 200 
,5-O03 	 TTCAGAGAGGAGCCTTCAA CA9CACCACCGTAGCTAACA C - CT -rCTA 
n-605 IT GAG A AGGG A CC T  TC A AG CA T GA A TA CC CTAEC TA ACT CC CCITT CIA -O36 	 CI GCTTGG •TCAACT T IAFGC ........TAGCCTACCCCAAACAGCCATCTT 
mt-O34 C 	CACTATCTCAAGA 	CAT -- ------SCCCTACCTAC1 	A 	A 	A 
210 	 220 	 230 	 240 	 250 
003 




GCAC - - MC I CCCTI 
ACC- CCGTTATTGATGTTACDC ACACTA ------ CCAC --i CCCCTT 
,6O3o 	 CCC - T- CACATTCATCTT GCTCACACTA ----- - TGACA-ACCAGCT 014
T C C T C C C C A A T 'I C A I 1 C C T A C --- C A C A C T A C CT C C A A C 1 C - A C C A C G C 
260 	 270 	 260 	 290 
,,-OII.l 	CT TTCAAACCTCAACCGA 'CC AACCAAAAAAAAAAAAAAAA A 
CI 	TTCAAACATCAACCTTCCC AAC CIA AAA A A A A A A A A A A A A A 
ml-010 	(I (ICC TCACGTCC CAGTTC TI TCA AAAA AS A A A A A AAA AA AA AAA A 
I-034 CTTCAA CTCCAAG ATATCTAAAAAAAAAAAAAAAAAAAAAA 
Figure 4.13.b. Pileup of the 3' untranslated region (UTR) of the ants showing the high level of 
sequence conservation shared by the four genes in this region. Identities are shown by the grey shaded 
boxes, with similarities shown in the lighter grey boxes. 
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4.3.2 Antibody Screening of Phage 
The results from this experiment are tabulated in Table 4.8 below. The positive controls 
used to ascertain positive antibody recognition were two variants of the abundant major 
TES product TES 32 (Clones 36 (variant: see Chapter 3) and 66). The negative controls 
in the experiment were those clones that were in the incorrect reading frame within the 
Bluescript vector and as a result incapable of protein production. These are indicated in 
the table shown overleaf. 
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ANT Cluster 	Clone Correct Reading cx-TES 
Numbers Frame? 
003 	 106 	-- NO - 
137 YES ++ 
239 YES ++ 
258 NO - 
268 YES ++ 
281 YES + 
318 YES + 
323 YES ++ 
CONTROL 	36 (TES 32v) YES 
66 (TES 32) YES 
005 	 005 YES ++ 
065 NO - 
077 NO - 
134 YES 
111 YES ++ 
234 YES ++ 
275 YES + 
CONTROL 	36 (TES 32v) YES 
66 (TES 32) YES 
030 	 030 NO 	 - 
045 NO - 
050 NO 	 - 
092 NO - 
128 NO 	 - 
133 YES ++ 
149 NO 	 - 
165 NO - 
219 NO 	 - 
231 YES ++ 
280 NO 	 - 
308 YES ++ 
CONTROL 	36 (TES 32v) YES 	 ++ 
66 (TES 32) YES ++ 
055 NO 	 - 
080 NO - 
108 NO 	 - 
148 NO - 
192 NO 	 - 
294 NO - 
299 NO 	 - 
315 NO - 
319 YES 	 + 
CONTROL 	36 (TES 32v) YES ++ 
66 (TES 32) YES 	 ++ 
018 	 018 	 YES 	 + 
031 031 YES ++ 
136 	 136 	 YES 	 + 
CONTROL 	36 (TES 32v) YES + 
66 (TES 32) 	YES 	 + 
Table 4.8. Summarised data of plaque screening assay. The reactivity of the anti-TES antibody is 
indicated by + or - where the strength of signal is signified by + = weak signal, ++ = moderate signal, or 
= strong signal. - denotes no signal. 
ELISA 
139 
Figures 4.14 and 4.15 shows the responses obtained from TEX coated plates probed with 
the pooled sera from CBA/Ca or Balb/c mice respectively, each immunised with the two 
pcDNA constructs. The results show a poor antibody response for ant-005 and not-018 
which are both barely above the background control (pcDNA alone). The results obtained 
from the analysis of the TES coated plates, shown in Figures 4.16 -.4.17, proved to be very 
different. Figure 4.16 shows that an antigen specific response was obtained from the 
CBA/Ca immunised with not-018 pcDNA. This was not the case for the cc-ant-005 
antibody, the response of which was barely above background. The antibody response was 
almost completely reversed in the BALB/c derived antibody, in that it was the a-ant-005 
antibody that gave the antigen specific response to TES with the response from a-not- 018 
scarcely above background. 
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pcDNA Ant 5 	Not 18 
Groups 
Figure 4.14 Graph showing response to Toxocara canis somatic extract (TEX) coated ELISA plates 
probed by pcDNA3. 1 (-) (Invitrogen) induced antibody to ant 005 and not 018. The antibodies were raised 
in the CBA/Ca strain of mice. Sera were diluted 1:500 










0 	 I - I 
pcDNA 	Ant 5 	Not 18 
Groups 
Figure 4.15. Graph showing response to Toxocara canis somatic extract (TEX) coated ELISA plates 
probed by pcDNA3.1 (-) (Invitrogen) induced antibody to ant 005 and not 018. The antibodies were raised 
in the BaIb/c strain of mice. Sera were diluted 1:500 






pcDNA 	Ant 	Not 18 
Groups 
Figure 4.16. Graph showing response to Toxocara canis secretory/excretory antigen (TES) coated 
ELISA plates probed by pcDNA3. 1 (-) (Invitrogen) induced antibody to ant 005 and not 018. The 
antibodies were raised in the CBA/Ca strain of mice. Sera were diluted 1:500. 
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pcDNA 	Ant 5 	Not 18 
Groups 
Figure 4.17. Graph showing response to Toxocara canis excretory/secretory antigen (TES) coated 
ELISA plates probed by pcDNA3.1 (-) (Invitrogen) induced antibody to ant 005 and not 018. The 




The amino acid analysis of the transcripts yielded little definative information in terms of 
putative function or structure of the transcripts (see Table 4.8). From the table the 
composition of the transcripts indicated that on a comparative basis ant-003 was the most 
hydrophobic and not-018 the most basic. 
Homology searching of the public databases again yielded little useful information. Table 
4.7 summarises the results of these searches. Although significant search results were 
obtained for ant-005 and not-018 these proved to be false positives. This is best 
demonstrated by Figures 4.12 (a) and (b). The amino acid pileup in Figure 4.11 seems to 
suggest a sequence similarity to the Japanese encephalitis virus protease (accession 
number Y16245). 
Interestingly a high degree of sequence conservation was shown at the 3' UTR for the 
four ants (Figure 4.13(b)). This level of homology was not exhibited at the 3' coding end 
of the genes (Figure 4.13 (a)). The high level of sequence conservation shown by the 
transcripts could be attributable to the fact that they may share a common ancestry. 
Perhaps, although of different putative function, the transcripts share similar gene 
regulatory elements. At present this is mearly speculation. 
The results of the plaque screening assay provided preliminary evidence for the fact that 
the transcripts encoded putative TES products. Table 4.8 summarises the results of this 
assay. This data suggested the ant-034 was not a TES product whereas the remaining ants 
and not 018 were. Support for this data came from the successful cloning of ant-005 and 
not-018 into the pcDNA (Invitrogen) DNA vaccine vector. Antibody obtained from 
immunisation of mice with the constructs gave strong specific antibody responses in 
ELISA's against TES coated plates (Figures 4.16 and 4.17). The data obtained from the 
assays involving TEX coated plates proved less conclusive (Figure 4.14 and 4.15). 
To summarise, sequence data alone proved insufficient in providing definitive information 
about the nature of these genes or of their products. From the partial sequences that have 
been obtained to date it is known that these molecules have varying degrees of N-linked 
glycosylation. The genes of ant 003, 005 and 030 all have 2 putative N-linked 
glycosylation sites, although ant 034 has just 1 putative glycosylation site. The gene for 
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not 018 has 4 putative N-linked glycosylation sites. But no real significance can be placed 
on the putative levels of glycosylation as full-length sequence is yet to be obtained. 
Work is currenly in progress to obtain full-length sequence for all five transcripts. 
Following this the next phase is to clone the remaining transcripts into the pcDNA vaccine 
vectors and initiate characterisation of the respective gene products. 
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SXC (six cysteine), or NC6 (nematode cysteine 6) domains, as they were formerly 
known, refer to an array of six conservatively spaced cysteines (CXD46C48C6 
17CX3CX7C), the function of which has not yet been determined. The domain is a short 
structure of between 36-42 amino acids, which together with the conserved cysteine has a 
number of other conserved residues (Blaxter, 1998). The first definition of this structure 
came from a report by Gems et al, (1996) in which this novel domain was found in both a 
lipid binding protein (phosphatidylethanolamine binding protein) (Gems et al., 1995) and 
a mucin-like protein (Gems and Maizels, 1996) associated with the surface coat of T. 
canis. At present 75 genes have been identified from C. elegans that contain 184 SXC 
motifs (Blaxter, 1998). Of these are included tyrosinases (developmentally regulated 
enzymes implicated in the synthesis of nematode cuticles) (Gerrits, unpublished). SXC 
domains have also been found in a number of a other nematode genera such as Ascaris, 
Trichuris muris and Necator americanus (Blaxter, 1998). 
SXC domains have also been identified in cnidarians Anemonia sulcata (Schweitz et al., 
1995), Stichodactyla helianthus (Tudor et al., 1996), Heteractis magnfica (Gendeh et al., 
1997) and Bunodosoma granuljfera (Dauplais et al., 1997). In these species, these 
proteins function as toxins which specifically block potassium ion channels. These 
domains have also been found in the hydra, Podocoryne carnea (Pan et al., 1998), where 
they are thought to play a role in tissue remodelling or cell migration and also digestion in 
the case of the adults (Pan et al., 1998). A mammalian homologue was found in 
microfibril-associated glycoprotein factor (MAGP), a protein involved in the biology of 
fibrillin-containing proteins and associated with the aetiology of inherited connective tissue 
disease, has also been isolated from a human cDNA (Faraco et al., 1995). Bovine 
(Gibson et al., 1989) and murine (Chen et al., 1993) homologues of MAGP-1 have also 
been found. 
This chapter deals with the identification of a number of proteins containing SXC domains 
isolated as part of the EST project described in Chapter 3. The common factor shared by 
these genes is the presence of a cysteine rich domain of unknown function termed 
NC6/SXC described in the text above. 
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5.2 MATERIALS AND METHODS 
5.2.1 Identification of clones 
Tc-muc-1, -2, -3, -4 and Tc-huf-1 were identified following procedures as outlined in 
Chapter 2. Tc-muc-5 was identified by expression screening of the T. canis cDNA library 
with a polyclonal antiserum raised to TES products (Loukas et al ms. in preparation). 
5.2.2 Sequencing and sequence analysis 
Sequencing and sequence analysis were performed as outlined in Chapter 2 and as 
discussed in Chapter 3. Figure 5.1 shows the primer map for the SXC-rich protein Tc-
huf-1. Figures 5.2 and 5.3 show the primer maps for Tc-muc-2 and -muc-4 respectively; 
sequence information for Tc-muc-1 was previously obtained by Dr. D. Gems and Prof. R. 
M. Maizels (Gems and Maizels, 1996). Further sequencing of Tc-muc-3 and sequence 
information for Tc-muc-5 were obtained by Dr. A. Loukas et al (ms. in preparation). 
I 	TTTAGGCTTGGGATACCTCTAAGCGAACGGGAG ATG TTC CGT CAC GCA GCG TTT GTA CTA CTT CTG ACT GTC TCG CTT TCA 	81 
H F R H A A F V L L L T V S IL S 
82 	TAT GGG CAA GAT TGC AAA GAT GAT GTGAT TTC TGC CAT TCG ATA GTT GAT CAG AAA AAG TGC TCG TTG GGA GCG 156 
Y 	G 4 Q DIC K D D V D F C H S I V D Q K K C S 7----7—Al 
157 	GCC AAG AGA CAC TGT CGC AAG TCA TGT GGA CAT TGC TCA GAA CCA GCA CCA CGA CGC GCC GCA CCA ACT GCA GAC 231 




	TGT TAC GAC GCC AGA GCT GAT TGT GAA GAC TCA TTC TAT ATA TGC GGG TTA TAT CCT CAG GT GCA GCT GAT TGC 306 
IC Y D A R A D C E D S F Y I C G L Y P Q V A A D 
307 	AAA CAG ACC TGC GAA ATT TGC GGC CAG CCA AGA ACC ACC AAG CCC AAC ACC AGG TTC —AGG ATG GGA AGA TCA AGC 381 
K Q T C E I IG Q P R T T K P N T R F R M G R S S 
382 	AGG TTC TGC TAT TTC ATC GTT GCA CAG AA C AAA TGC GGA CTG AAT GCC GCA AAA CGA CAG TGC CGA AAG TCG TGT 456 
R F IC Y F I V A Q N K C G L N A A K R Q C R K S C 
457 	GGG CAT TGT CAA GCA CCA GTA CCA GCA CTC CCA TCA CCC ACA ATT GACTGC TAC GAT AGT TAT GAT GAT TGT GAG 531 
G H CIQ A P V P A IL P S P T I DIC Y D S Y D D C E 
— 	 C 
532 	AAT TAT TT TAT GTC TGT GGA CGA TCC TCT GAA GAG GCA TCG ACG TGT CGA ATG ACT TGC GAG CTT TGT AGT GAT 606 
IN Y F Y V CG R S S E E A S T C R M T C E L CIS D 
11 
607 	AAT CG GAT GCT GCC GAG AAA CCT ATG GAG TAG AAAGAGCGAAATATACCTGATGAAGAGAAGCGCCGATCTATGGAAGTTGAATAG 693 
N R D A A E K P H E * 
697 TAAAAAAGCTTTAATATCTTATATAATTTCAGTGAACATAAAAGATAATAACATAAAAGTTAAAAAAA AAAA 	 779 
i 	Tc1pETF1 	5' CCA AGA TTG CAA AGA TGA TGT GG 3' 
ii Tc1pETR1 5' CCT CCA TAG GTT TCT CGG CAG CAT CCC G 3' 
A 	TC-EST-001 F 5' GGG TTA TAT CCT CAG GTT 3' 
B TC 1 F 	 5' CCA AGC CCA ACA CCA GGT TCA 3' 
C 	Tc-HUF-1R 	5' GAG GAT CGT CCA CAG ACA TAG 3' 
Figure 5. 1 Nucleotide and deduced amino acid sequence of an NC6/SXC rich protein of unknown function termed Tc-huf-1. Primer design and direction are 
indicated by the horizontal arrows. pET primers (see section entitled" Bacterial expression of Tc-huf- 1") are shown in blue and internal primers in red. The putative 
signal peptide is indicated in italics with the cleavage point shown by the black arrow. The SXC domains are shown by the grey shaded boxes with the conserved 
cysteines in red and conserved aspartic acid residues in blue. The cysteines forming the partial SXC domain or FC 1 (Five cysteine 1) domain are highlighted in 
green. 
	
1 	CGGTTTAGTTACCCAAGTTTGAGC TCG TGC CGA GTT CGT GTC GTC ATT CTT CTC ACA GTG CTA ATT AGT GTT GTT AAA -tG 81 
S C R V R V V I L L T V L I S V V K A 
A 
82 	'AG CCT GGT GCC CAA ACC ACA ACC ACG GCA GCA ACA ACT ACA ACC GCG GCA GCA ACA ACC ACA ACC GCG GCA GCA 156 
Q P G A Q T T T T A A T T T T A A A T T T T A A A 
157 	ACA ACC ACA ACA GCG GCA GCA ACT ACC ACA ACC GCG GCA GCA ACA ACC ACA ACT GCA GCA CCG ATG ACC ACA ACA 231 
T T T T A A A T T T T A A A T T T T A A P M T T T 
232 	GCT GGA GCG ACA ACC ACC GCA GCT GGA GCG ACA ACT ACA GCA GGT GGA CCG ACA ACC ACC GCT GCT GGA GCG ATA 306 
A G A T T T A A G A T T T A G G P T T T A A G A I 
B 	< 
307 	ACT ACC GCT GCT GGA GCG ACA ACA ACT GCA GCG GTG ATG ACA ACG ACT CCA GCGTGC ATC GAC ACCCC AAT GAC 381 
T T A A G A T T T A A V M T T T P AIC I 0 P A N D 
382 	TC CAG CTG TTC ATG CCA CTC TGT TTC GTT CAG CCA TAC AGC AGA GCA ATA CAG GGA AGA TGC CGA AG ACG TGC 456 
Q L FM P L C F V Q P Y S R A I Q G R C R R T C 
457 	AZC ATT TGC AGCTGT CAG GAC AGT GCG AAC GAC TGT GCA AAC TTT GTT TCA GTC TGC CTG AAC CCG ACC TAT CAG 531 
I CjSC Q D S A N D C A N F V S V C L N P T Y Q 
532 	CCA GTG CTT CGA TCG AGA TGC GCA CTG ACG TGC GGC TTC TGT TAG TGACTGCTGAATCGCTACGAACTGAATGGCCTTCTCGAAA 616 
P V L R S R C A L T C G F Cj 
617 	CTGCAGACCATTCGTTATGAACATGTGCCAACTTTGTTTAGTTGCCTGAGGGAAAATGTGATGGGAAAACAAGTTTGCTATCTTCCCCAATGATGTATTC 717 
718 TATCGCTTGTTTTGGATAAAGGAATGCATGCAAAAAAAAAAAAAAAAAAAAAAAAAAA 	 767 
A 	TcrnucR 	 5' GGT TGT GGT TTG GGC ACC AGG CTG CGG 3' 
B Tcmuc2F 5' CGA CTC CAG GGT GCA TCG ACA CCG 3' 
C 	Tc-EST-676 P.263 P 	 5' CAC TGT CCT GAC AGC TGC AAA TGT TGC ACG FCC 3' 
P Tr-EST-.- II M2 239 9 5' GGC ATG AAC AGC TGG CAG TCA TTG GCG GTG TCG 3' 
Figure 5.2. Nucleotide and deduced amino acid sequence of Tc-muc-2 showing primer design/direction. The signal peptide is shown in italics with the putative 
cleavage point indicated by the black arrow. The two SXC domains are shown by the grey shaded boxes The conserved cysteines are highlighted in red and the 
conserved aspartic acids are shown in blue. The original EST is shown in black text with sequence generated from 5' PCR shown in dark magenta 
I TGAGAATCACACA ATG AAC ACA COT GTC CTC TAT CTT CTC GCA CTG CTA ATT TCT OTT GTT GCA TCG CAA GCC GCT 76 N 	N F 	R V 	L Y 	L L 	A 	L 	L 	I 	S 	V 	V 	A4S 	Q 	A A 
77 ACA ACA ACA ACT ACA GCA GCA ACA ACC ACA ACT GCG GCA ACA ACA ACA ACT GCA GCA ACA ACC ACA ACT GCA GCA 152 T 	T T 	T T A A T T T T A A T T T T A A T T T T A 	A 
153 ACA ACC ACA ACT GCA GCA ACA ACC ACA ACT GCA GCA ACA ACC ACA ACT GCA ACA GGA ACG ACC ACA ACT GCA ACA 228 T T T T A 	A T 	T T 	T A 	A T 	T T 	T A 	T G 	T T 	T T A T B A 229 GGA ACG ACC ACA ACT GCA ACA GGA ACG tC ACA ACA GGG OCT GCG ACA ACC ACA ACA GCT GCA GGA ACG ACT AG 304 G 	T T 	T T A T G T T T T G A A T T T T A A G T 	T T B - 	 C 305 ACT GCA GCG GGG ATG CA ACT ACA GCA ACC GGA GCG ACG ACA ACT GGG COG GCA GTG ACA ACG ACG GCT OCT TGT 380 T A A 0 M T T T 	A T 	G A 	T T 	T G 	G A 	V T 	T T A A EC 1 
381 GTT GAC AAC OCT AAT GAC TGC CAG GTG TTC ATG CAA CTC TGT TTC GTC CAG CCA TAT AGT AGG GCA ATA CAG GGA 456 
Iv 	13 N 	A N 	D C Q 	V F M Q 	L C F V Q 	P Y S R A 	I Q 	GI 
457 AGA TGC CGA AGO ACA TGC AAC ATT TGC AACTGT CAG GAC ACT GCC AAC GAC TGT GCT AAC TAT GTC TCG GTG TGC 532 
-1--C R C R R T C N I N I C Q 	D T 	A N 13 	C A 	N Y V S V C 
533 TTG AAC CCG ACC TAT CAA CCA GTT CTT CGA ACGAGA TGC CCA CTG ACG TGC GGCTTGTGT TAA CAATGCTCGACATCGC 611 ¶L 	N P 	T Y 	Q P 	V L 	R T R C P L T C G L CI* 
612 AACGTGTTCTTCGGCCTTCTCGGGACTGTGCAAACCGTCCAGTACTCTAAACCTTCATTTTTCGGACACGGCCGAAATAGTGGGAACGTTGTTCCACCGA 712 713 TTGCATGAAAACGTAAAGOAAAAGTTATTGATTGTATTCGTTACGAAATTTCAATAAAAGATAGAAGCAP,.AAAAAAAAAAAAAAAA 798 
A 	Tc-EST-186 M4 P.286 R 	5' GTG GTT GTC GCA GCC CCT GTT GTG 0 3' 
B Tc-EST-186 M4 P.395 F 5' CGA CTA CGA CTG CAG CGG GGA TGA C 3' 
C 	Tc-EST-186 M4 P.282 R 	5' CAA GCA GCC GTC GTT GTC AC 3' 
Figure 5.3. Nucleotide and deduced amino acid sequence of Tc-,nuc-4 showing direction and position of primers used in obtaining full-length sequence of the 
transcript. The signal peptide is hown in italics with the putative cleavage site indicated by the black arrow. The two SXC domains of Tc-,nuc-4 are indicated by 
the grey shaded boxes. The conserved cysteine residues are shown in red and the conserved aspartic acid residues are shown in blue. 
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5.2.3 Bacterial expression of Tc-huf- 1 
The Tc-huf- 1 insert was amplified from phagemid template using the pET primers Tel Fl 
and Tel pET RI. The resulting amplicon was ligated into the pET 29-T (Novagen) vector 
according to the manufacturer's instructions. The ligated product was transformed into 
competent XL1-Blue E. coli cells which lack the T7 RNA polymerase gene, and grown 
overnight on LB-kanamycin (LB-kan) plates at 37°C. A single colony of cells carrying the 
plasmid insert was used to inoculate lOmis of LB-kan broth which was then grown in a 
37°C shaking incubator for 16-18 hours. Plasmid was purified from the bacterial culture 
using the Qiagen Spin miniprep (Qiagen) kit as outlined in the manual. The purified 
plasmid was diluted 1: 50 and transformed into E. coli strain BL21 (Novagen) carrying the 
DE3 episome, which express the T7 RNA polymerase gene. Expression of the protein 
from the BL21 DE3 E. coli was as outlined in the Novagen manual. Briefly, a single 
colony of the transformed BL21 DE3 expression cells was used to inoculate 1 litre of LB-
kanamycin broth and allowed to grow at 37°C for approximately 3.5 hrs or until an OD of 
0.5 was reached. Following this period, a imi aliquot was removed and centrifuged, 
before addition of isopropyl 3-D-thiogalactopyranoside (IPTG) to a final concentration of 
0.4 mM. Further samples were collected 1 and 2 hours post induction and the bacteria 
pelleted at 13,000 rpm. The resultant pellets were resuspended in SDS PAGE sample 
buffer and analysed on a 15% SDS PAGE minigel. 
Cells grown in a 1L culture fluid were pelleted in a Sorval centrifuge at 9000 rpm, 4°C for 
10 mins. The pellet was subsequently resuspended in 5 ml of binding buffer, and 
sonicated on ice using an MSE Soniprep 150 sonicator (Sanyo Gallenkamp) at an 
amplitude of 7 microns. Recombinant Tc-HUF- 1 (rHUF- 1) protein was only soluble in 
the presence of 6M urea, so subsequent purifications all included urea as the denaturant. 
Purification of the recombinant protein was achieved by using a metal chelating resin (His 
Bind Resin; Novagen) under denaturing conditions according to manufacturers 
instructions. A Bradford protein determination assay was performed on 4 chelating 
column-purified fractions of 0.5 ml using the Coomassie Plus Protein Assay Reagent 
(Pierce) on Nunc-immuno plates (Nunc). The concentration of each fraction was read 
using an Anthos Reader 2001 with the Delta Soft II ELISA analysis program. Protein 
concentrations were estimated at 2.0 mg/ml, 1.7 mg/ml, 2.2 mg/mi and 1.9 mg/ml for 
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fractions 1-4 respectively. The concentration of the recombinant protein post dialysis was 
1.3 mg/ml. 
Fractions containing protein were pooled and dialysed over three days in a stepwise 
manner using decreasing molarities of urea in PBS. This was done to reduce the 
likelihood of the recombinant protein precipitating; this only proved partially successful. 
5.2.4 Immunisation of mice with Tc-HUF-1 
Four BALB/c and four CBAICa mice were immunised with 20 jig in lOOjil with 100 jil of 
Freund' s complete adjuvant rHUF- 1. The mixture was emulsified by sonicating on ice for 
a total of 3 mins. The primary immunisation was followed by 2 boosts at days 28 and 42 
with 20 jig of rHUF-1 in incomplete Freund's adjuvant, delivered via the subcutaneous 
route. Sera were collected at day 54. Both strains of mice were used as strain related 
differences in the level of antibody production with different recombinant proteins are 
common (R. Maizels pers. comm.). Blood collected from the BALB/c and CBAICa mice 
were left at 4°C overnight. The samples were centrifuged at 13,000 rpm for 20 mins, the 
sera were then transferred to fresh tubes and stored at -20°C. 
5.2.5 Western blots with a-Tc-HUF-1 antibody 
rHUF-1 (1.0 jig), rMUC-1 (1.0 jig), TES (2.5 jig) and TEX (5.0 jig) were 
electrophoresed in quadruplicate lanes on a 5 - 25 % SDS PAGE gradient gel and proteins 
transferred onto nitrocellulose membrane at 45 mA for 1 hour using a Novablot 
electrophoretic transfer apparatus (LIKE Bromma). The nitrocellulose membrane was then 
treated as for a Western blot (see Chapter 2: Materials and Methods). Once transfer was 
complete the nitrocellulose membrane was cut into four panels, each panel containing all 
four antigen preparations, and probed with normal mouse sera (NMS) or sera from mice 
immunised with either rHUF-1, rMUC-1 (Chapter 4; negative control) or Tcn 2 (control 
monoclonal antibody that recognises carbohydrate epitopes on the majority of TES 
molecules; (Maizels et al., 1987) - see Chapter 1); all sera were diluted 1: 5,000 in PBS 
Tween (PBS-T), followed by incubation with horseradish peroxidase-conjugated rabbit 
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anti-mouse IgG (diluted 1:2,000; BioRad). A second experiment was carried out with 
extracts prepared by sequentially sonicating T. canis larvae in PBS then 0.5% Empigen 
(non-ionic detergent) and finally 1% SDS. Extracts were electrophoresed, transferred and 
probed with a-rHUF-1 and the monoclonal antibody Tcn 1 (which shows strong 
recognition for a 70 kDa protein in TES (Maizels et al., 1987) - see Chapter 1). Blots 
were developed using the ECL chemiluminescent substrate (Amersham). 
5.2.6 5' PCR ofTc-muc-2 
The original EST clones relating to Tc-muc-2 (Tc-EST-076, -130, and -241) were all 
truncated at the 5' end. In order to obtain the 5' end of the gene, a PCR reaction was 
carried out on the library using an internal primer. Tc-EST-076M2-P.263 R (Figure 5.4) 
a 5' specific primer was used in conjunction with the universal primers M13 R & F and 
also T3 & T7; and also the spliced leader 1(SL1) and oligo dT primers. As Tc-muc-] and 
-muc-3 both had Spliced Leader 1 the SL1 primer was used in this instance because it was 
thought likely that the other mucin members would also be SL1 transpliced. Bands 
obtained from Tc-EST-076M2-.P.263 RISL and Tc-EST-076M2-.P.263 R 1T3 were 
excised from the gel and cleaned of agarose and ethidium bromide using the Qiaquick Gel 
Extraction Kit (Qiagen). The cleaned PCR products were then ligated into the pGEM-T 
vector (Promega) as outlined in the pGEM-T manual. The ligated products were 
transformed into JM109 competent cells (Promega) and plated out onto LB-amp with Xgal 
and IPTG to screen for blue white colonies. Incubation of the plates was carried out 
overnight at 37'C. The following day the white colonies obtained (white denoting 
recombinant) were screened by PCR for the presence of inserts using Tc-EST-076M2-
P.263/T7. Positive clones were grown in 10 mis of LB-amp broth and plasmids prepared 
using the Qiagen Spin Miniprep Kit (Qiagen), which were subsequently used in dye 
terminator sequencing reactions (Perkin Elmer) (see Chapter 2 and 3). 
I ! 
600 -410-- 600 
Figure 5.4. Results of 5' library PCR using the specific primer Tc-EST-076M2-P.236 R in 
combination with /M13 R (vector primer), /Spliced leader I (SL1), ff3 (vector primer), /M13F (vector 




Figure 5.5. Results of PCR colony screen using the specific primer Tc-EST-076M2-P.263 in 
combination with the T3 (vector primer) and SL primers. The markers used were the 100 Kb DNA ladder. 
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5.3 Results and Discussion 
5.3.1 Tc-huf-1: an SXC rich protein of unknown function 
The clone Tc-huf-1 was represented in the EST project (Chapter 3; Tetteh et al., 1999) by 
two clones, Tc-EST-001 and Tc-EST-058. Tc-huf--1 contains a cDNA insert of 779 base 
pairs including a poly A+ tail. The deduced full-length protein contains 202 amino acids 
including an 18-aa potential signal peptide with a putative cleavage site after residue 18 
r gure 5.1). The gene encodes a protein containing 3 SXC domains and 1 partial SXC 
(FC 1) domain with a gap of 20 aa separating SXC domain 2 from FC 1 (Figure 5.1 and 
5.6). A 13 amino acid gap is also present between SXC domain 1 and domain 2, and also 
between FC domain 1 and SXC domain 3 (Figure 5.1 and 5.6). The partial SXC domain 
termed here FC 1 (Five cysteine 1) domain bears the consensus sequence CX8CX8CX3CX2C 
and was present in the sequences of both Tc-EST-001 and -058. The protein does not 
possess any putative N-linked glycosylation sites, although the possibility remains that 0-
linked glycosylation might occur. The predicted size of the protein was 22, 437 Da, 
although the recombinant protein migrated at 43,000 Da on SDS PAGE including the 5 
kDa added on due to the pET tag. Figure 5.7 shows an SDS PAGE gel with a duplicate 
analysis of the bacterial expressed Tc-HUF- 1 (rHUF- 1) recombinant protein. Figure 5.8 
shows the purified fractions of the His column purified rHUF- 1 as shown by SDS PAGE 
analysis. 
1 	signal Eli-Ill X[TT 	 202 
Figure 5.6. Schematic representation of Tc-HUF-1 showing the SXC domain arrangements. The 
putative signal sequence is shown by the open box. The partial SXC domain is designated 5C and is 
shown in green, while the SXC domains are in blue. 
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The closest homologues of Tc-huf-1 are a predicted protein from C. elegans (accession 
no. Z81529) and Tc-peb-1 (phophatidylethanolamine binding protein-TES 26) from 
Toxocara canis (Gems et al 1995). 
1 2 3 4 5 6 7 8 9 10 
200.0 .•- 	. 
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Figure 5.7. Fifteen percent polyacrylamide gel showing expression of recombinant Tc-HUF-1 (rHUF-1) 
by E. coli BL21 DE3 expression cells over a 3 hour time course (in duplicate). Lanes 1 & 10: molecular 
weight markers; Lanes 2 & 6: uninduced BL21 DE3 cells, pre-induction; Lanes 3 & 7: induced BL21 DE3 
cells, lhr; Lanes 4 & 8: induced BL21 DE3 cells, 2hrs; Lanes 5 & 9: supernatant from sonicated pellet. 
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Figure 5.8. Fifteen percent polyacrylamide gel showing rHUF-1 purified using nickel-chelate resin. 
Lane 1: molecular weight markers; Lane 2: blank; Lanes 3-6: His column purified fractions 1-4 
Note: Fraction numbers refer to the 0.5m1 aliquots obtained during the His column purification. 
Antibodies raised to the purified recombinant, rHUF- 1, were used to TES and TEX 
products of T. canis by Western blot. The results of the blots showed the antibody 
recognised two bands (Figure 5.9), a band of approximately 66 kDa in both TES and 
TEX, but also a higher band at 70 kDa in TES alone. Neither of these bands were 
recognised by the anti-carbohydrate monoclonal antibody Tcn 2, anti-MUC-3 antibody, or 
by the normal mouse serum (NMS) control (Figure 5.9). Additional reaction was seen by 
the rHUF-1 antibody at approximately 32 kDa in TES alone (Figure 5.9). Full-length 
sequence of TES 32, a C-type lectin and the most abundant protein in TES product, has 
been obtained (Loukas et al ms. submitted) and is shown not to contain SXC domains. 
There is no obvious explanation for the binding seen, excepting perhaps that recognition is 
a result of the abundance of this protein product. A second blot was run in which 
sequential detergent extracted parasite antigen was probed with rHUF- 1 and the 
monoclonal antibody Tcn 1 (shown to be specific for TES 70; (Page et al., 1992a)) 
(Figure 5.9). The monoclonal antibody Tcn 1 showed strong recognition of a band at 
approximately 70 kDa in both the PBS and SDS extracted TEX and to a lesser extent the 
Empigen® extracted TEX; banding patterns could also be seen at 66 kDa in the PBS and 
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SDS fractionated antigen only. In contrast, the a-HUF- 1 antibody showed recognition of 
a 70 kDa band in the PBS and SDS extracted antigen only, and a second band at 66 kDa in 
all three lanes. Thus it would appear that the MabTcn 1 and anti-HUF-1 are reactive to 
different antigens. 
Although the signal of recognition appeared specific for 66-70 kDa targets, the predicted 
size of the protein is around 22 kDa. The size discrepancy between the predicted protein 
and the reactive bands is not due to N-linked glycosylation but could be due to extensive 
O-glycosylation. It is impossible to predict from the primary sequence exactly where 0-
linked glycosylation sites might reside as consensus sequences have yet to be established 
(Gooley et al., 1994). However, very heavily glycosylated proteins tend to migrate very 
diffusely on SDS PAGE gels, whereas the proteins recognised by anti-HUF- 1 resolve 
sharply (Fig. 5.9 and 5.10). A number of other reasons may explain the size discrepancy. 
Firstly, there is the possibility of oligomerisation such as through tyrosine cross-linking. 
As no definitive function(s) have been assigned to SXC domains, the possibility exists 
that they allow the formation of stable non-reversible structures (dimers, multimers etc). 
In this case such interactions would have to resist boiling in a reducing agent 
(mercaptoethanol, dithiothreitol) in the preparation of samples for SDS PAGE. The 
second possibility is that cross-reactivity might be occurring between the SXC domains of 
Tc-huf-1 and other SXC containing proteins. So far the only TES proteins found to 
contain SXC domains are the mucins (Tc-muc-1 to muc-5), and TES 26 (PE binding 
protein) (Gems et al., 1995). It could be that the SXC domain(s) of a hitherto unidentified 
SXC containing protein with an electrophoretic mobility of approximately 70kDa (perhaps 
the as yet uncharacterised TES 70) is proving to be immunologically cross-reactive with 
the a-rHUF- 1 serum. 
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Figure 5.9. Western blot showing four panels, each with TES, TEX, rHUF-1 and rMUC-3 antigen*. 
The panels were probed from left to right with NMS (normal mouse serum), a-rHUF-1, c&rMUC-3 and 
Tcn 2 (monoclonal antibody, see Chapter 1). The bands recognised by a-rHUF- I are indicated by the 
arrows on the left side of the figure at 70 and 66 kDa. Molecular weight markers are indicated on the right 
Note: * Recombinant protein and antiserum provided by Dr. A. Loukas. 
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6.5 - 4 
Figure 5.10. Western blot showing probing of sequentially extracted TEX [using PBS (phosphate 
buffered saline), EMP (empigen) and SIDS (sodium dodecyl sulphate)] with anti-rHUF-1 and Tcnl 
monoclonal antibody. The two arrows on the right side of the blots indicates the positions of the, a-
rHUF-1 identified bands at 70 and 66 kDa. 
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5.3.2 A putative family of mucins from T. canis 
Earlier work by Page et al (1992c) showed that while preparing parasites for electron 
microscopy using a graded alcohol series, the surface coat of the parasite was removed 
from the underlying cuticle in 35% alcohol. Analysis of the alcohol-derived fraction 
showed that the predominant protein in this fraction was TES-120 (see Chapter 1) (Page et 
al., 1992b). This protein is one of the most abundant antigens secreted by the parasite and 
has also been shown to be the major component of the surface coat of the parasite (Page et 
al., 1992b). It has now recently been shown that the TES-120 proteins consist of a 
putative family of mucins, only one of which had previously been reported (Gems and 
Maizels, 1996). 
To date 5 mucins have been isolated from Toxocara canis (Figure 5.11). Of these Tc-
muc-] was first isolated by spliced leader (SL1) PCR (Gems and Maizels, 1996) and was 
also isolated from this EST project (see Chapter 3) as 7 clones which represent 2.6% of 
the 266 clones serendipitously sequenced as part of the project. This indicates the high 
level of expression of Tc-muc-1 within the parasite. In contrast Tc-muc-2, -muc-3 and - 
muc-4 were not as abundantly represented, appearing 3, 2 and 1 times respectively, which 
accounted for 1.1%, 0.75% and 0.37% respectively of the 266 clones analysed as part of 
the EST project (Tetteh et al ms submitted). The fifth mucin was recently identified, not as 
a clone from the EST project, but expression screening with a mouse polyclonal antiserum 
raised to TES products (Loukas A. et al ms. in preparation). Full-length sequence was 
obtained for Tc-muc-2 -muc-4 (Figure 5.2 and 5.3), and work is currently in progress by 
A Loukas to confirm the full-length sequence for muc-5 (previously obtained by A. 
Doedens). Figure 5.11 shows a schematic representation of all five mucins. Each of the 
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Figure 5.11. Schematic showing a diagrammatic alignment of the 5 T. canis mucins identified to date. 
The relative positions of the SXC domains is clearly indicated 
Note: Tc-muc-5 was identified as part of an antibody screen of the cDNA library (Doedens and Loukas pers. comm.) and was not 
isolated as part of the EST project (Tetteh et al submitted) 
As is shown in Figure 5.11 each of the translated mucin proteins have a putative signal 
peptide. All the proteins possess C-terminal paired SXC domains and Tc-muc-3 and-5 
each contain paired N-terminal and C-terminal domains. The SXC domains of the mucins 
show a remarkable level of sequence conservation (Figure 5.12). The SXC domains of 
MUC-1, -2 and -4 share between 86-97% identity to each other. The N-terminal SXC 
domains of MUC-3 proved to be less similar to both the C-terminal domains of itself 
(58%) and that of the remaining four mucins (65-70%) (Loukas A. per. comm.) (Figure 
5.12). Each single SXC domain of the mucins was compared in a pairwise manner to each 
SXC domain of the remaining mucins. The data for each pairing was represented as a 
percentile value as is demonstrated in Table 5.1. The compiled data shows that the highest 
levels of similarity existed between equivalent mucin SXC domains. When comparing 
SXC 1 of MUC- 1 to the analogous domains (where SXC 3 and 4 of MUC-3 and MUC-5 
correspond to SXC 1 and 2 of the remaining mucins) this value ranges from 50-97%. This 
appears to be the rule for MUC 1 to 4, but does not apply as stringently to MUC-5 and 
highlights the level of divergence existing between MUC-5 and MUC 1 to 4 (Table 5.1). 
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(Table 5. 1). The SXC domains of the mucins were then compared, for percentage 





97 40 MUC-2 
SxC  
40 97 40 MtJC 	2 
SXC2 
MUC-3 68 42 65 42 
SXC 1 
34 MUC-3 37 71 37 71 
62 
SxC 
37 NBC 3 
1 
74 34 74 34 
31 51 22 MUC 3 25 62 25 60 
68 37 74 25 MUC 4 85 40 88 40 
37 71 37 54 37 
SXC  
MUC 4 40 88 40 85 
45 54 37 42 37 
SXC 2 
54 MUC 5 37 57 37 57 
SxC 1 
42 54 42 54 40 54 37 42 40 54 51 MUC 5 
SXC 2 
37 57 37 57 40 60 34 48 37 54 68 60 	MUC 5 
SXC 3 
37 48 37 48 37 45 37 42 37 54 60 54 	65 	NBC 5 
SXC 4 
Table 5.1. Table showing percentage similarity between SXC domains from the T. canis mucins. Percentile values were obtained by 
pairwise comparison of each domain using the MacVector software (Oxford molecular). 
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domains isolated from T. canis (Tc-peb-1, Tc-huf-1 and Tc-vah-1), but also to the SXC 
domains isolated from two C. elegans predicted proteins, P. camea metalloproteinase 
(PMP1), potassium channel blocking toxins and the human MAGP1 protein (Table 5.2). 
Interestingly, the highest values were obtained in a comparison of the mucin SXC 
domains with SXC 1 and 2 of Tc-peb-1. For SXC domain 1 of Tc-peb-1, the highest 
values were again obtained for the equivalent SXC domains in the mucins. This pattern 
was repeated for SXC 2 of Tc-peb-1 for MUC-1 to 4, but for MUC-5 identical scores 
were obtained for SXC 1 to 3 with a marginal decrease with SXC 4. Table 5.3 shows the 
compiled data of the comparative analysis between the T. canis SXC domains of non-
mucin origin compared with the SXC domains from two C.elegans predicted proteins, 
PMP1, the cnidarian toxin homologues and the human derived MAGP1. The same 
patterns of SXC domain identity as demonstrated in Tables 5.1 and 5.2 also apply. 
Figure 5.12 shows an amino acid alignment of the SXC domains of five mucins, the PE 
binding protein, Tc-HUF- 1, a number of potassium channel blocking toxins from sea 
anemones and hydra, and a microfibril associated glycoprotein (MAGP 1) from humans. 
The SXC domains across these diverse species show a high level of conservation. 
Structural modelling of the SXC domains from Tc-MUC- 1 based on the known structure 
of Bunodosoma granuljfera (BgK) toxin (Dauplais et al., 1997) reveals that they share 
similar folding patterns (Loukas et al manuscript in preparation). Figure 5.13 shows the 
manner in which the cysteine residues are thought to interact with each other in folding and 
is based on the NMR structure ofBgK (Dauplais et al., 1997). 
Previous analysis of the serine/threonine content of TES products using radiolabelled 
amino acids(Page et al., 1991) showed TES-120 to have high levels of serine and 
threonine. Subsequent cloning of Tc-muc-1 (Gems and Maizels, 1996) suggested that the 
protein product of the MUC- 1 gene was responsible for the high serine content and that 
MUC-1 was TES-120. The identification of 4 new mucins - 3 from the EST project 
(Tetteh et al ms. submitted) and 1 from antibody screening (Loukas et al ms. in 
preparation) has shown that TES-120 consists of a family of mucins and not alternatively 
processed forms of one mRNA. Indicated in Figure 5.11 and in Figure 5.14 is the 
presence of serine/threonine rich regions which act as sites of potential 0-linked 
glycosylation within the mucins thus accounting for their high molecular weights. MUC-1 
is the only one of the mucins identified to date that possesses serine in its repeat region. 
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The other mucins each have a predominance of threonine with varying amounts of glycine, 
alanine and proline (Figure 5.11). 
Toxocara canis mucin SXC domains 
MUd/i MUC1/2 MUC2/1 MUC2/2 MUD/i MUC3/2 MUC3/3 MUC3/4 MUC4/1 MUC4/2 MUC5/1 MUC5/2 MTJC5/3 MUC5/4 
PFI1 48 42 48 42 57 40 57 31 48 40 45 34 40 34 
PFJ2 34 51 34 51 34 51 28 42 34 54 48 48 48 45 
HUF/1 25 25 25 25 22 28 25 28 25 25 25 34 31 25 
HUF/2 34 25 34 25 31 28 37 20 34 25 28 28 31 31 
HUF/Fi 20 20 20 20 17 22 20 20 20 20 17 25 20 17 
HUF/3 28 34 28 34 31 28 31 22 28 37 28 34 31 37 
VAH/1 25 25 25 25 22 28 25 28 25 25 25 31 28 25 
VAHI2 34 28 34 28 31 31 34 20 34 20 31 31 37 34 
VAHI3 25 25 25 25 22 28 25 28 25 25 22 31 25 25 
VAHI4 34 28 34 28 34 31 34 20 34 31 31 34 37 37 
CeT20G8.5/1 28 34 28 37 25 34 25 25 31 31 37 31 34 28 
CeKO9C8.3/ 1 25 34 25 34 28 31 28 37 25 28 31 37 28 25 
PMP1/1 22 17 22 17 25 17 25 20 25 17 28 20 25 22 
ShKi1 37 28 37 28 25 28 28 22 31 28 25 37 28 28 
1-IrnK'1 -18 25 28 25 25 28 31 22 28 25 25 40 31 25 
BgK/1 25 28 25 31 28 25 22 25 25 31 31 31 28 34 
AsKs/I 25 25 25 28 25 28 28 22 25 28 28 37 34 28 
MAGPI!1 22 22 22 25 25 1 22 1 	25 1 	25 25 22 28 20 20 17 
Table 5.2. Tabulated data showing the comparison between the mucin SXC domains with the other T.c. derived SXC domains, two predicted C.eiegans proteins 
(CeT20G8.5 and CeK09C8.3), Podocyrne metalloproteinase (PMP1), four cnidarian potassium channel blocking toxins (ShK, HmK, BgK, AsKs) and microfibril 
associated glycoprotein 1 (MAGP1). The figures are shown as percentages based on thelevel of similarity between each domain pairs. 
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20 25 90 
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34 33 25 34 31 
PMP1/i
28 33 25 36 25 27 25 
25 31 39 28 38 31 36 28 36 28 24 25 60 H
- 
28 31 24 15 19 15 27 18 21 18 31 21 25 39 48 
25 28 33 21 26 21 33 21 30 21 1 	40 1 	21 25 39 45
28 22 27 25 26 18 27 18 27 21 28 29 22 27 24 
52 	I ASK/1 
Table 5.3. Table showing percentage similarity between T. canis SXC domains of non-mucin origin, two C.elegans predicted proteins, Podocyrne 
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Figure 5.12. Amino acid pileup showing the paired SXC domains of the T. canis mucins. 
Tc-muc-1 SXC 1 
Tc-mac-1 SXC 2 
Tc-,nac-2 SXC 1 
Te-muc-2 SXC 2 
Tc-muc-3 SXC (N) 1 
TI.-muc-3 SXC (N) 2 
Tc-muc-3 SXC (C) 3 
TI-,nuc-3 SXC (C) 4 
Tc-,nuc-4 SXC 1 
Tc-,nuc-4 SXC 2 
Tc-muc-5 SXC (N) I 
Tc-muc-5 SXC (N) 2 
Tc-rnuc-5 SXC (C) 3 
Tc-muc-5 SXC (C) 4 
Tc-peb-I SXC 1 
Tc-peb-J SXC 2 
Tc-huf-I SXC I 
Tc-huf-1 SXC 2 
Tc-huf-1 F  1 
Tc-huf-1 SXC 3 
Tc-vah-1 SXC 1 
Tc-vah-J SXC2 
Tc-vah-1 SXC3 
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Figure 5.13. Amino acid pileup showing the SXC domains from predicted proteins from Toxocara 
canis (Tc-rnuc-1, -,nuc-2, inuc-3, ,nuc-4 & rnuc 5*, Tc-peb-1 (TES 26), Tc-hnj'-1, two C. elegans 
predicted proteins (Ce T20G8.5 [Ace. No. Z304230] and Ce K09C8.3 [Ace. No. Z68006], a 
metalloproteinase from Podocoryne carnea, PMP1 (AJ005052), and potaslum channel inhibitors from 
Stichodaclyla heiianthu.s, ShK toxin (P29187), Heteractis magnifica, HmK toxin (AF020047), 
Bunodosorna granu1fera, BgK toxin (P29186) and Anemonia sulcata, AsKS toxin (1181911) and the 
C-terminus of the microfibril associated glycoprotein (MAGP 1) from humans (P55002) 
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Figure 5.14. Pileup of the serine/threonine/alanine/glycine/proline repeat regions from the five Toxocara .'nucins 
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5.4 Concluding remarks 
First identified as a secreted component from T. canis (Gems et al., 1995) SXC domains 
have been identified in a number of diverse species (Blaxter, 1998; Pan et al., 1998). The 
C. elegans project alone has identified 75 genes that contain 184 SXC domains (Blaxter, 
1998). A number of these C. elegans open reading frames are composed solely of SXC 
domains (up to four), others are mucin-like with the SXC domains separated by serine or 
threonine rich regions, and yet others still possess SXC domains coupled to known 
enzymatic domains, such as tyrosinases, myeloperoxidases, and astacin-like zinc 
metalloproteinases (Blaxter, 1998). Yet the function(s) of these domains remains elusive. 
It has been hypothesised (Blaxter, 1998) that these domains are involved in protein-protein 
interactions with a probable specificity to the nematode cuticle. It has also been suggested 
that perhaps these domains are analogous in function to that of the epidermal growth factor 
(EGF) domains (Blaxter, 1998). While these suggestions may be valid, there is no 
supporting data as yet to lend credence to such hypotheses. It seems unlikely that these 
domains would function in a manner analogous to EGF as the arrangement of cysteines 
(CX7CX5CX10CXCX8C) and therefore the folding of each molecule would be different 
(figure 5.14). 
EGF NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR 
1 	2 	3 	 45 	 6 
SXC CXDXXXXXXCXXXXXXXXCXXXXXXXXXXXXCXXXCXXC 
1 	2 	3 	 456 
Figure 5.15. Figure showing the characteristic disulphide linkages of EGF compared to the deduced 
disulphide linkages of the SXC consensus The conserved cysteines are highlighted in red and the conserved 
aspartic acid in the SCX domain is shown in blue. 
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The SXC rich protein, Tc-HUF-1 was first assumed to be a member of the TES-120 
family of mucins. But analysis of the completed sequence showed it to be too dissimilar 
from the other members of this putative mucin family. 
It may be of note to point out that the domains of Tc-huf-] are separated from each other 
by a 13 aa gap, followed by a 20 aa gap and then by another 13 amino acid gap (Figure 
5.1 and 5.6). The amino acids of these gaps are predominantly composed of serine, 
threonine, proline, alanine and glycine, amino acids indicative of the core proteins of 
mammalian mucins (Devine and McKenzie, 1992). 
Mucin-like structures have been found in a number of different species, such as the novel 
Drosophila surface mucin, hemomucin (Theoplod et al., 1996); dSR-C1, a class C 
macrophage specific scavenger receptor also from Drosophila (Pearson et al., 1995). 
Mucins have been reported from parasitic protozoans and are thought to be involved in 
immune evasion. Examples are the mucin-like proteophosphoglycans of Leishnwnia 
species (Ilg et al., 1996), a filamentous macromolecule thought to be implicated in cell 
aggregation (hg et al., 1996). The membrane mucin Ag CIO from Trypanosoma cruzi 
modulates the host immune response by binding to the surfaces of macrophages and 
specifically inhibiting monoclonal antibody binding against CD62L/L-selectin (de Diego et 
al., 1997). Glycosyiphosphatidylinositol-anchored mucin-like glycoproteins from T. 
cruzi were shown to be potent inducers of nitric oxide synthesis in addition to induction of 
microbicidal activity in murine macrophage (Camargo et al., 1997). 
Although the exact function of the mucin rich surface coat of the parasite is unknown, it 
appears that one of its main roles is to serve in a protective capacity. Badley et al (,1 987) 
showed that this structure was frequently shed from the larval epicuticular surface under 
immune attack when incubated in infection serum and immune cells. It seems safe to 
assume that this structure plays a major role in the parasite's ability to survive for extended 
periods of time in the hostile environment of the host's immune system. The mucinous 
nature of the surface coat may also provide lubrication for the parasite during its tissue 
migratory phase. Extrapolating from de Diego et al (1997), perhaps the surface coat of T. 
canis might be effecting similar immune modulatory roles that aid its survival within the 
host. 
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6.1 Final Discussion 
6.0.1 Relevance of study 
It is an intuitive assumption that the mechanisms employed by parasitic organisms have 
been developed over evolutionary time to be able to serve the parasite in terms of immune 
modulation and evasion. As such the establishment of an infectious organism within a 
host depends on the abilities of both the parasite and the host. In order to understand the 
subtle mechanisms involved at the host parasite interface both parasite derived and host 
derived components must be investigated. The release of functional products from 
parasites has long been thought to significantly confer a major physiological adaptation to 
survival within the host. 
For these reasons, a number of excreted components have long been of interest to 
investigators. Proteases, in particular cysteine proteases have attracted a lot of interest due 
to the vital biological roles that they play both in the extracellular and intracellular 
environments. Of all the cysteine proteases the papain family is probably the best 
characterised (Barret and Rawlings, 1996). 
Members of the Cl family of the CA clan have been shown to play vital roles at the host 
parasite interface (Barret and Rawlings, 1996). 	Cysteine proteases isolated and 
characterised from the protozoan parasite Entamoeaba histolytica were demonstrated to be 
released during infection. These proteins were shown to be responsible for the formation 
of liver abscesses in SCID mice (Stanley et al., 1995) and also in modulation of the host 
immune response by degradation of the anaphylatoxic complement components C3a and 
C5a (Reed et al., 1995). The effect of degrading the complement components initiates the 
activation of the alternate complement pathway which promotes lysis of the 
nonpathogenic, but not pathogenic strains of the parasite (Reed et al., 1995). 
The ability of parasitic nematodes to penetrate and/or migrate within the host has been 
linked with parasite derived proteases. Such proteases have been identified and partially 
characterised in a number of systems (Haffner et al., 1998) including Toxocara canis 
(Robertson et al., 1989). An excellent example of host penetration and tissue migration is 
demonstrated in the parasitic nematode Strongyloides stercoralis, in which the parasite has 
been shown to travel at speeds in excess of 10 cm per hour through the dermal 
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extracellular matrix (McKerrow et al., 1990). The proteases involved in this process are 
thought to be neutral metalloproteinases, of which a homologous metaloprotease has been 
found in Onchocera volvulus, a leading cause of blindness and chronic dermatitis in both 
the African and South American continents (Haffner et al., 1998). 
The components that comprise parasite excretory/secretory antigens are not restricted to 
proteases. A number of novel products have also been identified. The parasitic nematode 
Strongyloides venezuelensis secretes a glycoprotein mucin-like substance with strong 
adhesive properties (Maruyama and Nawa, 1997). Further characterisation of this 
mucosubstance is required although investigators hypothesis that the secretion has roles in 
the invasion and establishment of the parasite in the host epithelia (Maruyama and Nawa, 
1997). 
6.0.2 Future work 
Just over 53% of the clones identified from the EST project had known homologues in the 
database. These included a number of metabolic and respiratory enzymes, remarkably few 
structural proteins and no DNA replication proteins. This finding is consistent with the 
developmentally arrested state of the parasite. There were also a small number of 
transcripts that were heavily represented within the library. Of these the novel C-type 
lectin, TES 32 (Loukas et al manuscript submitted) was the second most abundant 
(16/261= 6.1%). Work has been planned to determine the host ligand or ligands for 
which TES 32 is the receptor, and thereby determine a putative role for this novel lectin. 
A detailed description of these genes can be found in Chapter 3. 
Included as part of the 53% of the clones with identified homologues were a group of 
clones for which functions within the nematode system were not intuitively obvious. It is, 
however, assumed that at least some of these genes will prove to be valuable subjects for 
immunological and biochemical studies. 	These included three venome allergen 
homologues; lupus autoantigen homologues; epithelin/granulin precurser homologues; 
olfactomedin; and the tubby-like protein, which bears homology to the mouse obesity 
gene. A number of these clones have been partially characterised in terms of gene 
structure (Chapter 3). In order to investigate the potential function of thses clones, the 
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most likely stratergy will involve a two pronged approach. Firstly, full-length transcripts 
will be cloned into appropriate vectors and antibodies raised to recombinant proteins or 
against DNA vaccine vectors. At around the same time proteins purified from the cloned 
constructs would be submitted to an appropriate institute (e.g. ICMB, Edinburgh 
University, BBSRC centre for structural biology, UCL), for the construction of 3 
dimensional structures. It is theorised that from the 3D structures created using nuclear 
magnetic resonance (NMR), crystalography, or electron microscopy putative functions of 
these molecules can be better elucidated. Antibodies raised against these molecules can be 
used to further characterise these genes in terms of distribution within the parasite as well 
as to determine putative functions. 
Five clones for which homologues were identified but for which functions within the 
nematode system were not obvious proved to be of interest. Of these clones, 
granulin/epithelin precursor, lupus autoantigen homologue, olfactomedin, interferon-
related protein and the tubby-like protein, only olfactomedin and the epithelin/granulin 
homologues have been partially characterised in terms of gene structure (see Chapter 3). 
The first step is to obtain full-length sequence for these clones. Following this they will 
be expressed and antibodies raised in order to further characterise these genes in terms of 
location and function within the parasite. 
The abundant novel transcripts (see Chapter 4) represented by four clusters (ant-003, - 
005, -030, -034) represented 2.7 - 5.7% respectively. Of these ant-005 has been cloned 
into the DNA vaccine vector pcDNA3.1(-) (Invitrogen) and shown to be a component of 
TES. Work is presently ongoing to clone the remaining members of this novel clad and 
raise antibodies in order to be able to localise and deduce putative functions for them. This 
work is presently ongoing. 
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6.0.3 Conclusion 
The scope of substances secreted by nematode systems represent a very complex antigenic 
mixture designed to enhance the parasites ability to survive the inhospitable environment 
that is the host defence machinery. In order to be able to apply suitable strategies for the 
effective treatment and/or control these ingenious organisms investigators must first 
understand them. The generation of the Toxocara canis EST database provides a major 
step forward towards the beginning of a comprehensive database of biological 
information. 
In depth genomic analysis of nematodes is still in its infancy. Although with the 
completion of the C. elegans genome the significance of such ventures have been well 
advertised (Blaxter, 1998). Analytical tools are available and are also constantly being 
improved that will improve the rate at which genome projects are being completed. It will 
also allow questions to be asked of the T. canis genome in terms of the presence or 
absence of operons and the nature of the promoters. Thus shedding light on the gene 
organisation of the parasite. This level of further characterisation of the genome will 
enable the identification of gene loci through which possible variations across T. canis 
isolates can be mapped in terms of geography and between canid species. 
It should be noted that the EST approach could enable researchers to identify 'new' gene 
sequences more rapidly than whole genome sequencing. Care should be taken that the 
relevance of abundant clones is not over-emphasised. The lack of complete genome 
information means important experiments such as transgenics cannot be performed. 
Although an excellent nematode transgenic model exist in C. elegans, the potential benefits 
of having a parasite model in which transgenics experiments could be performed should 
not be ignored. 
Clones isolated from the EST project have been submitted to the dbEST public database 
and are available to investigators on request. The main aim of this project was to enhance 
existing knowledge about Toxocara canis and other zoonotic parasites in global sense. 
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Appendix 
Chapter 2: Materials and Methods (pp.39) 
Solution M (Main Gel) 
480 ml 1MHCL 
	
363.3 g 	Tris base 
8 g Sodium dodecyl sulphate (SDS) 
Adjust pH to 8.9, make up volume to 1000 ml with water. 
Solution S (Stack Gel) 
121.1 g 	Tris base 
pH to 6.8 with HCL 
8 g 	SDS 
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Larvae of Toxocara canis, a nematode parasite of dogs, infect humans, causing visceral and ocular larva 
migrans. In noncanid hosts, larvae neither grow nor differentiate but endure in a state of arrested development. 
Reasoning that parasite protein production is orientated to immune evasion, we undertook a random sequenc-
ing project from a larval cDNA library to characterize the most highly expressed transcripts. In all, 266 clones 
were sequenced, most from both 3' and 5' ends, and similarity searches against GenBank protein and dbEST 
nucleotide databases were conducted. Cluster analyses showed that 128 distinct gene products had been found, 
all but 3 of which represented newly identified genes. Ninety-five genes were represented by a single clone, but 
seven transcripts were present at high frequencies, each composing >2% of all clones sequenced. These high-
abundance transcripts include a mucin and a C-type Jectin, which are both major excretory-secretory antigens 
released by parasites. Four highly expressed novel gene transcripts, termed ant (abundant novel transcript) 
genes, were found. Together, these four genes comprised 18% of all eDNA clones isolated, but no similar 
sequences occur in the Caenorhabditis elegans genome. While the coding regions of the four genes are dissimilar, 
their 3' untranslated tracts have significant homology in nucleotide sequence. The discovery of these abundant, 
parasite-specific genes of newly identified lectins and mucins, as well as a range of conserved and novel 
proteins, provides defined candidates for future analysis of the molecular basis of immune evasion by T. canis. 
Toxocara canis is a common nematode parasite of dogs and 
related species. Adult worms live in the gastrointestinal tract, 
releasing eggs which enter the environment by the fecal route. 
Within the eggs, larval T canis develop over a 2- to 3-week 
period (27). Embryonated eggs are then infective if ingested by 
a new host, as larvae hatch in the stomach and penetrate the 
epithelial layer. T. canis larvae show a remarkable lack of host 
specificity, infecting a wide range of taxa, including humans 
(27, 28). In the definitive (canid) host, larvae may mature by 
migrating to the intestine and developing to the adult stage; 
such maturation is favored in pups and in reproducing females 
(40). In most other dogs and in all paratenic hosts such as 
humans, development is arrested at the larval stage. 
The arrested stage is remarkable for surviving for as long as 
9 years in vivo (7), without reproduction or differentiation and 
without succumbing to attack by the host immune system. This 
diapausal state is mirrored in vitro, where larvae survive for 
many months in serum-free medium, secreting quantities of 
excretory-secretory antigens which have been characterized in 
biochemical (5, 50, 58) and immunological (44, 45, 56) terms. 
We hypothesized that in the absence of cell division, tissue 
growth, or gametogenesis, a significant proportion of larval 
protein production, and therefore mRNA, is likely to be di-
rected at immune evasion. To characterize abundant mRNAs, 
we conducted a small-scale expressed sequence tag (EST) 
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Kingdom. Phone: (44) 131 650 5511. Fax: (44) 131 650 5450. E-mail: r 
.maizelsfued.ac.uk. 
t Present address: London School of Hygiene and Tropical Medi-
cine, London WC1E 7HT, United Kingdom. 
Present address: Molecular Parasitology Unit, Queensland Insti-
tute of Medical Research, Queensland 4029, Australia. 
project. EST sequencing was pioneered for mammalian cells 
(1, 2) and Caenorhabditis elegans (49) and is an important 
component of major parasite sequencing projects (15, 18, 22, 
23, 46, 64). By this means, we have identified a series of abun-
dantly expressed genes from larval T canis, among which are 
likely to he important mediators of parasite immune evasion. 
MATERIALS AND METHODS 
eDNA library. T. canis larvae were hatched and maintained in vitro as previ-
ously described (20, 50) for a period of 6 months, with weekly changes of 
serum-free medium. From 200.000 cultured T. canis larvae, using a single-step 
guanidine-phenol-chloroform extraction, 265 g of total RNA was recovered, 
from which 6 l.Lg of poly(A) RNA was isolated by oligo(dT) chromatography. 
eDNA synthesized from this mRNA was unidirectionally cloned into the Uni-
Zap XR phage vector, using packaging extracts from Stratagene. The amplified 
library contained 1.9 x tO° PFU/ml with 91% recombinants. The possibility of 
host contamination was essentially eliminated because eggs were first incubated 
in vitro in formalin. and once hatched, larvae were cultured in serum-free RPMI 
1640 medium. 
Isolation of cDNA clones and in vivo excision of phagemids. Single clones were 
randomly picked phage from the plated out eDNA library. Phagemids were 
rescued in vivo by using ExAssist helper phage and nonsuppressing Escheridua 
coli SOLR (Stratagene). 
Selection and maintenance of clones. Plasmids were prepared from overnight 
cultures by using a Qiaprep Spin Miniprep kit (Qiagen) and stored at —20CC. 
Insert sizes sverc determined by PCR using vector primers (M13 reverse and M13 
forward primers or T3 and T7 primers). In the few cases where insert sizes could 
not he determined by PCR, restriction digestion of purified recombinant plas-
mids was performed with Xbal and Xhol (Promega). All clones are available to 
the research community on request. 
Sequencing. Plasinid templates were sequenced by using dye terminator cycle 
sequencing chemistry with Amplitaq DNA polymerase (FS enzyme) on an ABI 
377 automated sequencer (Applied Biosystems. Foster City, Calif.). Both 5' and 
3' ends were sequenced in some cases where 5' sequences gave high-quality 
sequence through the poly(A) tail or where the 5' sequence showed unequivocal 
identity with a previously characterized T canis clone. 
Analysis. SeqEd version 1.0.3 (Applied Biosystems) was used to edit out vector 
sequence and flanking sequences. Sequences were aligned by using Assent-
blyLign and MacVector 6.0 software (Oxford Molecular). Nonredundant data-
base searches used ungapped BLAST (basic local alignment search tool) (3) on 
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the National Center for Biotechnology Information server. Nucleotide sequences 
were subjected to BLASI'X searches against the GenBank or (non redundant) 
protein database. Nucleotide sequence searches used BLASTN (on both nr and 
dhEST databases), and deduced protein sequence from any unambiguous open 
reading frame was used to search with TBLASTN (against the nr nucleotide 
database). 
Nomenclature. Gene naming follows the convention for nematodes (Il. 14) of 
a three-letter name and a nuosher, and a prefix indicating the source organism, 
in this case Te. Genes are denoted in italics: proteins are capitalized. Three sets 
of interim gene names were used where no functional homology exists: Tc-not 
novel transcript). Tc-ant (abundant novel transcript, where ml clones of 263 are 
identical), and 'Ii-lwf (homolog of unknown function, where similar sequences 
have been found in other nematode species). For interim gene designations, the 
number of the EST clone first sequenced is retained; for cDNAs assigned func-
tional names, clones are generally numbered sequentially (e.g., 'ic-ri/-I and -2 for 
C-type lectins), except where numbering is significant in other organisms, prin-
cipally for rihosonial proteins (e.g.. 'I'c.rp.s-4. -5, and -9 to conform with estab-
lished nomenclature). 
Database deposition. All sequences have been deposited in NCBI dhEST (17) 
with separate entries for 5' and 3' reads. 
RESULTS AND DISCUSSION 
Sequencing and similarity searches. A total of 261 clones, 
containing inserts ranging from 128 to 2,050 hp, were taken for 
analysis once nonrecombinant and chimeric clones were dis-
carded. All were sequenced from the 5' end, and 218 were also 
sequenced from the 3' end. Most similarities were found, or 
were stronger, with the 5' sequences, but a significant minority 
of similarity relationships were found only with 3' sequence 
reads. In general, a probability value of 10 ° was sought as a 
minimum degree of similarity. 
Clustering analysis. EST sequences were clustered on the 
basis of nucleotide identity. It was noted that in some of the 
larger clusters, identity of the 3' sequences was critical to 
correctly group differentially truncated clones with nonover-
lapping 5' sequences. 
As a result of these analyses, a total of 128 distinct gene 
products were identified. Of these, only three, mucin 1 (Tc-
muc-1 1251), phosphatidylethanolamine-binding protein (Tc-
peb-1 [26]), and the fiOS ribosomal protein L3 (Tc-rpl-3 [51]), 
have been previously characterized. Approximately 50% (65/ 
128) of the total number of genes have informative similarity to 
genes of known function from other species, a further 17 
clones have database homologs of unknown function, and 47 
genes (37%) show no similarity to known genes; among this 
last class, designated novel genes, 4 were classified as abundant 
transcripts (see below). 
Abundant transcripts. A small number of transcripts are 
heavily represented in the library. Just 8 transcripts (6.2% of 
genes) account for 102 clones (39.1%) sequenced, while the 20 
most abundant (all those isolated three or more times) ac-
counted for 143 clones (54.8%). Table I presents the tran-
scripts characterized in order of frequency, with the most 
highly sampled clone being cytochrornc c oxidase subunit II 
(25/261 = 9.6% of clones), which is a mitochondrial DNA-
encoded gene in other nematodes (36, 52). The second most 
common clone is a C-type lectin (16/261 = 6.1%) which in 
work to be published elsewhere we demonstrate encodes the 
major surface and secreted glycoprotein of T. canis larvae, 
TES-32 (42). 
Abundant novel transcripts. Unexpectedly, four more abun-
dant clones are all novel, with no similarities in the database or, 
in the coding regions, to each other. These transcripts each 
represent between 2.7 and 5.7% of ESTs and together account 
for more than 18% of the library. They have consequently been 
designated ant genes and retain the number of the EST clone 
from which they were first isolated (ant-003, -005, -030, and 
-034). 
The four ant genes differ in length and composition, but all 
TABLE 1. Frequency of transcripts 
Transcript 
(gene) 




Cytochrome c oxidase subunit 11 (cox-2) 25 9.6 
C-type lectin, TES-32 (cli-1) 16 6.1 
Abundant novel transcript 003 (ant-003) 15 5.7 
Abundant novel transcript 034 (ant-0.14) 13 5.0 
Abundant novel transcript 030 (ant-030) 13 5.0 
Abundant novel transcript 005 (ant-005) 7 2.7 
Mucin I, TES-120 (muc-I) 7 2.7 
Phosphtitidylethanolarnine-hinding protein, 5 1.9 
TES-26 (jmb-l) 
Novel transcript 095 (not-095) 4 1.5 
Protein tyrosinc phosphatase (pip-1) 4 1.5 
60S ribosomal protein L19 	'p!-]9) 4 1.5 
ADP/ATP transbocase (nut-1) 3 1.1 
ASP homolog ETC-CRISP (salt-1) 3 1.1 
Mucin 2 (niuc-2) 3 1.1 
Novel transcript 018 (not-018) 3 1.1 
Novel transcript 120 (not-120) 3 1.1 
61/S ribosomal protein P0 (ipp-O) 3 1.1 
Superoxide dismutase 3 (sod-3) 3 1.1 
Tubulin alpha-3 chain (tua-3) 3 1.1 
14 transcripts present as two clones" 28 10.7 
95 transcripts present as single clones 96 36.7 
Total no, of clones sequenced 261 
"The 14 genes present as two clones are aki-], ash-2, cap-i, liuf-OO], up-I. 
,nuc-3, not-069, not-216, ofin.I, pa/n-], pcc-I, rpl-7a, ,p/-9, and sod-4. Details for 
these, apart from not genes, are given in Table 3: details for ash-2 and hufOOI are 
in Table 2. 
are 1.6 kb or more in length. The characterization of their 
full-length sequences, and of the protein products encoded by 
these genes, is currently under way, as none of the ESTs iso-
lated include 5' methionine start codons. Figure 1 presents a 
map of the EST clones isolated for each ant gene. From this it 
can be seen that 3' sequencing proved essential in identifying 
all members of the cluster, because 5' sequences do not in all 
cases overlap. Because the multiple clones all have different 5' 
termini, the abundance of these transcripts appears not to be 
an artifactual amplification of single clones in the construction 
of the library. 
Homology in 3' UTRs of the four ant genes. Although ant-
003, -005, -030, and -034 showed no similarities between coding 
regions, the 3' untranslated regions (UTRs) of all four genes 
bore significant levels of identity. It is notable also that none of 
these 3' ends contain consensus polyadenylation motifs such as 
AATAAA or similar sequence. This is not unprecedented 
among nematode genes: a recent survey of C. elegans 3' UTRs 
found that 7% of mRNAs bore no identifiable polyadenylation 
signal (16). 
An alignment of the 3' coding regions and UTRs of these 
four transcripts shows little identity in coding region nucleo-
tides (Fig. 2A) or amino acids (not shown) but similar se-
quences in all four genes immediately after the stop codon 
(Fig. 213). No similar sequences were found in any other T. 
canis genes or in genes from other organisms such as C. el-
egans. In C. elegans, there are examples of 3' UTR motifs 
associated with repression of translation in genes such as ira-2 
and fem-3 in germ line cell differentiation (4, 68). This is 
unlikely to be a useful parallel for the T. canis ant genes, as 
there is no similarity in 3' UTR sequence between the two 
species and there is no gonadal development in the larval stage 
of T canis. Translational suppression of the ant genes would be 
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FIG. , 1. Alignments of clones corresponding to ant-003. -005. -030. and -034. Segments sequenced in single-pass reactions are lightly shaded; unsequenced portions are shown unshaded in broken lines. Darker shading 
corresponds to 3' UTRs. The position and codon of the stop signal are indicated for each transcript. Numbers to the left of the bars indicate the approximate start of the eDNA relative to the longest clone. No start 
codons have yet been identified for any of these genes, and hence numbering is provisional. Note that without 3' sequence data, the longer EST clones belonging to ant-005 and ant-034 would not have been recognized. 
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A. 3 coding sequence (250 nt per transcript) 
70 	 20 	 30 	 40 	 50 
	
ant-003 	 C A I A AT C TG C C C T C G C A I T C C C C 13 0 A T T C CHTA A AGHIG~A A
ant-005 A T A C C C T A T C A A T C T T C (06 C T C 0 A C C A T C I C C A G C T C C I A C AC T A A1 A
ant-030 	C T T T T T C C C A I T C C C A A A A A 0 T I A A G C I T - A A A C C C I A - C C G G TC A
ant-034 C T T T C G C A C C AF1G A A A C T 0 A G A C I C C C T T A T T A T C A C CFlA A 0 
60 	 70 	
]8 






ant-005 CGTATAATATAC AGCC, ACGATGTCCAA(7GCATAGATATCCAAAACCACG 
ant-030 CATTTCAAAC(C ATICCACGAGC,(1TGAA((,C-ACCTCCTGCA(ATTGAA 
ant-034 ATCGTCACTTC;TTTCTAAAACCCCT(AAACrT00000TATCAAA(IATG46 
ItO 	 120 	 130 	 40 	 150 
ant-003 	A T A C AC 0 (0 T A C CC T T C A C C I G A T T A A C T (0 C A C T A T TjA C A C T T C. (I C C C T 
ant -0 05 C I T A C C A T (0 T A T 0 C T C A A C C T A T C A G A - A C A T G C A T C C A C C A A A C 13 T A I C 
ant -030 	0 C C A - T T 0 A G C (0 C C C T A A C I A T C I G A - A (0 A A A 0 G A C T C C C C A A C A C T C C 
ant 034 G AG C AT C A C CF1A GA A C A T C A G G A C A A A - T C IC A A C C CT C 113 C A A C A C T I T 
160 	 170 	 780 	 790 	 200 
ant-003 	T T C T 13 G I A I I 0 C C C CT C A T GA T C G I T T C GA C A C A I (0 A A C G A A C AA I T T C 
ant-005 AAGATAGAACtOAI- -TTGTGACTT2T- - -GAACACTOCCTCAGT-45AICAC 
ant-030 	GAGAGAGCAAGGTGATCTTC.CATTTTACGAGCAATGGCTGAC -- AACCAC 
ant-034 G 0 T A C C A T C A T I I 1 0 A T C C A A C A I C 6 1 0 1 A G A A (1 1 A A A I C I C C I A C I I (1 1 
210 	 220 	 230 	 240 	 250 
A C A C G C T I T TF'T[1C A A (IA (6 A AlA A11A C C C C T C AIlA C G T CIT[C T AC T an -0 03 	
UTTGAFT T 13 G A[ICIAlC AT (, 1G A A1CIAIC G A GIlT A (FT CIAA 
C T -[A C CJT1CIA lIT (5ant-005 
A A T AIG A A C C CJT T T .\FTG A A G1[. jC C C GITIA C TfjG AC - 01116 A TICICT]TICant -0 30
ant-034 	I01GG A G CG 0 T T C Ajfj3iAf( C C A A CWA C C - - (5 A A C - 	j ARC gJG3Jt5 A 
260 
ant-003 CGTCATC.L&.&. 
ant-SOS 	C C C T C CrAG 
ant -030 T T C T  
ant -034 	CIJT A C AG TAG  
B. 3' untranslated sequence (220 - 281 nt per transcript 
tO 	 20 	 30 	 40 	 50 
ant-003 
ant -005 	TA GA C T C C A C T I I T C C C A C A C C I T A C A A A T C A A A A A A C A T T T C C C T C A C C 
an -030 
ant -034 	 T A C A 
60 	 75 	 80 	 90 	 tOO 
ant-003 	 TAATT( AAAATTTCCTTCTAAA(TTCIrGCITT - IIITA 
897-005 CCC,ACAGCTAAGACAGCC,(AAAATATGCCATT - TTTCTTCAATT CAA 
ant -030 	 T 13 A A 1 T C C (0 C A A C A G C (1 A T T T I C C A A T I C I C A 
an 034 TGAATCCTATCATCCCA(5,C,( ( (SAC ACGTAACACA(SC,CCAGAAACATCTAT 
110 	 722 	 130 	 740 	 i5o 
ant-003 	- TX C Al T TIC I T I C TA A CIA GA - - - A CMC T;~A2A A A 4 C C C C A A C T T AGO T C 
ant -005 A I T I I T I C T I C I T I C T A A C A C A T GA A CAA A'.A C C C T G A C T I C C C T C 
ant-030 	C 1 1 1 C A A A C I T C I T C. A A T T A C A A A A A A T C A A --- T A A (0 C 1 13mG 13 A 
ant -034 0 1 1 1 6 TA A C n I I A T C A 1 5 A A A 6 Ci A 0 A C(6 C Ci A G 	Ci C A (1 C C C C C T 
160 	 770 	 18 	 150 	 25 
ant-003 	TTGACACAGCACCCTTCAAGGACACC- AGC13EAGC1AAGACil CGCCITTGTAI 
ant -005 T T C 
A 
C A A C C C A C C T C I CA A CC A I C A A T A CC C T AmC TA A C T C C C C TELl (1 T A 
ant-030 	CTGCTTCG - TCAACTTTATCCTG --- TAGCCTACCCGAAAGAGGCjTi5T1 
891-034 CT(CACTATCTCAACACACATGC---------.CCTAC(TACIAG A G(;AFiCTC AA 
270 	 225 	 2(5 	 240 	 250 




- -  - -ICGGAOI-  T
ant -005 13 C C - C CC I TIA I I C A I C C T T A CC A (6 A C T A --- - --A I CC iSA 	- 	 T C CC C
aot-030 	C. C C - I - GA CIA T I C AT C FT C C, CT GAGACIA 	 C_A C TO A C A A C C A CC 
ant -034 1 CC T C C C C A5T T C A T T CS C, TA CT GA C A C IA C C T C CT I C A A C T C - A C C A C C C 
260 	 270 	 280 	 280 
ant-003 	CT CIT F F; A Aj 6 C, F C A A C C]6 A C C C A A C C A A A A A A A A A A A A A A A A A A A A 
an -005 CT TEL? C, AjA 6 A I I. A A (gjT I C C C A A C C A A A A A A A A A A A A A A A A A 
ant -030 	C. C GjT (1 A[fo 1 13 C CmA cE F C T T I C A A A A A A A A A A A A A A A A A A A A A A A 
an -034 CIT T C A AIC C T C C A A C CI.\ TmA I C I A A A A A A A A A A A A A A A A A A A A A A 
FIG. 2. Alignment of 250-nucleolide (81) 3 let ni sal CodiliC seqicnec'. (A) and complete 3' UTRs (B) of the lour ant genes: identical settings were used for both 
a! gntslcnls in MacVector ('lustalW aligtttttent (gap penalty 	1(1(1. extend gap penalty - 5(1). The stop codoits at the end Of the codittg seqitetice and the beginning 
of the U'FR are Underlined. Bases identical in lit Fee OF four of the sequences are boxed and shaded. The polyadetiylated tail is showti boxed without shad ing. 
Homologs of genes of unknown function. Sixteen clones 	clone. One clone, Tc-hutOOl, contains a tandem array of four 
showed significant similarities to known nematode sequences blocks of 36 amino acids each containing six cystcines in iden- 
with no assigned function (Table 2). These were all designated 	tical alignment. This motif, termed the NC6 (26) or SXC (12) 
huf genes, retaining the number of the corresponding EST domain, is found in T canis and C. elegans proteins, particu- 
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TABLE 2. Homologs to proteins of unknown function in other nematodes" 
Gene Similarity to: 1' EST name I nsert size 
Read GenBank accession no. 
Tc-huf-001 NC6/SXC domain Tc-EST-001 800 764 666 AA683457 AA683458 
Tc-huf-012 C. elegans R515 gene 3.8E-06 Tc-EST-012 850 599 342 AA563573 A1374481 
Tc-I,uf-053 C. elegans CI3A10 gene 2.8E-38 Tc-EST-053 1.000 589 602 AA610971 AA610972 
Tc-1iuJ062 C. elegans F4ID9.1 gene 4.3E-42 Tc-EST-062 760 482 521 AA612566 AA907959 
Tc-/tuf-/59 C. elegans C56E6.5 gene 7.6E-I5 Tc-EST-l59 1.850 387 288 AA836705 AA836706 
Tc-ht/169 C. elegans K02E10.6 gene 6.2E-17 Tc-EST-169 1,050 466 393 AA874757 AA874758 
TcIiuJ252 C. elegans Y57G1 lC.12 gene 7.7E-30 Tc-EST-252 1.150 547 558 AA684533 AA684534 
Tc/t uJL264 C. elega,ts B0034.3 gene 1.4E-25 Tc-EST-264 1,420 589 444 AA684531 AA684532 
Tc-1itiJ287 C. elegans K12H4.5 gene 5.3E-23 Tc-EST-287 452 429 416 AA875794 AA979711 
Tc-hiif-296 C. elegans T24F1.6 gene 1.9E-l1 Tc-EST-296 2.300 259 491 AA875806 AA875807 
Tc-Ituf-302 malayi MBAFCE2BO9T3 2.3E-29 Tc-EST-302 760 283 621 AA879342 AA879343 
Tc-Ittif-316 elegans T24D8.5 gene 3.7E-21 Tc-EST-316 720 542 578 AA874711 AA874712 
Tc-1iuF325 0. voirulus L3CAN05CO8SK 7.4E-47 Tc-EST-325 1,250 370 351 AA879368 AA879369 
Tc-ra/t-I C. elegans T05AI0.5 venom allergen/ASP homolog 4.6E-15 Tc-EST-269 1.870 459 590 Al 083044 Al 083045 
Tc-rah-2 B. ntalavi venom allergen/ASP homolog 1.OE-13 Tc-EST-303 1,600 550 699 A1083048 AI0$3049 
Tc-rah-3 B. malayi venom allergen/ASP homolog 4.7E-16 Tc-EST-249 650 507 512 A1083050 AI083051 
All cDNAs were isolated as single transcripts except iah-] (three clones), i'a/,-2 (two clones), and huf-ODI (two clones) 
larly those associated with nematode surfaces, but the function 
of the array is not known. 
In addition, we found three genes which show similarity to 
Ancylostoma secreted protein (ASP), which is associated with 
larval activation and development in other nematode species 
(10, 30, 31, 61). However, the I canis stage from which the 
eDNA library was made is developmentally arrested and is not 
analogous to activated hookworm larvae. This gene family 
shows similarity to hymenopteran venom allergens and, in 
common with members reported for Brugia malayi and On-
chocerca voh'ulris, has been designated va/i (venom allergen 
homolog). Tc-vah-1, previously reported as Tc-CRISP (cys-
teine-rich secreted protein) by Liu (39a), is remarkable for 
containing two NC6/SXC domains in tandem with a VAH 
homology unit. Further characterization of these clones, Tc-
va/i-], -2, and -3 is in progress (51a). 
Other novel genes. A total of 43 additional transcripts were 
found to have no significant similarities to any other sequences 
deposited in GenBank nr protein and dbEST databases. These 
were present at between one and four copies in the 261-mem-
ber data set from I canis and are designated not genes. Fur-
ther studies on selected clones, such as not-018, for which 
antibodies to the protein product strongly recognize I canis 
larval excretory-secretory antigens (61a) are ongoing. 
Homologs of known genes. Sixty-five genes with database 
homologs were found; these are listed in Table 3. There are 23 
metabolic and respiratory enzymes but remarkably few struc-
tural proteins (only actin, calponin, and cx-tubulin) and no 
DNA replication proteins, consistent with the arrested state of 
the larval parasite. The various categories of genes are de-
scribed below. 
Mucins. A mucin gene, Tc-muc-]. has previously been re-
ported to be abundantly expressed by I canis larvae (25). 
Consistent with this, seven clones of Tc-muc-1 were recorded 
(2.7/ of the library). Three new mucin genes were found 
among the EST clones, each of which contains similar mucin 
domains and flanking NC6/SXC domains (26). The mucins 
differ in the composition of repeat motifs, and in the number 
and positions of NC6/SXC domains, and work in progress 
indicates that all are members of the TES-120 glycoprotein 
family associated with the parasite surface coat (40a). 
C-type lectins. One of the most abundant transcripts (16/ 
261) was found to correspond to peptide sequence obtained 
from TES-32, a prominent secreted glycoprotein. These ESTs  
showed weak similarity to C-type lectins, but the homology was 
firmly established from full-length sequence. A detailed anal-
ysis of the functional lectin properties of TES-32/Tc-ctl-I has 
been submitted for publication (42). Two variants of this se-
quence, designated Tc-ctl-2 and Tc-ctl-3, were also noted. 
Proteases. Proteolytic enzymes have been prominent in most 
studies of parasitic helminths at the biochemical (32) and mo-
lecular (43) levels. Three transcripts, with strong similarities to 
cathepsin L (41), cathepsin Z (43), and asparaginyl endopep-
tidase (19), were each present as single copies. Full-length 
sequences of the cathepsins L (41) and Z (22a) have been 
determined. A protease inhibitor similar to the aspartyl pro-
tease inhibitor of Ascaris and Brugia (Bm33) (21) was also 
isolated as a single clone. 
Transporters and receptors. One clone homologous to the 
acetylcholine receptors reported from other nematodes (24) 
has been isolated. A relatively frequent transcript (5/263) en-
codes Tc-PEB-1, a previously identified phosphatidylethanol-
amine-binding protein (26) which is present in parasite secre-
tions as a 26-kDa protein (TES-26). 
Structural proteins. Few structural proteins were identified 
in the EST data set, probably reflecting the arrested state of 
this parasite stage. Actin (67) and calponin (33) have been 
sequenced from other parasitic nematodes. For tubulins, most 
attention has focused on the 1-tubulins (29), with which benz-
imidazole resistance is associated. Tc-tua-] has strong similar-
ity to ce-tubulins from Haernonchus contortus (37) and C. ele-
gans. 
Protein synthesis and modification. Two genes essential for 
protein synthesis (elongation factors la and ib) were identi-
fied, as well as peptidyl-glycine alpha- hydroxylating monooxy-
genase, which modifies the C termini of peptides. Protein di-
sulfide isomerase is a well-known requisite for protein folding 
and correct formation of disulfide bonds. In C. elegans, the pdi 
gene is found in an operon with one cyclophilin gene (55); a 
homolog from 0. i'olvulus has also been characterized (65). 
Peptidyl-prolyl cis-trans-i some rase is similarly essential for cor-
rect protein conformation; the Tc-ppi-1 gene product is related 
to the FK506-binding proteins of mammals and not to the 
multigene cyclophilin family of peptidyl-prolyl cis-trans isomer-
ases described for C. elegans ( 55, 57). 
Glycolysis, respiration, and other metabolic and citric acid 
cycle enzymes. Some 18 distinct metabolic enzymes had very 
high levels of similarity to I canis ESTs and represent the 
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TABLE 3. Homology of T canis ESTs with known genes" 
Read 
Gene 	 Gene product 	 Closest species 	P 	
Clone 	Insert 
no. size 
GenBank accession no. 
Full-length 
5' 	3' 	verified 
sequence 
Mucin 1, surface coat T canis 6.3E-104 Tc-EST-087" 810 557 539 AA583105 AA907963 U39815 
TES-120 
Mucin 2 T. can/s 3.8E-49 Tc-EST-130" 990 612 694 AA583106 AA583107 AF 167707 
Mucin 3 T. canis 2.6E-36 Tc-EST- 162" 1,010 603 555 	AA583 It I AA583 112 AF 16770$ 
Mucin 4 T. canis 1.6E-45 Tc-EST-186 560 553 586 AA583108 AA583109 AF167709 
C-type lectin!TES-32 glyco- Tc-EST-209 830 615 393 AA874713 AA874714 AF041023 
protein 
C-type Iectin-2/variant of Tc-EST-036 780 596 618 A10788$0 A1078881 
TES-32 
C-type lectin-3/variant of Tc-EST-155 610 590 737 	A1080917 A1080918 
TES-32 
Asparaginyl endopeptidase Homo sapiens 3.5E-28 Tc-EST-262 1,300 520 64$ AA825116 AA875769 
Aspartyl proteinase inhibitor C. elegans 1.5E-09 Tc-EST-096 650 570 638 AA820019 AA820020 
Cathcpsin L cysteine proteinase 	C. elegans 2.3E-40 Tc-EST-013 1,150 604 390 AA563518 A1078$78 U53172 
Cathepsin Z proteinase 0. vol,'ulus 1.2E-73 Tc-EST-2((5 1,000 56$ 701 	A1080921 A10$0922 AF 143817 
precursor 
ADP/ATP translocase 	C. elegans 	 1.913-69 Tc-EST-041" 	750 515 663 AA603955 AA683466 
Acetylcholine receptor (tar-I) Trchostrongylus co/u- 1.2E-35 Tc-EST-121 1,300 529 547 AA835586 AA835587 
hrifo,-rnis 
Phosphatidylethanolamine- 	T canis 	 ME-76 Tc-EST-1645 1,200 406 459 AA864177 AA86417$ U29761 
binding protein (TES-26) 
Actin C. elegans 1.3E-$1 Tc-EST-097 1,450 524 AA820021 
Calponin Me/oidocyne javanica 4.2E-21 Tc-EST-292" 621) 462 537 AA875799 AA907961 
Tubulin alpha-3 chain Cricetulus griseus 1.513-69 Tc-EST-297" 1,500 4011 439 AA979712 AA907952 
Elongation factor la C. elegans 3.5E-84 Tc-EST-300 1,600 49$ 572 AA879374 AA879375 
Elongation factor lb C. elegans 3.1E-42 Tc-EST-081 830 355 756 AA8$$759 AA888760 
Peptidyl-glycine alpha-hydrox- Drosophila ine/ano- I. 1E-07 Tc-EST-200" 420 385 357 AA874705 A1080786 
ylating nsonooxvgcnase ga ster 
Protein disulfide isomerase Gal/us gal/us 5.9E-18 Tc-EST-235 474 445 468 AA874740 AA874741 
Peptidyl-prolyl cis-trans M,,s musculus 3.2E-15 Tc-EST-019 1,200 319 AA563572 
isornerase 
Protein tyrosine phosphatase M. inusculus 5.9E-49 Tc-EST-1 18 1,590 589 628 AA820013 AA820014 
Acetyl coenzyme A acetyl- C. elegans 9.$E-33 Tc-EST-059 
transf erase 
Adenylate kinase isoenzyme I gal/us 9.2E-39 Tc-EST-32$ 
Aldehyde dehydrogenase Boa hovis 1.3E-45 Tc-EST-299 
Alanine aminotransferase C. elegans 4.OE-42 Tc-EST-294 
Cystathionine gansnla lyase C. elegans 6.4E-54 Tc-EST-090 
Cytochronie b 5 sapiens 4.5E-10 Tc-EST-032 
Fructose hiphosphate aldolase 0. volvu/us 2.IE-98 Tc-EST-183 
Fumarate dchydrogenasc H. sapiens 1.713-26 Tc-EST-237 
precursor 
Fumarate reductase, cyto- Ascaris suuin 2.9E-32 Tc-EST-0$3 
chrome b small subunit 
Glutamate dchydrogcnase H. contortus 4.7E-74 Tc-EST-026 
Propionyl coenzyme A carh- C. elegans 8.6E-64 Tc-EST-074 
oxylase 
Phosphoenolpyruvate carb- A. sawn 4.4E-69 Te-EST-004 
oxykinase 
Phosphoglycerate kinase Sc/,i,stosonia ,nansonl 1.8E-41  Tc-EST- 1(19 
Succinate dehydrogenase iron- A. suuin 3.CE-73 Tc-EST-166 
sulfur protein 
NADH uhiquinone oxido- Bos taurus 1.9E-39 Tc-EST-201 




















































626 626 560 AA610965 AA907958 
800 452 505 AA873889 AA873920 
1,700 559 360 AA979715 AA979716 
1,440 472 357 AA875802 AA875803 
750 555 685 AA583117 AA583118 
406 406 	AA569419 
1,010 480 533 AA915868 AA915869 
317 317 314 AA285389 AA874746 
1,560 452 480 AA888752 AA888753 
1,740 584 331 AA568090 A1078879 
1,560 320 399 AA888750 AA888751 
2,740 599 425 AA470327 A1374480 
1,400 576 805 AA8251 17 AA825 118 
630 518 423 AA8O4181 A1374479 
521 501 480 AA874708 A1080786 
Continued on fbi/owing page 
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TABLE 3-Continued 
Read 	GenBank accession no. 
Gene 	 Gene product 	 Closest species 	p 	Clone 	Insert Full-length 
no. size 	- 




Tc-atp-6 ATP svnthase A chain A. snuni 1.9E-68 Tc-EST-064 610 576 557 AA612565 AA979708 
(protein 6) 
Tc-cox-2 Cytochrome c oxidase 11 .4.suu,n 7.IE-75 Tc-EST-038 850 496 669 AA569422 AA569423 
Tc-uho-4 NADI-1-uhiquinonc oxido- A. suum 2.6E-29 Tc-EST-163 220 213 216 AA864175 AA864176 
reductase chain 4L 
Antioxidants 
Tc-sod-2 Superoxide dismutase 2 C. albicans I.5E-23 Tc-EST-084 850 401 340 	A1117$885 A1078886 
Tc-sod-3 Superoxide dismutase 3 Zea mars 2.IE-18 Tc-EST-100 900 449 608 A1080774 A1080775 
Tc-sod-4 Superoxide dismutase 4 C. elegans 3.6E-40 Tc-EST-143 804 630 520 A1050778 A1080779 
Tc-sod-5 Superoxide dismutase 5 C. elegans 2.4E-39 Tc-EST-266 900 731 730 A1080782 A1080783 
Ribosomal proteins 
Te-ip/-10 60S ribosomal protein L10 C. elegans 8.6E-44 Tc-EST-271 800 321 590 AA875777 AA875778 
Tc-rp/-19 60S ribosomal protein L19 M. mnusculus 2.IE-60 Tc-EST-244" 900 439 555 AA$74749 AA874750 
Tc-rpl-3 60S ribosomal protein L3 T canis 5.5E-60 Tc-EST-257 500 498 457 AA$75762 A11180789 	P49149 
Tc-ipl-31 oOS ribosomal protein L31 H. sapiens 4.8E-49 Tc-EST-072 580 440 491 	AA728649 AA728650 
Tc-mpI-37a fiOS ribosomal protein L37 S. mansoni 3.6E-34 Tc-EST-267 400 372 381 AA875772 AA875773 
Tc-rpl-7 OOS ribosomal protein L7A H. sapiens 7.2E-29 Tc-EST-054" 750 513 560 AA610961 AA907956 
Tc-i7)1-9 60S ribosomal protein L9 H. conforms LIE-54 Tc-EST-182" 630 396 480 AA873890 A1080784 
Tc-rpp-O 60S ribosomal protein p0 C. elegans 4.4E-35 Tc-EST-122" 1,100 476 552 AA835588 AA835589 
Tc-r7)p-2 60S ribosomal protein P2 B. mnalayi 3.6E-08 Tc-EST-088 288 288 275 AA907964 AA907965 
Tc-mps-4 40S ribosomal protein S4 C.ets 4.1E-61 Tc-EST-006 750 582 AA563574 
Tc-rps-5 40S ribosomal protein S5 C. elegans l.4E-70 Tc-EST-215 610 571 675 AA874719 AA874720 
Tc-,7,.s-8 40S ribosomal protein S8 H. sapiens 7.4E-66 Tc-EST-277 640 481 600 A1080929 A1080930 
Tc-r7)s-9 405 ribosomal protein S9 Rattus non'egicil.s 8.6E-38 Tc-EST-270 410 381 AA875776 
Others 
Tc-gep-1 Granulin/cpithelin precursor M. musculus 8.4E-31 Tc-EST-141 1,000 654 625 AA836692 AA836693 
Tc-/,ih-4 Histone H4 C. elegans 3.5E-60 Tc-EST-l74 250 444 459 AA557121 AA$73915 
Tc-lah-1 Lupus auloantigen homolog C. elegans 1.5E-22 Te-EST-177 450 607 520 A1083048 A1083049 
Tc-nips-J Metallopanstirnulin (=rps27) Stron,egloides raid 8.3E-41 Tc-EST-178 1,430 367 400 AA873918 AA979709 
Tc-ojin-1 Olfactomedin (FttC3.2) C. elegans 1.6E-54 Tc-EST-079" 1,870 479 628 AA728643 AA728644 
Tc-pth-I PC4/TIS7/"interferon-related M. mnusculims 4.IE-20 Tc-EST-0755  1.440 616 299 AA618627 A1078882 
protein" 
Tc-tlp.1 Tubby-like protein H. sapiens 1.6E-42 Tc-EST-242 1,530 506 585 AA874759 AA874760 
Numerous sequences for which closest species listed is not a nematode show a higher BLASTX score with a C. elegans sequence for which there is either no 
assignation or which is described as similar to the nonnematode sequence given here. One ribosomal RNA gene (Tc-EST-052. 5 AA610968. 3' AA610969) was also 
identified. 
Longest clone. 
major metabolic pathways of glycolysis and aerobic respiration, 
as well as essential processes such as amino acid synthesis and 
degradation. Particularly prominent among these is the mito-
chondrial cytochrome c oxidase subunit 11(25/261 = 9.7% of 
all clones). As mitochondrial mRNAs are not polyadenylated, 
the presence of mitochondrial DNA-encoded sequences in the 
eDNA library is difficult to interpret quantitatively. 
Antioxidants. Oxidative stress is highly detrimental to both 
parasitic (54) and free-living (34) nematodes. In tissue-dwell-
ing parasites, reactive oxygen intermediates from aggressive 
granulocytes may be countered by expression of antioxidants 
such as glutathione peroxidase and/or superoxide dismutase 
(SOD). Previous work characterized a SOD gene (Tc-sod-1) 
from I canis larvae and showed that no glutathione peroxidase 
activity or gene sequence was detectable in this parasite (47). 
The EST data set contained seven clones encoding SOD iso-
forms, all quite distinct from Tc-sod-1 (approximately 66% 
divergence in protein sequence) and more similar to C. elegans 
gene F55H2.1. The seven clones represent four distinct iso-
forms each showing 10 to 20% divergence in nucleotide and 
deduced amino acid sequence, including two-codon insertions/ 
deletions. This level of divergence and the presence of triplet 
insertions/deletions led us to designate these four isoforms as  
separate genes, Tc-sod-2, -3, -4, and -5. Confirmation of this 
assignation is under way. 
Ribosomal proteins. Twenty ESTs (comprising 13 different 
genes; 8.4%) encode ribosomal proteins. This is close to the 
range found with EST projects for other nematodes; for ex-
ample, 8.5% (1,339/15,811) of B. rnalayi ESTs deposited are 
ribosomal (12a), as are 5.0% (11/218) of Necator americanus 
ESTs (12a). 
Other proteins. Some ESTs had homology to mammalian 
proteins for which a function in nematodes is not obvious. Five 
particularly interesting findings were noted. 
Granulin/epithelin precursor (Tc-gep-1). Granulins are 
synthesized as large (500- to 600-amino-acid) precursors from 
which are derived seven small (-60-amino-acid) 12-cysteine 
peptides with growth factor-like activity (8. 9, 69). Mammalian 
and fish kidney epithelial cells are rich sources of these pep-
tides (8, 60), as are human and rodent leukocytes, suggesting 
that granulins may fulfill cytokine-like functions (6). If this is 
so, the synthesis of a granulin homolog by T. canis larvae may 
be important in the interaction between parasite and the host 
immune system. 
Lupus autoantigen homolog (Tc-lah-1). The lupus au-
toantigen (also known as Sjogren syndrome type B antigen) is 
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a highly conserved rihonucleoprotein which is a targct of au-
toantibodies in systemic lupus erythrcmatosus (39). As auto-
immune responses can be initiated by infectious agents (53), 
the expression of this homolog by T canis may he significant. 
Similarly, 0. volvo/us expresses the RAL-i product, which is 
homologous to the Sjogren syndrome type A antigen (48). 
Olfactomedin (Tc-ofm-1). A T canis member of the 
olfactomedin gene family was found. The prototype gene en-
codes a 57-kDa glycoprotein in the extracellular mucus matrix 
of the olfactory neuroepithelium of frogs (66), but additional 
homologs are widely expressed in mammalian brain (35). Tc-
ofm-1 shows maximum similarity to a C. elegans homolog. As 
T canis larvae produce high levels of mucins, including those 
constituting the surface coat (25. 59), Tc-OFM-1 protein may 
be involved with mucus layers in this parasite. 
PC4/TIS7/"interferon-related protein" (Tc-pth-1). A 
T. canis gene which is similar to a mammalian product de-
scribed as PC4 or TIS7, induced in cell lines by activators such 
as nerve growth factor or phorbol esters (63), has been iso-
lated. The same mammalian gene has also been designated 
interferon-related protein, due to an erroneous deposition of 
this sequence in 1985 as murine beta interferon (accession 
no. J00424). We have named the T. canis gene, which bears 
no similarity to mammalian interferons, pt/i-/ (PC4/TIS7 
homolog). 
Tubby-like protein (Tc-tlp-1). Recently, a new multigene 
family related to the mouse gene tubby has been recognized 
(38). Mutations in tubbt' in the mouse result in obesity and 
degenerative changes in adult life; however, the existence of 
conserved homologs in nematodes (including C. elegans) 
and in plants indicates that this gene encodes a protein 
which fulfills a fundamental-and as yet unrecognized-func-
tion in all higher organisms. 
Conclusion. The analysis of expressed genes that we present 
here has achieved its aims of identifying a number of abundant 
transcripts, one of which (al-1) corresponds to a major se-
creted product and four of which (ant-003, -005. -030, and 
-034) represent novel gene sequences. We have also made the 
first steps toward a comprehensive gene catalogue of a biolog-
ically intriguing and clinically significant parasite, providing a 
resource and springboard for future studies. 
The outcome of this study supports the proposition that the 
EST strategy is highly applicable to many metazoan organisms 
which have relatively large genome sizes (~10 hp) (13, 14), 
especially where interest is focused on genes expressed at mod-
erate to high levels. In addition, genes restricted to a life cycle 
stage can he identified in this manner. Further evidence for the 
success of this approach is seen in the Filarial Genome Project, 
which in 3 years has deposited in dhEST over 15,000 se-
quences, which are estimated to represent some 5,000 separate 
gene transcripts, or around 33% of the total gene complement 
of B. rnalayi (15, 62). The availability of the full genome se-
quence of C. elegans lends an exceptional opportunity to com-
pare free-living and parasite gene sequences and structure, 
with the potential to identify adaptations requisite for parasit-
ism at the molecular level. Along their evolutionary path, par-
asitic species must have developed a myriad of immune evasion 
mechanisms, and we anticipate that our study and others like it 
will be instrumental in identifying the novel immune evasion 
genes upon which parasite survival depends. 
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A novel C-type lectin secreted by a tissue-dwelling parasitic 
nematode 
Alex Loukas*,  Nicholas P. Mullint,  Kevin K.A. Tetteh*,  Luc Moenst 
and Rick M. Maizels* 
Many parasitic nematodes live for surprisingly long 
periods in the tissues of their hosts, implying 
sophisticated mechanisms for evading the host immune 
system. The nematode Toxocara canis survives for 
years in mammalian tissues, and when cultivated in 
vitro, secretes antigens such as TES-32. From the 
peptide sequence, we cloned TES-32 cDNA, which 
encodes a 219 amino-acid protein that has a domain 
characteristic of host calcium-dependent (C-type) 
lectins, a family of proteins associated with immune 
defence. Homology modelling predicted that TES-32 
bears remarkable structural similarity to mammalian 
immune-system lectins. Native TES-32 acted as a 
functional lectin in affinity chromatography. Unusually, 
it bound both mannose- and galactose-type 
monosaccha rides, a pattern precluded in mammalian 
lectins by a constraining loop adjacent to the 
carbohydrate-binding site. In TES-32, this loop 
appeared to be less obtrusive, permitting a broader 
range of ligand binding. The similarity of TES-32 to host 
immune cell receptors suggests a hitherto unsuspected 
strategy for parasite immune evasion. 
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Results and discussion 
Identification of TES-32 as a C-type lectin 
TES-32 is a 32 kDa N-glvcosylated protein secreted by 
tissue-stage T. canis parasites [1].  Secreted Toxocara excre-
tory—secretory (TES) products collected from larval T. canis 
in culture [2] were separated by SDS—PAGE, electrotrans-
ferred to PVDF membrane and the TES-32 band excised. 
Peptides from trvpsinised TES-32 were then separated by 
reverse-phase HPLC and sequenced. Peptide sequences 
were matched against a database of 250 expressed 
sequence tags (ESTs) from a larval T. can/s eDNA library 
[3]. Clone Tc-EST-070 (Tc-ct/-1) encoded one of the 
TES-32 peptides. On complete sequencing, Tc-ct/-1 proved 
to contain a full-length 762 bp eDNA insert, and to encode 
a second peptide derived from gel-purified TES-32. 
The deduced CTL-1 protein sequence comprises 
219 amino acids, including a putative 18 amino-acid signal 
peptide and three potential N-glvcosylation sites 
(Figure la). The amino-terminal portion (amino acids 19 to 
80) of the mature protein includes eight cysteine residues, 
four of which are in (V)CVAP-like motifs (using the single-
letter amino-acid code), and a short threonine-rich tract 
(Figure Ia). This amino-terminal portion shows no signifi-
cant homology to other known proteins. The carboxy-ter-
minal domain (amino acids 81 to 219), however, was found 
to have strong similarities to mammalian and invertebrate 
C-type lectins (CTLs), including the macrophage mannose 
receptor (MMR), CD23 and E-selectin (Figure ib). 
Maximal amino-acid identity was 31% (43/139) between 
amino acids 81 to 219 of TES-32 and the carbohydrate-
recognition domain (CRD) 8 of human MMR (amino acids 
1230 to 1359). The gene encoding TES-32 was therefore 
designated Tc-ctl-1. 
Antibodies to recombinant Tc-CTL-1 (rCTL-1) reacted 
with native TES-32 in Western blots (Figure 2), and with 
the 27 kDa recombinant protein (a dimeric form is also 
apparent). Furthermore, rCTL-1 was also recognised by 
monoclonal antibody Tcn-3, which specifically binds 
TES-32 [21 (Figure 2). The difference in size between the 
predicted mature Tc-CTL-1 protein (22 kDa) and the 
actual protein found in TES products can be attributed to 
N-glycosylation [4,5]. Monoclonal antibody Tcn-3 showed 
TES-32 to be localised to the parasite epicuticle [1]; an 
anti-rCTL-1 antiserum showed a similar surface-binding 
pattern (data not shown). Additional bands of 45 kDa and 
200 kDa were recognised in TES products by the anti-
rCTL-1 antiserum; peptide sequence data indicated that 
the native 45 kDa component is a second lectin derived 
from a distinct gene (unpublished observations). 
TES-32 is a bispecific lectin 
The lectin-like properties of native TES products were 
then tested on affinity columns of different monosaccha-
rides in a Ca2 -containing buffer. A 32 kDa protein was 
selectively retarded on a GaINAc column (Figure 3). Dis-
sociation from the ligand occurred slowly, with protein 
evident throughout ten column-volume washes, and was 
completed in the presence of EDTA. Binding was greatly 
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Sequence of Tc-CTL-1 and its similarity to 
other CTLs. (a) Amino-acid sequence of 
Tc-CTL-1 showing the signal peptide (pink), 
the CTL CR0 (grey shading) and N-
glycosylation sites (green lettering). Cysteine 
residues are yellow, the carbohydrate-binding 
motif is in white lettering on a blue background, 
and tryptic peptide sequences are red. 
(b) Alignment of CTLs. Cysteine residues are 
yellow; the five conserved Ca2 -ligating 
residues (site 2) in MBP-A are indicated by 
arrows (MBP-A numbering). The sugar-binding 
motifs QPD and EPN are in white lettering on a 
blue background. Residues that are identical 
between Tc-CTL-1 and the other CTLs are in 
white lettering on a black background; similar 
amino acids are shaded grey. The WIG motif 
(red shading) in Tc-CTL-1 is conserved with 
minor substitutions [10]. GenBank accession 
numbers: human MMR, M93221; rat MBP-A, 
Ml 4105; mouse CD23, M99371; human 
E-selectin, M24736. Ce W04E1 2.6 is a 
predicted protein from Caenorhabdifis ale gans. 
reduced when free Ga1NAc was added to the TES prod-
ucts before loading (data not shown). Surprisingly, the 
same 32 kDa molecule bound almost as well to 
D-mannose—agarose but not to unconjugated agarose alone 
(Figure 3). Although different affinity matrices may not 
hear comparable ligand densities, distinctly weaker 
Figure 2 
Identity of Tc-CTL-1 and TES-32. A western blot of native TES 
products (lanes 1,3 and 5) and of rCTL-1 (lanes 2,4 and 6) showing 
that both proteins are recognised by anti-rCTL-1 serum (lanes 1,2) and 
by monoclonal antibody Tcn-3 (lanes 3,4). Normal mouse serum 
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Carbohydrate binding by Tc-CTL-1. SOS—PAGE profiles of TES 
products after affinity chromatography on GaINAc—agarose, 
0-mannose—agarose or unconjugated agarose. Fractions of 1 ml were 
collected from a 1 ml column loaded successively with 4 ml loading 
buffer (flow-through), 10 ml wash buffer and 5 ml elution buffer. 
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binding of the 32 kDa protein was observed to GIcNAc 
and D-galactose compared with GaINAc or D-mannose 
(data not shown). Both the anti-rCTL-1 serum and mono-
clonal antibody Tcn-3 bound the 32 kDa protein eluted 
from both GaINAc and D-mannose columns, confirming 
that the retarded native protein in each case was 
1'i-CTL-1. In addition, a second 45 kDa protein, similar to 
the one detected in western blotting, exhibited weak 
binding to D-mannose (Figure 3), consistent with data 
indicating that it is encoded by a distinct lectin gene 
(unpublished observations). 
Structural conservation between mammalian and 
nematode lectins 
Co-crystallisation of rat mannose-binding protein-A 
(MBP-A) and an oligomannose ligand has identified the 
residues at which CTLs ligate Ca2 and saccharides [6]. 
We aligned the CRDs of 7-CTL-1 and CTLs with 
known structure, and modelled the CRD of T—CTL-1 
(Figure 4). In this prediction, Tc-CTL-1 shows a remark-
able structural similarity to MBP-A, with the major beta 
sheets and alpha helices being in corresponding positions. 
All CTLs possess a conserved Ca2 -binding site (designated 
Ca2 number 2) [71, and D- CTL-1 contains four of the five 
residues necessary to ligate Ca2 in MBP-A (Figure 4): the 
fifth Ca2 -binding residue cannot be determined from the 
alignment. But the similarity of this site to that of MBP-A 
indicates that sugar ligation by T(,--CTL-1 is likely to resem-
ble that observed in the crystal structure of MBP-A [6].  Both 
MBP-A and tetranectin, but not E-selectin, contain a 
second (auxiliary) Ca2 binding site (Ca2 number 1), which 
does not bind directly to sugar. This site appears to he 
absent from Tc-CTL-1 which in this regard is more similar 
to E-seleetin than to MBP-A or tetranectin. 
Figure 4  
CTLs can be loosely grouped into those that bind D-galae-
tose and its derivatives (Gal-type), and those that bind 
D-mannose, 1)-glucose and their derivatives (Man-type). 
The specificity of MBP-A, a Man-type CTL, is deter-
mined by calcium-binding residues at positions 185 and 
187 (NIBP-A numbering) [6] and by residue 189 and the 
adjacent loop [8].  Thus, Man-type CRDs typically have 
Glu185 and Asn187, whereas Gal-type CRDs have G1n185 
and Asp 187, with Trp- or Phe189 [8,9]. The mannose-spe-
cific MBP-A can be converted to bind galactose by 
replacement of residues at positions 185 and 187 with 
Gal-type residues, and rendered galactose-specific by 
gaining Trp189 and the adjacent five-residue loop from a 
natural galactose-binding lectin [8].  In Tc-CTL-1, this 
loop appears significantly modified. Thus, in place of a 
fold which brings His/Trp189 close to the ligand, the 
protein backbone in D.--CTL-1 is more extended and the 
bulky aromatic residue replaced by an unusual pair of eys-
teines at positions 179 and 180 (equivalent residues are 
189 and 190 in MBP-A). The predicted position of these 
cysteine residues is too distant for them to have a direct 
role in forming the binding site for Ca2 and saccharides. 
As a consequence of these changes, the ligation of 
Tc-CTL-1 to either Gal-type or Man-type saccharides may 
be unimpeded. Site-directed mutagenesis to convert this 
region of T(- CTL-1 would test this hypothesis. 
Biological significance of parasite lectins 
This is the first report of a gene encoding a CTL from a 
pathogenic organism; in contrast, most other CTLs are 
involved in host defence against infection [10]. The latter 
include the selectins, the low affinity IgE receptor CD23, 
the NK cell receptors Ly-49 and CD94, and antigen-pre-
senting cell lectins such as the MMR and the dendritic 
cell receptor DEC-205. Genes encoding CTLs have now 
Similarity of mammalian and nematode lectins. 
Structural model of the CRD of Tc-CTL-1 
based on the crystal structure of MBP-A. The 
Hisi 89 residue of MBP-A is close to the 
sugar-binding site, but no equivalent large 
residue exists in Tc-CTL-1. The conserved and 
auxiliary Ca2 -binding sites in MBP-A are 
depicted as black spheres. It is not yet known 
whether the two newly identified cysteine 
residues (Gysi 79 and Cysi 80) in Tc-CTL-1 
retain free SH groups, as shown. CRD 
sequences of Tc-CTL-1 (amino 
acids 81-219), rat MBP-A (M14105), human 
E-selectin (M24736) and human tetranectin 
(X64559) were aligned for the MODELLER 
program [19], and figures were produced 
using MOLSCRIPT [20]. Five separate models 
of Tc-CTL-1 with near-identical structures 
were produced, differing only in the carboxy-
terminal loop (residues 201 onwards). 
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been identified in invertebrates, including arthropods, 
molluscs, echinoderms and tunicates, and some of the pro-
teins encoded by these genes are thought to be involved 
in agglutinating pathogens [11]. The free-living nematode 
C. elegans contains 102 genes encoding CRD-like domains 
of C'lLs [12]. Interestingly, Tc-CTL-1 has only weak sim-
ilarity with these putative gene products, sharing greater 
identity with mammalian CTLs than with the closest 
C. elegans  homologue (Figure 2b). 
T. canis secretions contain a substantial glycan content 
-40% by weight [4]-and the predominant 0-linked 
glycan contains a terminal fucose which is 0-methylated at 
position 2 [13]. These carbohydrates are abundant on other 
secreted proteins such as mucins [2,141. As adjacent hydrox-
yls at carbons 2 and 3 of fucose (or 3 and 4 of other hexoses) 
are required for binding to mammalian CTLs[6], 0-methy-
lation may prevent the parasite lectin from binding to car-
bohydrate structures being secreted at the same time. 
It is intriguing that helminth parasites secrete proteins 
with significant homology to host molecules that are 
instrumental in the immune response against the very 
same pathogens. This finding suggests an exciting new 
parasite immune-evasion strategy [15]. Although there is 
much information on the role of host lectins in the innate 
and acquired immune responses to infectious organisms, 
little is known about the role of pathogen-derived CTLs. 
We are now investigating the potential host ligands of 7-
CTL-1, at both a molecular and cellular level, in an 
attempt to elucidate the biological function of this class of 
CTL proteins in host-parasite interactions. 
Materials and methods 
Parasites, protein sequencing and expression 
Larval I cams were maintained in vitro in serum-free medium, from 
which secreted TES products were collected [161. TES proteins were 
separated by SDS-PAGE and transferred to PVDF membrane as pub-
lished [17]. TES-32 was excised and digested with trypsin [17], and 
HPLC-purified peptides sequenced on an ABI-471-B sequencer 
(Applied Biosystems). The larval eDNA library made in Uni-ZAP XR 
(Stratagene) was a generous gift from C. Tripp and R. Grieve (Heska). 
The mature region of Tc-CTL-1 (Cys19-Leu219) was expressed by 
cloning into the pET-29T expression vector (Novagen), and purified on 
metal chelation columns. BALB/c mice were immunised with 
three doses of 10 .tg rCTL-1. 
Detection of lectin activity using immobilised monosaccharides 
Ligand-binding assays [18] employed 100 pg TES product diluted in 
500 p1 of low-calcium loading buffer (1.25 M NaCl, 25 mM Tris pH 7.4, 
2.5 mM CaCl2)  and applied to 1 ml columns of 4% beaded agarose 
cross-linked to GaINAc (Sigma A2787, 6 hydroxy-linked), GIcNAc, 13-o-
glucose or D-mannose (Sigma A2278, G2019 and M6400, respec-
tively; all hydroxy-linked). Columns were rinsed with 4 ml 2.5 mM CaCl2 
buffer and washed with 10 ml 25 mM CaCl2 buffer. Bound proteins 
were eluted with 2.5 mM EDTA in calcium-free buffer. 
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